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MicroRNAs (miRNAs) are small non-coding RNA molecules that exert regulatory 
actions in gene expression acting mainly via RNA silencing and post-transcriptional 
changes. Their actions are involved in important cell processes such as stress 
signalling, cell cycle progression, differentiation, and cell death. Mammalian gametes 
and pre-implantation embryos selectively express miRNAs that control oocyte 
maturation, spermatogenesis, fertilisation, embryonic division and growth, 
development and differentiation, and implantation.  
Blastocyst-stage embryos release miRNAs in the surrounding micro-environment and 
these can be quantified in vitro. The levels of specific cell-free miRNAs are linked to 
embryo aneuploidy and implantation outcomes in human assisted reproduction cycles. 
However, there are no reports about the value of miRNAs as biomarkers of embryonic 
quality and their use for embryo (de-)selection purposes. Importantly, basic science 
evidence about the roles of secreted miRNAs at the peri-implantation period is lacking. 
The main objective of this thesis is to investigate the biological reason that embryos 
differentially release specific miRNAs and whether miRNAs have effects on 
reproduction with specific focus on embryo-maternal communication at the  
pre-implantation period.  
This was addressed firstly by analysing miRNAs in spent media samples from 
blastocysts and correlating their levels with embryo quality markers (apoptosis and 
morphokinetics). It was found that highly apoptotic mouse embryos release more  
miR-294 in spent media. Further research showed that it is the process of apoptosis 
which triggers the release of this miRNA. This finding was reproduced in bovine 
embryos where the homologue miR-371 was also linked to extensive blastomere 




and were analysed for transcriptomic changes using microarray technology. Global 
genome changes were caused by this miRNA which impaired processes related to 
implantation. 
The original findings presented here suggest that miRNA analysis of individual spent 
media samples using current technology could be a valuable method for assessment 
of embryo quality. Potentially, miRNA analysis could be integrated in the future in 
multi-OMICS platforms for increasing the effectiveness of embryo  
(de-)selection for clinical purposes. The findings that apoptosis triggers the release of 
specific miRNAs from pre-implantation embryos which then cause major gene 
expression changes influencing implantation provide novel insights on the roles of 
miRNAs in reproduction. Ultimately, this thesis concludes that embryo-secreted 
miRNAs have key-roles in the communication between the embryo and the maternal 
cells and act as molecular cues to promote or impair implantation. Future research is 
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1. CHAPTER ONE: LITERATURE REVIEW 
1.1 Assisted Reproduction Technologies 
In a biological sense reproduction ensures the self-perpetuation of the species 
and is a mechanism of life to move forward. In humans creating a family is much more 
than conserving our species – reproduction fulfils emotional, behavioural, and social 
needs. Unfortunately, 15% or reproductive-aged couples worldwide, translating to 48 
million couples or 186 million individuals, are affected nowadays by infertility 
according to the World Health Organization (WHO). Infertility is defined by the 
failure to achieve a pregnancy after 12 months or more of regular unprotected sexual 
intercourse and may occur due to male factors, female factors, a combination of both, 
environmental and lifestyle factors, or may be unexplained (WHO, 2021). Assisted 
reproduction technology (ART) treatment is often the only solution for affected people 
and the European Society of Human Reproduction and Embryology (ESHRE) 
estimates that around 2.4 million ART cycles are carried out worldwide each year, 
with about 500.000 babies born per year (ESHRE, 2020). 
Since the first baby was born in 1978 through in vitro fertilisation (IVF), major 
steps have been made to improve medical treatment, optimise techniques, and develop 
assessment methods that overall aim to increase the success of IVF. ART treatments 
vary from simple interventions like intrauterine insemination (IUI) and fertility drug 
administration to conventional IVF and intracytoplasmic sperm injection (ICSI) and 
more complex interventions like surgery of the reproductive system, fertility 
preservation, surrogacy, embryo testing, and add-on treatments. Sadly despite all the 
advancements in the field the success rates remain relatively low, with recent figures 
from the Human Fertilisation and Embryology Authority (HFEA) showing an average 
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of 23% in live birth rates per embryo transferred that falls dramatically to below than 
5% as the maternal age increases to 43 and above (HFEA, 2020). Achieving a live 
birth from the first IVF cycle is very important firstly because of the high costs that 
are covered by national or private healthcare providers or by the patients themselves. 
Even more importantly, patients undergo considerable physiological and 
psychological stress throughout IVF and thus it is crucial to increase the chances of a 
live birth the earliest possible. Therefore, identifying the factors affecting IVF success 
and adjusting the clinical treatment to overcome these are major topics of study and 
discussion in the assisted reproduction field.  
1.1.1 Factors affecting IVF success 
Reproductive system pathologies, diseases, advanced maternal age, obesity, 
smoking, and stress are all factors that can have negative effects on IVF treatment 
(Bashiri et al., 2018). Many of these affect the gamete quality which ultimately results 
in a developmentally compromised embryo that fails to develop, implant, or grow 
further into a healthy foetus. Indeed, oocytes from patients of advanced age have more 
frequently chromosomic errors or have spindle abnormalities that lead to high 
aneuploidy incidence in the embryo (Cimadomo et al., 2018). Moreover, poor sperm 
quality is associated with aneuploidy, mosaicism, and abnormal morphokinetic 
development of embryos (Kahraman et al., 2020) which possibly explains the lower 
pregnancy rates in these patients (Chapuis et al., 2017). Even when embryo quality is 
excellent, uterine pathologies as well as hormonal and metabolic disorders can have 
adverse effects on the implantation process, inflammatory response, placental growth, 
and overall the maintenance of pregnancy (Vannuccini et al., 2016). 
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Technical factors can also impair IVF success mainly because of the effects they 
have on oocyte and embryo quality. Conventional IVF treatment comprises four main 
steps: the collection of oocytes from the ovaries and collection and processing of 
sperm, the fertilisation in vitro of the oocytes, the culture of the embryos, and the 
transfer of the embryo(s) into the uterus. Initially ovarian stimulation drugs are 
administered to the patient to allow the retrieval of multiple mature oocytes that can 
be used for fertilisation. Undoubtedly the regimen used for ovarian stimulation 
impacts IVF outcomes primarily because the oocyte quality is strongly influenced by 
different stimulation drugs (Bosch et al., 2016).  
Moreover, fertilisation and in vitro culture methods become more and more 
refined in the latest decade in order to mimic as close as possible the conditions in 
vivo. At the very early stages embryos depend on the ingredients of the culture media 
(amino acids, chelators etc.) and are susceptible to environmental changes, namely 
temperature, pH, and atmospheric conditions (CO2, O2). It is therefore not surprising 
that extended culture in in vitro conditions impairs clinical outcomes. Additionally, 
the culture medium type impacts on live birth rates, meaning that not all commercially 
available media are equally efficient for IVF treatment (Castillo et al., 2020). Lastly, 
the timing of embryo transfer, the type of catheter used, and the uterine location where 
the embryo is placed are all critical factors of implantation success at the last step of 
IVF treatment (Schoolcraft, 2016). Naturally, specialised training and advanced skills 
are required for all the laboratory procedures to ensure fast, safe, and efficient 
performance. 
Apart from the technical difficulties to mimic in vivo conditions, one of the 
problems embryologists face is choosing which embryos have the best chances of 
implantation and should be therefore transferred. This has been made even more 
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challenging since the HFEA started to actively monitor and regulate embryo transfers 
in the UK (HFEA, 2017) in an effort to eliminate the adverse effects of multiple 
gestations (Sazonova et al., 2013). As predicted by Gardner and colleagues (Gardner 
et al., 2000), single transfers indeed lower multiple gestation rates and the associated 
risks without compromising pregnancy rates (Hodes-Wertz et al., 2013, Grady et al., 
2012). Consequently, the need for assessment systems that can effectively distinguish 
the best embryo for transfer became even more apparent. 
1.2 Embryo assessment 
1.2.1 Pre-implantation embryo development 
The events and mechanisms occurring at the early stages of mammalian embryo 
development are briefly described to introduce the topic of embryo assessment. 
Initially the fertilised egg undergoes a series of division cycles producing increasing 
numbers of cells known as blastomeres. Protein synthesis in the zygote relies on the 
maternal mRNA cargo. During the initial cleavage cycles the embryo transcribes its 
own mRNA machinery upon the process of zygotic genome activation (ZGA). In 
humans, the initial divisions produce an embryo with 16 blastomeres that exhibit 
augmented intercellular adhesion known as compaction. At this stage the blastomeres 
slowly acquire polarity and as the embryo grows, two populations of cells are created: 
outside, polar cells and inside, non-polar cells. This polarity is maintained through the 
next division cycle which produces 32 blastomeres. From the 32-cell stage onward, 
the two cell populations have distinct developmental fates with the outside cells 
contributing to the trophectoderm (TE) lineage and the inside cells contributing to the 
inner cell mass (ICM), the group of cells that will further diverge into epiblast (EPI) 
and primitive endoderm (PE) lineages by the late blastocyst stage. The next stage is 
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the formation of a fluid-filled cavity known as blastocoel which marks the early 
blastocyst stage. During this stage, the embryo actively pumps water in the inside 
compartment through the actions of membrane transporters and the TE forms tight 
junctions that create a seal which prevents water leakage. As the pressure from the 
blastocoele increases and cell divisions take place, the embryo diameter grows larger 
until the surrounding zona pellucida (ZP) breaks and the fully-grown blastocyst 
hatches in preparation for implantation into the endometrium (Cockburn and Rossant, 
2010).  
The mouse embryo and other animal models are often used in experiments to 
elucidate the mechanisms controlling these early stages of life due to the many 
morphological similarities with the human embryo. However, caution must be taken 
before any conclusions are made for human embryology because of important 
differences between species. For instance, the ZGA occurs in different stages between 
human, murine, and bovine and compaction is also initiated later in the human embryo. 
Additionally, the molecular mechanisms guiding the cell fate are mostly studied in 
mouse embryos with obvious differences in the transcription factors involved in 
human embryo development. In Figure 1.1 the embryonic stages are illustrated in two 





















1.2.2 Embryo morphology assessment 
The most widely used approach to assess the quality of pre-implantation 
embryos is the observation of an embryo through a microscope and the subsequent 
categorisation of the embryo in quality grades (A, B, or C) based on specific 
morphological markers. In the early pronuclear oocyte morphological scoring is based 
on the location of the maternal and paternal pronuclei and the orientation and 
polarisation of the enclosed nucleolar precursor bodies. The embryos are then further 
cultured and morphological assessment is typically carried out before the embryo 
transfer process. Therefore morphological assessment differs depending on the day of 
transfer (usually cleavage-stage or blastocyst). For cleavage-stage embryos the cell 
Figure 1.1 Mouse and human pre-implantation embryo development. (A) In the mouse 
embryo compaction starts at the 8-cell stage. Subsequent divisions produce two cell populations 
occupying the inside and outside regions of the embryo. At the 32-cell stage, the outside cells 
increase their expression of Cdx2 whereas Oct4 is limited in the inside cells The blastocoele 
starts forming at this stage. By the late blastocyst stage, the inside cells differentiate into two 
cell types with different gene expression profiles (Nanog/Gata6). (B) Compaction happens at a 
later stage in the human embryo while the mutually exclusive CDX2/OCT4 expression profiles 
are not established until the late blastocyst stage. The transcription factors guiding the second 
lineage decision are unclear in human embryos. E0.5-6: Day of embryonic development 
(Cockburn and Rossant, 2010). 
CHAPTER ONE: LITERATURE REVIEW 
7 
 
number, percentage of fragmentation, symmetry of blastomeres, multinucleation, and 
vacuole presence are considered when scoring the embryos (Balaban et al., 2011). 
However, morphological scoring of the early embryo is a poor indicator of later 
development because it is not possible to predict whether embryos will continue to 
arrest, grow, or form excellent quality blastocysts (Graham et al., 2000). Therefore 
blastocysts transfers are preferred so that only embryos which have already reached 
the final stages of pre-implantation development and are developmentally competent 
are transferred. In Figure 1.2, the features that are assessed in traditional 
morphological assessment of pronuclear stage oocytes, cleavage-stage embryos and 













Figure 1.2 Key morphological features of human embryos with high (left) and medium 
to low (right) viability. ICM: inner cell mass; TE: trophectoderm (Gardner and Balaban, 
2016). 
CHAPTER ONE: LITERATURE REVIEW 
8 
 
Historically Gardner and Schoolcraft (1999) introduced a blastocyst scoring 
system which described the blastocyst quality in terms of expansion degree, cell 
number and cohesiveness of the ICM and TE populations (Gardner and Schoolcraft, 
1999). This system set the basis for minor changes and additions in later years which 
included phenomena such as vacuolation and hatching patterns (Hardarson et al., 
2012, Balaban et al., 2011). Although blastocyst scoring can indicate the risk of 
aneuploidy in human embryos (Figueira et al., 2012), studies fail to show an 
association of blastocyst grade with clinical outcomes in IVF cycles (Capalbo et al., 
2014, Van Den Abbeel et al., 2013). The weakest points of morphological evaluation 
is that firstly the observation is static, i.e at a specific timepoint, and thus dynamic 
phenomena cannot be observed and secondly that it is highly subjective and depends 
on the experience and training of an embryologist. 
1.2.3 Morphokinetics 
Nowadays, high-tech incubation systems with integrated cameras are used in 
clinics worldwide for thorough observation of embryo development. Time-lapse 
technology generates detailed information regarding morphology and kinetics 
throughout the whole pre-implantation development and aids the observation of 
dynamic events, defined as morphokinetic variables. For instance, embryologists can 
now annotate the time of pronuclear fading at the zygote stage, durations and 
synchronicities of division cycles, abnormal cleavage patterns such as trichotomous 
mitosis and reverse cleavage, and blastocoel collapsing patterns at the blastocyst stage 
(Ciray et al., 2014) (Figure 1.3). Perhaps the strongest advantage of  
time-lapse technology is the ability to save all records and annotate at a later time with 
more than one observer present or even apply artificial intelligence (AI) software to 
automatically score and rank embryos for transfer. This reduces the subjectivity of 
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traditional morphological assessment and refines the selection process. Furthermore, 
time-lapse incubation has the added benefit of a closed, undisturbed culture system 
which means that the environmental conditions are stable throughout the culture 









In regards to its diagnostic value, specific morphokinetic variables have been 
linked to embryo quality and clinical outcomes. For example, the exact times of the 2-
, 3-, 4-, and 5-cell divisions and morula formation predict blastocyst formation and 
quality (Cruz et al., 2012, Motato et al., 2016, Milewski et al., 2015) and the durations 
between the 2- with the 3-cell stage, 3- with the 4-cell stage, and 5- with the 8-cell 
stage predict blastocyst formation and implantation (Motato et al., 2016, Milewski et 
al., 2015). Moreover, the time of compaction, initiation of blastulation, and full 
blastocyst formation are associated with the risk of aneuploidy in embryo selection 
cycles (Campbell et al., 2013). The timing of the 5-cell stage and expansion stages 
significantly reflect on the implantation potential of embryos (Meseguer et al., 2011, 
Motato et al., 2016) and time of morula formation is correlated with live birth rates 
after euploid blastocyst transfers (Rienzi et al., 2019). Additionally, duration of 
blastulation can be predictive of ongoing pregnancy rates (Mumusoglu et al., 2017).  
Figure 1.3 Time-lapse snapshots of mouse embryo development. The exact timings of 2-
cell, 3-cell, 4-cell, 5-cell, and 8-cell divisions are depicted and the durations and 
synchronicities of the second ( ECC2 and s2 respectively) and third cell cycles (ECC3 and s3 
respectively) and duration of blastulation (dB) are calculated using the exact timings. 
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Although in the beginning time-lapse technology was expected to become a 
valuable tool for selecting embryos in a non-invasive manner (Kirkegaard et al., 2012), 
there is now an ongoing debate about whether this add-on treatment is indeed 
improving clinical outcomes (Harper et al., 2017). For instance, whereas pregnancy 
rates do not improve with the use of time-lapse (Goodman et al., 2016), a minimum 
of 19% increase in the incidence of live birth has been found when morphokinetic data 
are used to select embryos (Fishel et al., 2017). It is evident that unless there is a 
consensus as to which morphokinetic markers are the most valuable, and further 
studies control for patient characteristics, treatments, and time-lapse systems used, 
direct comparisons between findings and formulation of conclusions are impossible. 
Indeed, most clinics develop in-house selection algorithms which are only beneficial 
for on-site applications (Barrie et al., 2017).  
Apart from these inconsistencies, perhaps one of the weakest points of 
morphological and morphokinetic evaluation is the inability to accurately detect and 
identify aneuploidies, now and in the future; them being a major reason of low success 
in IVF cycles. Indeed, it is impossible to assess the type of chromosomal error and 
whether an embryo carries certain genetic loci that cause a diseased phenotype by sole 
observation of the embryo’s phenotype. To identify genomic abnormalities one needs 
to analyse the genetic material itself. Therefore, more accurate and reproducible 
methods are needed for selecting embryos for transfer. 
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1.2.4 Biomolecular methods 
Biomolecular techniques were employed for embryo assessment purposes 
because of the high accuracy, sensitivity, reproducibility, and objectivity that these 
methods offer. For those techniques, embryonic material is obtained through embryo 
biopsy, either cleavage-stage or blastocyst, and the cells are then processed to amplify 
RNA or DNA. From there on, monogenic mutations, aneuploidy and chromosomal 
abnormalities, SNP genotyping, and whole genome sequencing can be carried out 
depending on the technology used. Conventionally, pre-implantation genetic 
diagnosis (PGD) refers to the identification of monogenic mutations whereas PGT-A 
refers to pre-implantation genetic testing for aneuploidies (formerly pre-implantation 
genetic screening, PGS). Initially, polymerase chain reaction (PCR) technology was 
used for identifying monogenic mutations however technological advancements in 
array comparative genomic hybridisation (aCGH) allowed DNA copy number 
profiling and SNP genotyping simultaneously. Lately, improvement of next 
generation sequencing (NGS) platforms allowed whole genome sequencing from a 
single cell with high accuracy thereby providing information of the whole genome that 
can be used to identify gene mutations and assess the chromosomal status (Vermeesch 


































Although during the last decade these methods are more and more refined, there 
are also some inevitable disadvantages. For instance, the embryologists need to be 
specially trained to perform biopsies which also increases the treatment costs for 
patients, the embryo is even minorly damaged and is also exposed to laboratory 
conditions throughout the biopsy (Cimadomo et al., 2016), and the small number of 
biopsied cells is often not adequate to assess the degree of mosaicism in the whole 
embryo and thereby accurately assess the chromosomal status (Ou et al., 2020). In an 
effort to overcome these problems, nowadays the focus of clinical embryology is to 
use available technology for assessing embryos in a non-invasive manner. 
Figure 1.4 The available methods for diagnostic services. Multiplex quantitative PCR 
(qPCR) for mutation detection and/or genotyping, array comparative genomic hybridisation 
(aCGH) for aneuploidy screening and/or diagnosis, and next-generation sequencing (NGS) for 
aneuploidy screening. Embryos are prioritised for transfer based on the genomic (PGD) and 
chromosomal status (PGT-A). F:fluorophore; Q:quencher. Figure adapted from Vermeesch et 
al. (2016). 
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Currently, there is active research on the use of spent culture media for analysis 
of embryo-secreted/released molecules. The development of -OMICS platforms 
supports this research and nowadays it is possible to analyse spent culture medium 
from individually-cultured embryos for genomics, proteomics, metabolomics, and 
transcriptomics. One of the hot topics for research with immediate clinical applications 
is the detection of DNA in embryo culture media. Specifically, cell-free embryonic 
DNA is present in culture media and NGS can detect this DNA for PGT-A purposes. 
This method is intensively studied to establish the concordance rate between cell-free 
DNA and embryonic cells and if this method is superior for assessing the degree of 
mosaicism compared to embryo biopsies (Rubio et al., 2019). Moreover, clinical 
proteomics and metabolomics are candidate emerging technologies with possible 
applications in embryo assessment. In proteomics, protein profiling in spent culture 
medium identifies biomarkers that are associated with embryo viability and even 
implantation potential of an embryo. In metabolomics, the molecular metabolites in 
spent medium are used as biomarkers to determine the degree of oxidative stress and 
the embryonic potential and viability (Egea et al., 2014). Furthermore, transcriptomic 
profiling of small RNA molecules is a newly-introduced approach for non-invasive 
embryo quality assessment. In this approach, microRNAs (miRNAs) are candidate 
molecules for research because of their numerous biological functions and 




















The present thesis studies the roles of cell-free miRNAs in embryo development 
and reproduction in order to contribute to the limited knowledge in this topic. The 
literature review continues with describing the biology of miRNA molecules and how 
these regulate mammalian reproduction. Chapter 1 ends with the hypothesis and 
objectives of the thesis. In Chapter 2 the general methodology and techniques used 
throughout are described in detail. Moreover, Chapters 3-6 include the original work 
and experiments carried out for the purposes of this thesis. Lastly, a general discussion 
with conclusions are given in Chapter 7. 
 
 
Figure 1.5 Spent culture media analysis for non-invasive embryo assessment. The media 
from single-cultured blastocysts is collected and analysed with respective platforms for 
genomics, transcriptomics, proteomics, and metabolomics analyses. The molecular profiles are 
analysed and used to select the embryo with the highest probabilities for implantation and 
pregnancy. This embryo is then transferred to the uterus. 




MicroRNAs (miRNAs) are small (~22 nucleotides), single-stranded, non-coding 
and highly conserved RNAs whose genes either express a single miRNA or are found 
in transcriptional miRNA clusters. miRNAs act as guide molecules for RNA silencing 
by direct translational repression, mRNA destabilisation, or a combination of the two 
(O'Brien et al., 2018). To date it is estimated that approximately 2.300 mature miRNA 
forms exist in human cells (Alles et al., 2019). Their actions are involved in numerous 
cell processes including stress signalling, cell cycle progression, development, 
differentiation, and apoptosis (Mendell and Olson, 2012). It is therefore not surprising 
that specific miRNAs have been linked with the onset of diseases such as cancer, 
cardiovascular disorders, and neurodegenerative diseases (Kumar et al., Wijnhoven et 
al., 2007, Condorelli et al., 2014). 
The biogenesis of miRNAs is under tight temporal and spatial control and the 
involved pathways have been reviewed extensively in the past (Ha and Kim, 2014b, 
Winter et al., 2009). In brief, miRNA genes are transcribed by RNA polymerase II 
which produces a long primary transcript (pri-miRNA) with a local hairpin structure 
within which the mature miRNA sequence is found. The primary miRNA then 
undergoes several steps of maturation starting with processing of the molecule by the 
“Microprocessor complex” formed by the nuclear RNase III Drosha and essential co-
factor DGCR8. This complex precisely recognises and cleaves the pri-miRNA stem-
loop releasing a hairpin-shaped RNA molecule (~65 nucleotides) known as precursor 
miRNA (pre-miRNA). Then the pre-miRNA is transported from the nucleus to the 
cytoplasm via the action of Exportin-5 in complex with Ran-GTP. The RNase III Dicer 
completes the maturation process by cleaving the terminal loop to generate the mature 
duplex miRNA molecule which is ~22 nucleotides long. miRNAs are then loaded onto 
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an Argonaute (AGO 1-4) protein forming a complex known as the miRNA-induced 
silencing complex (miRISC). The directionality of the miRNA strand determines the 
name of the mature miRNA. The 5p strand derives from the 5´ end of the pre-miRNA 
hairpin whereas the 3p comes from the 3´ end; however the selection of the strand is 
based partly on the thermodynamic stability of the 5´ end with the less stable strand 
being preferentially loaded into AGO (guide strand). The miRNA then guides the 
RISC complex to complementary sequences on the target mRNA where it exerts its 
actions on miRNA-mediated silencing. The unloaded strand (passenger strand) will be 
unwound from the guide strand  and the strands that contain no mismatches are cleaved 
by AGO2 and degraded by cellular machinery. Alternatively, miRNA duplexes with 
central mismatches or non-AGO2 loaded miRNA are passively unwound and 
degraded (Ha and Kim, 2014a). The Drosha-Dicer pathway is the most-described 
miRNA biogenesis pathway yet; however non-canonical mechanisms of miRNA 
processing are also emerging. 
In general, the non-canonical miRNA biogenesis can be grouped into 
Drosha/DGCR8-independent and Dicer-independent pathways (Figure 1.6). In the 
mirtron pathway short introns are processed by spliceosomes and debranching 
enzymes in the nucleus to produce miRNA hairpins that are exported by Exportin-5 in 
the cytoplasm where they are cleaved by Dicer. Thus this pathway replaces the 
microprocessor processing with splicing activity and then merges with the canonical 
miRNA pathway. Another example is the 7-methylguanosine (m7G)-capped pre-
miRNA. These small RNAs are exported to the cytoplasm through Exportin-1 and are 
cleaved by Dicer following the canonical pathway. Dicer-independent miRNAs are 
processed by Drosha/DGCR8 from endogenous short hairpin (shRNA) transcript, 
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transferred in the cytoplasm via Exportin-5 and require AGO2 to slice their strand 



















Figure 1.6 miRNA biogenesis pathways. Canonical biogenesis begins with the generation 
of the pri-miRNA transcript in the nucleus which is processed by the Drosha/DGCR8 complex 
to produce the precursor-miRNA (pre-miRNA). The pre-miRNA is exported to the cytoplasm 
via Exportin-5/RanGTP action and is processed by Dicer to produce the mature miRNA 
duplex. Either miRNA strand is then loaded into the Argonaute (AGO) family of proteins 
forming the miRNA-induced silencing complex (miRISC). In the Drosha/DGCR8-
independent non-canonical pathways, mirtrons are processed by spliceosomes and exported 
by Exportin-5 whereas 7-methylguanosine (m7G)-capped pre-miRNAs are transferred via 
Exportin-1 in the cytoplasm where they are cleaved by Dicer activity and follow the canonical 
pathway. In the Dicer-independent biogenesis, small hairpin RNAs (shRNA) are initially 
cleaved by the microprocessor complex and are exported via Exportin-5/RanGTP where they 
are further processed via AGO2-dependent cleavage. All pathways lead to a functional 
miRISC complex which ultimately binds to target mRNA sequences possibly by interacting 
with the EIF4F complex. Next, GW182 proteins bind to AGO and recruit the poly(A)-
deadenylases PAN2/3 and CCR4-NOT. The former initiate deadenylation of the mRNA and 
CCR4-NOT removes the m7G cap on target mRNA (decapping). The mRNA may then 
undergo 5´-3´ degradation through exoribonuclease XRN1 (O'Brien et al., 2018). 
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Even when cells utilise other mechanisms to produce functional miRNAs, it is 
important to note that Dicer is almost always indispensable in the production of 
miRNAs and without it the vast majority of the miRNA cargo in a cell is lost. On the 
other hand, Drosha and Dgcr8 are only needed to process miRNAs in the canonical 
pathway so their deletion causes complete loss of canonical miRNAs but preserves 
non-canonical miRNA biogenesis. Therefore, the understanding of miRNA biogenesis 
and the actions of key-factors in each pathway is necessary when knockout 
experiments are designed to study specific miRNA roles. For instance, deletion of 
Dicer will completely deplete cells from miRNAs whereas deletion of Drosha/Dgcr8 
will only affect the miRNAs produced by the canonical pathway. Deletion of  
Exportin-5 will affect the transport of miRNAs in the cytoplasmic region for final 
miRNA maturation and deletion of Ago genes will affect the loading of miRNAs in 
RISC complexes which will block the transportation of miRNAs to their targets. 
After they are synthesised, miRNAs bind to specific sequences at the 3´ UTR of 
their target mRNA to induce translational repression and mRNA deadenylation and 
decapping (Ipsaro and Tor, 2015). miRNAs also bind to 5´ UTR and coding regions 
and have silencing effects on gene expression (Forman et al., 2008), whereas 
interactions with promoter regions has been reported to induce transcription (Zhang et 
al., 2018).  
MicroRNA-mediated gene silencing starts with the miRISC specifically 
targeting complementary sequences on mRNA called miRNA response element 
(MREs). This interaction enables the AGO protein to act as a mediator of RNA 
interference and is followed by the recruitment of the GW182 family of proteins which 
provide the scaffolding needed to recruit other effector proteins such as the poly(A)-
deadenylase complexes PAN2/3 and CCR4-NOT (Behm-Ansmant et al., 2006, Jonas 
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et al., 2015, Christie et al., 2013). These proteins initiate poly(A)-deadenylation after 
which decapping takes place through the actions of decapping protein 2 (DCP2) and 
associated proteins (Behm-Ansmant et al., 2006), followed by 5´-3´ mRNA 
degradation by exoribonuclease 1 (XRN1) (Braun et al., 2012).  
Translational activation through miRNAs is less common and is activated under 
specific conditions. The mechanisms are not clear yet, however miRNAs are able to 
mediate activation of translation which involves association with AU-rich elements at 
3´ UTR through AGO2 and FXR1 actions or binding to the 5´ UTR of mRNAs 
encoding ribosomal proteins (Vasudevan et al, 2007). Lastly, miRNAs also mediate 
transcriptional and post-transcriptional gene regulation within the nucleus. This is 
achieved through the actions of Importin-8 or Exportin-1 which allows the human 
AGO2 to shuttle between the nucleus and cytoplasm (Nishi et al., 2013). When the 
miRISC is transferred inside the nucleus it can regulate both transcriptional rates and 
post-transcriptional levels of mRNA and associate with euchromatin at gene loci with 
active transcription (Cernilogar et al., 2011, O'Brien et al., 2018). 
Intracellular miRNAs are important regulators of many biological processes. 
Interestingly, miRNAs circulate extracellularly and cell-free miRNAs are found in 
abundance in body fluids including serum and amniotic fluid (Cortez et al., 2011). 
miRNAs circulate using miRNA transporters or by binding to other molecules (Figure 
1.7). Often miRNAs are encapsulated in vesicular transporters, namely exosomes and 
microvesicles, which are secreted by cells and fuse with plasma membranes releasing 
the miRNA cargo in other cells, serving thus as mediators of cell-to-cell 
communication. Another miRNA carrier is the apoptotic body which is formed at the 
final stages of cellular apoptosis and can have post-apoptotic effects in other living 
cells. The main difference between exosome packaging and binding to apoptotic 
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bodies is that the latter is a random process and independent of cell types. Some 
proteins such as NPM1, HDL, and Ago2 are also used as miRNA carriers by cells. 
miRNA-protein complexes circulate in body fluids and enable inter-cellular 
communication via miRNAs. Exosome release by cells is an ATP-dependent process, 
as it includes membrane fusion and breakage, and similarly formation of apoptotic 
bodies as well as protein secretion are also energy-demanding processes. A small 
fraction of miRNAs could also be released passively by leakage from damaged cells; 
however, it is generally thought that miRNA release/secretion is an active, selective 

















Figure 1.7 miRNA transporters. In the GW body, which is formed by accumulated GW182 
in the Processing Body (P-body), the GW182 dissociates the RISC on the membranes of 
multivesicular bodies (MVBs) by endosomal sorting complex required for transport (ESCRT) 
and the RISC is sorted into intralumenal vesicles (ILVs) for degradation in the lysosomes. An 
alternative pathway for sorting miRNA cargos into ILVs is the selection of raft-based 
microdomains in the MVBs and exosome release (MVBs-exosomes pathway). Ceramide 
accumulation in these microdomains promotes exosome secretion. miRNA transport via 
exosomes is achieved through fusion between MVB and plasma membranes or through 
budding of plasma membranes of microvesicles. Binding to proteins or apoptotic bodies are 
also mechanisms of miRNA transport in the extracellular environment (Xu et al., 2013). 
CHAPTER ONE: LITERATURE REVIEW 
21 
 
Circulating miRNAs are highly stable in body fluids and experiments show that 
these molecules do not degrade as easily as other RNAs withstanding prolonged 
exposure in room temperature, repeated freeze-thaw cycles (Mitchell et al., 2008, 
Gilad et al., 2008), and pH changes (from pH=1 to pH=13) (Xi et al., 2008). 
Endogenous miRNAs are also resistant to RNase digestion in contrast to other cell-
free RNAs that are destroyed from extracellular RNases (Mitchell et al., 2008, Gilad 
et al., 2008). However, synthetic miRNAs are easily degraded by RNase activity 
which suggests that endogenous miRNAs are protected from degradation probably by 
vesicles or proteins with which they bind (Mitchell et al., 2008). Indeed, miRNAs 
rapidly destabilise and degrade after treatment with proteinase K at 55oC (Arroyo et 
al., 2011) and addition of membrane permeabilising factors (Triton X-100), meaning 
thus that miRNA stability is achieved by encapsulation of miRNAs in membrane 
vesicles and/or protection by RNA-binding proteins. 
Overall the available information on miRNA roles and actions highlights the 
competence of these molecules as gene regulators and their potential as mediators of 
cellular processes. Considering the multiple roles of miRNAs in normal cellular 
functions it is not surprising that a number of research work has been carried out in 
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1.3.1 miRNAs in male reproduction 
MiRNAs are expressed in male reproductive tissues and have essential roles in 
male fertility (Reza et al., 2019). Aberrant miRNA expression in male tissues can 
cause structural changes in male gonads, affect spermatogenesis, increase germ cell 
apoptosis, and impair the production of spermatozoa and their maturation. Complete 
miRNA absence caused by deletion of Dicer in germ cells of mutant mice results in 
reduced testis size, significant reduction in testis weight by 55%, and smaller diameter 
of seminiferous tubules. Cellular associations within the seminiferous tubules are also 
disturbed, including disbalanced proportions of different cell populations, presence of 
leptotene spermatocytes, absence of elongated spermatids and presence of round 
spermatids. Additionally, meiotic progression is severely affected by global miRNA 
deletion and cell apoptosis is 8-fold higher in mutant testes compared to controls. 
Moreover, acrosome fragmentation, abnormal head shape and chromatin 
condensation, and abnormal mitochondria shape are prominent morphological defects 
in round and elongated spermatids of mutant mice. All these changes cumulatively 
result in the absence of functional spermatozoa and complete infertility in Dicer 
knockout males (Romero et al., 2011). 
The roles of specific miRNAs have also been studied in relation to male 
reproduction. Starting from germ cell commitment and differentiation to 
spermatogonia, the pluripotency-related miR-290/295 cluster members are 
downregulated whereas the pro-proliferation and pro-differentiation miR-136, -743a, 
-483 are upregulated in spermatogonia compared to primordial germ cells (PGC) and 
gonocytes (McIver et al., 2012). MiR-143 is transiently increasingly expressed from 
PGC to spermatogonia cells and spermatozoa which suggests that this miRNA is likely 
necessary for the differentiation of PGC to spermatozoa (García-López et al., 2015). 
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Moreover, miR-21, and miR-221/222 are expressed in spermatogonial stem cells 
(SSC) with actions on stemness, proliferation, and survival which overall promote the 
maintenance of the SSC population reserve (Niu et al., 2011, Yang et al., 2013a). 
Additionally, miRNAs miR-20 and miR-106a trigger post-translational molecular 
mechanisms which promote renewal of SSCs (He et al., 2013) while miR-17-92 and 
miR-106b-25 cluster members cooperatively regulate spermatogonial differentiation 
and development (Tong et al., 2012). It is therefore evident that miRNAs form 
complex regulatory networks controlling the very early stages of male reproduction. 
Moreover, miRNAs are involved in the regulation of the subsequent stages of 
spermatogenesis – from the differentiation and mitotic proliferation of spermatogonia 
to the meiotic divisions of spermatocytes and later on the process of spermiogenesis 
which involves the maturation of round spermatids to elongated spermatids (He et al., 
2009). More specifically, miR-146 is a key miRNA for spermatogonial differentiation 
and is highly expressed in undifferentiated spermatogonia compared to differentiated, 
by 180-fold difference. MiR-146 actions are exerted through direct binding on the 
retinoic acid mediator Med1 and overexpression of this miRNA modulates the effect 
of retinoic acid on spermatogonial differentiation (Huszar and Payne, 2013). Let-7 
miRNA family members also seem essential for differentiation of spermatogonia and 
expression of these miRNAs is decreased upon differentiation to primary 
spermatocytes. These miRNAs act through targeting IGF1 and regulating Erk1/2 and 
PI3K signalling pathways and overall block the IGF1-induced spermatogenesis (Shen 
et al., 2014). On the other hand, miR-383 expression is restricted to spermatogonia 
and is necessary for the production of spermatocytes. MiR-383 regulates the 
expression of proliferation factors (cyclin dependent kinases CCND1, CDK2 and p21 
inhibitor) and overall controls the process of mitotic divisions to spermatocytes (Lian 
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et al., 2010). Furthermore, miR-34c promotes the meiotic divisions of spermatocytes 
by inhibiting Nanos2 and simultaneously upregulating the Stra8 retinoic acid mediator 
(Yu et al., 2014). Additionally, the stage-specific meiotic miRNAs miR-221, -203, and 
-34b target c-Kit, Rbm44, and Cdk6 genes respectively and coordinate this way the 
meiotic progression of spermatocytes to produce haploid gametes (Smorag et al., 
2012).  
MiRNA expression is also necessary for the structural and molecular transition 
of spermatocytes to elongated spermatids during spermiogenesis. Indeed, miRNA-
dependent regulation of Tdrd6 is crucial for the formation of chromatin bodies in 
round spermatids (Vasileva et al., 2009). Additionally, the testis-specific miR-469 
plays an important role in chromatin remodelling and elongation of spermatids via 
repression of Tnp2 and Prm2. Spermatids fail to elongate in absence of this miRNA 
which severely impacts on male fertility (de Mateo and Sassone-Corsi, 2014). Lastly, 
the sperm miRNA signature is substantially modified during epididymal maturation 
compared to other spermatozoal stages (Nixon et al., 2015) and differential expression 
is also found among the segments of the epididymis (caput, corpus, cauda) and 
compared to ejaculated sperm in different species, including human (Belleannée et al., 
2012) and mouse (Nixon et al., 2015). This suggests that epididymal miRNAs are 
involved and necessary for the final stages of in sperm maturation contributing to 
sperm motility and the content of seminal fluid. It is evident from the above that  
abnormal miRNA expression can impair any of these processes, separately and 
cumulatively, leading to male-factor infertility. 
Lastly, cellular apoptosis during spermatogenesis appears to be, at least partly, 
under miRNA regulation. Notably, spermatocyte apoptosis is a necessary process in 
order to establish the precise homeostasis of cell types in the testis needed for 
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spermatogenesis. In mice, the miR-449 cluster and miR-34b/c are expressed in high 
levels upon meiotic initiation in the testis and act redundantly to suppress the activity 
of E2F1. This suppression has protective effects that prevent meiotic male germ cells 
from undergoing apoptosis, which is crucial to overcome at this stage as the mitotic to 
meiotic progression requires double strand breaks for DNA recombination (Bao et al., 
2012). In sheep with impaired spermatogenesis, miR-144 is highly expressed and 
inhibits the expression of apoptosis-related genes FASL, CAS3, and TP53, suggesting 
that controlled apoptosis is crucial for normal spermatogenesis in the adult testis (Guan 
et al., 2015). In pigs, miR-34 and miR-16 are upregulated during germ cell 
development and negatively regulate the cell cycle progression (Luo et al., 2015) and 
miR-16 in the mouse testis specifically targets and downregulates the Ccnd1 gene 
which suppresses cell growth and promotes cell apoptosis (Li et al., 2016b). 
Furthermore, miR-17-92 has pro-survival actions in mouse testicular cells as deletion 
of this miRNA upregulates pro-apoptotic proteins (Bim, Stat3, c-Kit, Socs3) and leads 
to increased germ cell apoptosis, testicular atrophy, empty seminiferous tubules, and 








Figure 1.8 miRNA regulations of spermatogenesis. miRNAs involved in each stage of 
spermatogenesis are given for Sertoli cells, SSCs: spermatogonial stem cells, SPC: 
spermatocytes, RS: round spermatids, ES: elongated spermatids, and sperm (Chen et al., 
2017). 
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Many studies have investigated whether miRNA profiling in ejaculated semen 
is predictive of male infertility, embryo quality, and even clinical outcomes. In 
specific, miRNAs let-7a, miR-7-1-3p, -131, -200a, and -429 are significantly 
upregulated whereas miR-15b, -34b, and -122 are upregulated in infertile males 
compared to normozoospermic men. These profiles are consistent in spermatozoa and 
seminal fluid samples and are significantly correlated with sperm concentration 
(Mokánszki et al., 2019). Moreover, miR-449 and miR-15b are decreased while miR-
141 and miR-200a are increased in semen samples of oligozoospermic males 
(McCubbin et al., 2017), but miR-122 is decreased which contradicts the findings of 
Mokánszki and colleagues (2019). Additionally, miR-371a-3p levels in ejaculate are 
positively correlated with sperm concentration and total sperm count (Radtke et al., 
2019). Furthermore, the promoters of miR-34 family members (miR-34a,b,c) are 
hypermethylated in sperm samples of infertile men which leads to the under-
expression of these miRNAs with possible impacts on spermatogenesis (Momeni et 
al., 2020). A recent study identified miRNA pairs as potential biomarkers for 
classification in male infertility groups. The best biomarker potential was found for  
pairs miR-942-5p/miR-1208 (asthenozoospermia), miR-265-5p/miR-328-3p 
(teratozoospermia), miR-139-5p/miR-1206a (oligozoospermia), and miR-34b-
3p/miR-93-3p (unexplained male infertility) (Corral-Vazquez et al., 2019).  
Regarding embryo parameters, miR-191-5p in sperm samples is an indicator of 
fertilisation rate, blastocyst formation, and embryo quality and as such is a potential 
non-invasive marker for improving success rates in IVF cycles (Xu et al., 2020). 
Lastly, miR-34c expression in spermatozoa is linked to higher rates of good-quality 
embryos, implantation, pregnangy, and live birth rates in ICSI cycles, which suggests 
that this miRNA can be used as an indicator for clinical otucomes (Cui et al., 2015). 
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1.3.2 miRNAs in female reproduction 
Similar to male reproduction, miRNAs are expressed in female reproductive 
tissues and play essential roles throughout folliculogenesis and oogenesis (Reza et al., 
2019) (Figure 1.9). Dicer knockout experiments offer insights about the broad 
regulatory roles of miRNAs in female reproduction. Dicer1 is abundant in ovarian 
tissues of mice and is expressed throughout the different developmental stages in 
oocytes and supporting cells – from oocytes of primordial follicles to oocytes of the 
follicles from primary to antral stage, in granulosa cells, and notably in the corpus 
luteum and stromal cells (Lei et al., 2010). 
Unsurprisingly, inactivation of Dicer1 in ovaries inevitably affects the normal 
functions of ovaries with adverse effects on oogenesis. Firstly, deletion of Dicer1 leads 
to morphological alterations as shown by Dicer1 knockouts which have more tertiary 
follicles, more degenerate follicles, presence of cysts in the centre of the ovaries, and 
abnormal vascularisation and cytoplasmic size of the corpus luteum (Lei et al., 2010). 
Additionally, follicular development is altered with knockout ovaries showing an 
increased primordial follicle pool endowment, enhanced early follicle recruitment, 
increased number of tertiary follicles, but lower numbers of antral follicles which 
suggests increased atresia before ovulation (Leit et al., 2010). Moreover, gene 
expression is altered in Dicer1 knockout ovaries in different reproductive stages (day 
4, day 8, 8 weeks), with significant dysregulation of Bcl2, Bax, Nobox, and Inhba in 
day 4 ovaries, downregulation of Zp2 and Bmp15 in day 8 ovaries, and downregulation 
of Inhba (activin/inhibin assembly), Cyp11a1, Cyp17a1, and Cyp19a1 (hormone 
synthesis), Casp3, Ccnd2, and Cdkn1b (granulosa cell development), Zp2, Zp3, Gdf9, 
and Bmp15 (oocyte-specific) in 8 week ovaries (Lei et al., 2010). Taken together, these 
findings suggest that miRNAs are essential for maintaining the morphological 
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structures and molecular profiles of the ovarian cell populations which cooperate for 
the production of the maternal gamete. 
Specific miRNAs regulating the different stages of folliculogenesis have been 
identified by a number of studies. During the initiation of primordial follicle 
development in mice, 24 miRNAs are differentially expressed in ovaries of 3- and 5- 
day-old mice and these miRNAs are involved in at least 77 miRNA-mRNA regulatory 
networks which modulate growth, development, and maintenance of primordial 
follicles. One of the networks is the TGF-beta signalling pathway in which miR-145 
has important regulatory actions. MiR-145 is abundant in ovaries in which follicle 
development has been initiated and specifically targets and downregulates Tgfbr2 
while activating Smad signalling. These actions are essential for controlling early 
folliculogenesis as loss of miR-145 over-activates primordial follicles (decreased 
proportion and number of primordial follicles and increased number of growing 
follicles), and affects the oocyte size (increased diameter in primordial follicles, 
smaller in growing follicles) (Yang et al., 2013b). In addition, miR-224 directly targets 
Smad4 in mouse ovaries and promotes early folliculogenesis through enhanced 
granulosa cells (GCs) proliferation in cooperation with Tgfb1 (Yao et al., 2010). 
Moreover, miRNAs have actions in later stages including selection of dominant 
follicles, formation of germinal vesicle (GV) oocytes, oocyte maturation, ovulatory 
follicles, and development of metaphase II (MII) oocytes. In bovine, there are distinct 
miRNA profiles between granulosa cells of subordinate and dominant follicles in the 
early luteal phase, with at least 16 miRNAs differentially expressed at day 3 of the 
oestrous cycle and 108 miRNAs at day 7. Temporal miRNA expression dynamics is 
,also observed in dominant follicles from day 3 compared to those from day 7, with 
miRNAs involved in important processes of follicular development such as Wnt, TGF-
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beta, GnRH signalling pathways and meiosis. This shows that miRNA expression 
patterns are likely associated with follicular recruitment, selection, and dominance 
during the early luteal phase (Salilew-Wondim et al., 2014).  
Additionally, miR-424 and miR-10b are abundantly expressed in GV oocytes 
compared to ovarian somatic cells in bovine and these patterns persist to the MII 
oocyte and early stage embryos (16-cell) before declining in further development, 
meaning that these miRNAs are possibly essential for the formation of GV oocytes, 
progression to the MII stage, with possible involvement in maternal transcript turnover 
in early embryo development (zygote genome activation occurs at 8-cell stage in 
bovine embryos) (Tripurani et al., 2010).  
Furthermore, bovine immature oocytes preferentially express 31 miRNAs 
compared to matured oocytes, and inversely 28 miRNAs are distinctly expressed in 
mature oocytes compared to immature (Tesfaye et al., 2009). miRNAs miR-205, -150, 
-122, -96, -146a, -146b-5p dramatically decrease as the oocyte matures (0 to 22 h 
maturation) and their levels are maintained up to the 8-cell embryo stage before further 
reduction following a typical bovine maternal transcript profile (Abd El Naby et al., 
2013). In pigs, miR-27b-3p has negative effects in oocyte maturation (GV to MII) 
through regulation of PPARγ which is essential for fatty acid metabolism (Song et al., 
2016) and miR-574 supresses maturation through direct downregulation of 
hyaluronan synthase 2 (HAS2) (Pan et al., 2018). In contrast, miR-205 mediates the 
expansion of cumulus-oocyte complexes (COCs) through Ptx3 targeting, promoting 
this way maturation (Li et al., 2016a). Large bovine follicles highly express miR-144, 
-202, -451, -652, and -873 compared to small follicles and these miRNAs regulate 
multiple signalling pathways involved in follicular cell proliferation, steroidogenesis, 
luteinisation, and oocyte maturation (Sontakke et al., 2014). Moreover, miR-21 is 
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essential in mouse ovaries where it is highly expressed in granulosa cells transitioning 
to luteal cells and exerts its pro-maturation actions through inhibition of cellular 
apoptosis (Carletti et al., 2010). Lastly, human MII oocytes express higher levels of 4 
miRNAs and lower levels of 11 miRNAs compared to GV oocytes, with miR-15a and 
miR-20a gradually decreasing through transition of GV to the MI and MII stages 
which suggests that dynamic temporal expression is essential for the successive stages 















Figure 1.9 miRNA regulation of oogenesis. miRNAs are listed according to their 
involvement in each stage. The miRNA roles are discussed within the text using literature 
around mammalian oogenesis in general. Therefore, their actions may differ between species. 
CL: corpus luteum. 
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Interestingly, hormone-miRNA interactions in ovarian cells and the pituitary 
gland control the ovulation process. More specifically, LH/hCG triggers the 
differential expression of 13 miRNAs in peri-ovulatory granulosa cells, with miR-132 
and miR-212 amongst the highly upregulated miRNAs causing elevated transcription 
of the pro-ovulation gene Ctnp1 (Fiedler et al., 2008). MiR-200b and miR-429 are 
essential for female fertility and are expressed in the pituitary gland where they 
suppress Zeb1. Deletion of these miRNAs leads to lowered serum LH concentration, 
impaired LH surge, and ovulation failure in mice (Hasuwa et al., 2013). Moreover, 
miR-7a2 is essential for pituitary development and hypothalamic-pituitary-gonadal 
(HPG) function in adulthood with genetic deletion of this miRNA resulting in low 
levels of gonadotropic and sex hormones, small ovaries, anovulation, and infertility. 
Mir-7a2 is expressed in the pituitary where it suppresses Glg1 and Ptgfrn (FSG and 
LH inhibitor) and BMP4 signalling, regulating this way sexual maturation and 
reproductive function (Ahmed et al., 2017). 
MiRNAs have pivotal regulatory roles during apoptosis of granulosa cells and 
follicular atresia. Programmed cell death and the consequent follicular atresia is a 
normal process that regulates the number of follicles in the developing pool. In 
humans, granulosa cell apoptosis is promoted by miR-146a which directly targets the 
interleukin-1-receptor-associated kinase, IRAK1, and tumour necrosis factor receptor-
associated factor 6, TRAF6, and indirectly affects factors of the caspase cascade family 
(Chen et al., 2015). Moreover, the let-7 family controls follicular atresia in pigs 
through MAPK, TGFβ and p53 pathways, with significant reduction of let-7a, -7b, -
7c, -7i and increase of let-7g in atretic follicles compared to healthy ones (Cao et al., 
2015). Moreover, miR-26b promotes granulosa cell apoptosis in porcine ovaries 
through direct targeting of ATM (Lin et al., 2012). In mice, miR-18a1 regulates ovarian 
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follicle development and inhibits GC proliferation by supressing Acvr2a and activin 
signalling (Zhang et al., 2013a). Additionally, miR-21 blocks apoptosis in granulosa 
cells, prevents follicular atresia, and regulates follicle survival (Carletti et al., 2010) 
and miR-125b suppresses pro-apoptotic genes of the Bcl2 family in GCs and promotes 
follicular survival (Sen et al., 2014). Furthermore, miR-376a in ovaries regulates 
follicle assembly, by modulation of the proliferation factor Pcna, and is correlated 
with increased number of primordial follicles and reduced apoptosis in oocytes (Zhang 
et al., 2014). Finally, in bovine, miRNAs miR-21-5p, -21-3p, -222, -155, -199a-5p are 
upregulated in atretic follicles compared to healthy follicles meaning that these 
miRNAs possibly form a regulatory network which promotes atresia (Donadeu et al., 
2017). 
Moreover, the formation and normal function of the corpus luteum (CL) appears 
to be regulated by miRNAs. Firstly, Dicer1 knockouts display impaired growth of 
capillary vessels in the ovary which results in CL insufficiency. More specifically, the 
lack of miRNAs miR-17-5p and let-7b leads to dysregulation of the anti-angiogenic 
factor tissue inhibitor of metalloproteinase 1 (Timp1) which results in impaired 
angiogenesis (Otsuka et al., 2008). The follicular-luteal transition and CL regression 
are also under miRNA regulation. In ruminants, 17 miRNAs are differentially 
expressed during luteal transition and these miRNAs regulate at least 29 gene targets 
specifically involved in follicular differentiation (McBride et al., 2012). Specifically, 
miR-503 is a key-factor during luteinisation as this miRNA targets, amongst others, 
hormone receptors in the ovary (Fshr, Lhr, Ar, E2r, Actr, Lhr), cyclin and caspase 
genes that altogether are directly involved in CL formation and maintenance (Lei et 
al., 2010). Reduction of this miRNA in pre-ovulatory follicles marks the onset of 
luteinisation and its expression is restored in subsequent CL development (Lei et al., 
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2010, McBride et al., 2012). Furthermore, 7 miRNAs are preferentially expressed in 
non-regressed CL and 6 miRNAs are highly expressed in regressed CL in bovine. Of 
these, miR-378 is upregulated by 8.54-fold in non-regressed CL and this miRNA plays 
an anti-apoptotic role in luteal cells by targeting interferon gamma receptor 1 
(IFNGR1) and suppressing its expression (Ma et al., 2011). Considering the above, 
miRNAs are indispensable molecules for the CL formation, maintenance, and 
regression in female reproduction. 
Due to their numerous actions in female reproduction, the value of miRNAs as 
biomarkers is under research. Currently, miRNA profiling in cumulus cells and 
follicular fluid (FF) are promising non-invasive approaches for assessing the oocyte 
quality, embryo developmental potential, and even predicting the reproduction 
outcome in assisted reproduction cycles. Unfortunately, preliminary evidence shows 
that miRNA expression profiles in cumulus cells of oocytes that formed blastocysts 
and non-cleaved oocytes were not significantly different in the bovine species (Uhde 
et al., 2017).  
However, follicular fluid is rich in miRNAs and cell-free miRNAs may have 
roles in follicle maturation (Santonocito et al., 2014, Sang et al., 2013, Da Silveira et 
al., 2015). In bovine, differences in 25 miRNAs in exosomes and 30 miRNAs in non-
exosomal fraction are found between good oocyte quality and poor oocyte quality 
(distinguished by BCB staining) FF samples (Sohel et al., 2013). Regarding circulating 
miRNAs in human FF, miR-92a and miR-130b are over-expressed in samples from 
oocytes that fail to fertilise, miR-888 is over-expressed and miR-214, miR-454 are 
under-expressed in samples that result in impaired Day 3 embryo quality compared to 
top quality embryos (Martinez et al., 2018). In addition, FF samples from oocytes that 
develop into blastocysts have significantly lower levels of miR-663b compared to FF 
CHAPTER ONE: LITERATURE REVIEW 
34 
 
samples from oocytes that do not produce viable blastocysts in women undergoing 
IVF (Fu et al., 2018). Moreover, FF let-7b predicts the development of expanded 
blastocysts with 70% sensitivity and 64.3% specificity and miR-29a is promising as a 
predictor of clinical pregnancy with a sensitivity of 83.3% and specificity of 53.5% in 
a cohort of women with normal ovarian reserve and polycystic ovarian syndrome 
(PCOS) (Scalici et al., 2016).  
MiRNA differences are also found in relation to reproductive diseases in 
women. FF from PCOS patients differentially express 29 miRNAs compared to the 
healthy control group (Butler et al., 2019) and miR-451 is significantly lower in FF of 
women with endometriosis which impairs the developmental potential of embryos 
deriving from this group (Xiong et al., 2019). Although the evidence so far is limited, 
studies on miRNAs as non-invasive biomarkers of female fertility are currently 
ongoing and new evidence is expected to shed more light on the miRNA-mediated 
regulation of human reproduction. 
1.3.3 miRNAs in early embryonic development 
Since miRNAs are by nature regulatory molecules that control thousands of 
genes which in turn create complex molecular networks, it is only logical that miRNAs 
actions are pivotal in early embryonic development. During the initial stages of 
development tightly-controlled cellular processes support the normal growth of an 
embryo – this is the result of cooperative action of epigenetic reprogramming, DNA 
synthesis, cellular proliferation, division, cell differentiation, programmed cell death 
(just to name a few) – and miRNAs are key-factors mediating these pathways. Initially 
miRNAs are transferred to the zygote upon fusion of the parental gametes and 
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fertilisation, hence the miRNA cargo in the zygote is of parental inheritance until the 
zygote genome activation (ZGA) takes place to transcribe the RNA machinery. 
Sperm-borne miRNAs are crucial for the early stages of embryo development 
and there is evidence to support that paternal transfer of miRNAs at the time of 
fertilisation is required for normal embryo developmental potential. For instance, 
sperm from Drosha and Dicer knockout male mice is able to fertilise wild-type eggs, 
but the embryos created have significantly impaired developmental potential in terms 
of disrupted maternal transcript turnover and failure of zygotic gene activation. 
Interestingly, when wild-type sperm is injected to these embryos, the deleterious 
knockout effects are reversed (Yuan et al., 2016).  
Altered expression of a single paternal miRNA can also affect normal embryo 
development. Indeed, paternal miR-34c is necessary for the zygotic division and 
absence of this miRNA supresses the first cleavage division possibly via inhibition of 
DNA synthesis and modulation of the Bcl-2 pro-apoptotic factor (Liu et al., 2012). 
Moreover, sperm-borne miR-216b is associated with low fertility in bovine, 
specifically affecting cell proliferation via K-RAS targeting which affects the first 
cleavage rate, division number, and blastocyst cell number in the resulting embryos 
(Alves et al., 2019). In mice it is estimated that around 20% of miRNAs found in the 
nuclear and peri-nuclear compartments of spermatozoa are introduced into the oocyte 
upon fertilisation (Amanai et al., 2006). It is therefore evident that the spermatozoon 
does not only transfer the DNA, acrosome enzymes, and the oocyte activation factor 
PLCζ, but is also contributing to the RNA content in the early embryo which is 
essential for the initial stages of development. 
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Maternal contribution of miRNAs is necessary for normal embryonic growth. 
Even though the embryo transcribes its own miRNAs upon zygote genome activation, 
oocyte miRNAs are vitally important for the early stages of development and their 
loss or malfunction has consequences in further embryonic development. miRNA 
expression patterns in mature oocytes are similar in zygotes which is a first indication 
that the miRNAs detected in zygotes are maternally inherited and not de novo 
transcribed. miRNA levels then dramatically drop through global active degradation 
(~60%) before the embryo initiates the transcription of embryonic miRNAs (Tang et 
al., 2007). To investigate the effects of maternal miRNA absence, specific deletion of 
Dicer is used to block miRNA cleavage and deactivate the mature miRNA cargo in 
growing oocytes. Interestingly, deletion of this gene in Dicer mutant oocytes results 
in gene dysregulation (specifically upregulation) of more than 1/3 of genes expressed 
in control oocytes which means that miRNAs control gene expression of an 
astonishingly large number of genes. Naturally embryo growth is impaired in mutant 
mice, with zygotes failing to progress through the first cell division mainly due to 
anomalies in spindle formation (Tang et al., 2007). 
Unlike the highly differentiated gametes, the early embryo is able to differentiate 
into any cell type. The totipotency properties are gained by extensive molecular 
reprogramming which starts with degradation of the maternal transcriptome (loss of 
oocyte identity) and is followed by reprogramming of gene expression (through 
alterations in epigenetic marks) during the ZGA (2-4-cell stage in mouse, 4-8-cell 
stage in human, 8-16-cell stage in bovine) (Svoboda et al., 2015). miRNAs likely play 
some roles in ZGA, as the maternal miRNA cargo is present up to this event with the 
most abundant family being the let-7, followed by miR-30 and miR-16. Maternal 
miRNA levels rapidly decline as the embryo approaches the two-cell stage (mouse 
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species), and the zygote transcribes its own miRNAs with the miR-290 family being 
the earliest de novo synthesised. There are also maternal-zygotic miRNAs present in 
oocytes and embryos, like the miR-17-92 cluster, miR-103, miR-342, and miR-200 















Upon development of mouse embryos, there is a shift in the presence of small 
RNA molecules from predominantly siRNAs and piRNAs at the zygote to 
predominantly miRNAs by the blastocyst stage (Ohnishi et al., 2010). This is further 
supported by the lowered expression of genes involved in the canonical biogenesis of 
miRNAs at the zygote stage. In specific, the genes for Dgcr8 and Drosha splicing 
enzymes, the Dicer processing protein, Exportin5, and the Ago-1, -2, -3, -4, -5 loading 
proteins are all downregulated in zygotes. The expression of Ago-1 -3 -4 increases 
again in the 2-cell embryo and of Ago-2  in 4- and 8-cell embryos (García-López and 
Figure 1.10 miRNAs involved in embryonic development. The miRNAs are listed 
according to their expression profiles and actions in each stage using available literature 
around mammalian embryogenesis. However, the exact roles may differ between different 
species. 
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del Mazo, 2012). Thus the embryos have reduced capacity to process miRNAs at the 
very early stages of embryogenesis. However, miRNA duplexes or bound-to-target 
forms are protected by degradation and potentially act as a reservoir of mature 
miRNAs for functional use in cells without the need for canonical processing (García-
López and del Mazo, 2012).  
In early zygotes and 2-cell stage mouse embryos miRNAs are also protected 
from massive degradation through a modification at the miRNA strand (3´ mono- and 
oligo-adenylation), and this modification is removed after the 2-cell stage to enable 
the embryo to recruit active miRNAs and regulate genes important in embryonic 
development (Yang et al., 2016). In support of the above, Dgcr8 oocyte and zygotic 
knockouts do not show impaired pre-implantation development, with normal 
allocation patterns of inner cell mass and trophectoderm populations. The 
transcriptomic profiles between wild type and Dgcr8 null oocytes are identical, 
meaning that miRNAs biogenesis is not essential during oocyte maturation and early 
pre-implantation development and that the inherited stock of miRNAs is sufficient to 
carry out gene regulation in these stages whereas other small RNAs likely have more 
prominent roles than miRNAs in early embryogenesis (Suh et al., 2010). 
Knockout studies shed some light on the importance of miRNAs in later stages 
of embryonic development. Deletion of Dicer1 is embryonically lethal, with the 
number of Dicer1-null embryos being ~50% lower than expected. At Day 7.5 of 
development these embryos are depleted of stem cells, and they do not express neither 
the primitive streak marker T brachyury or stem cell marker Oct4 (Bernstein et al., 
2003). Moreover, Dgcr8 knockouts arrest early by Day 6.5, and their stem cells fail to 
silence self-renewal upon differentiation. Upon chemical induction of differentiation 
(with retinoic acid) the stem cells abnormally continue to express pluripotency 
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markers Oct4, Rex1, Sox2, and Nanog which suggests that miRNA functions are 
necessary for lineage commitment at the blastocyst stage (Wang et al., 2007). 
MiRNA are expressed in a temporal fashion in early embryogenesis, with miR-
125a expression at the 4-cell stage, miR-127 and miR-145 predominantly at the 8-cell 
stage, miR-208 and miR-496 at the morula stage, and miR-25 at the blastocyst stage 
in bovine (Tesfaye et al., 2009). In mice, miR-450 and miR-503 are abundant in  
2-cell stage embryos, miR-211, -294, -293, -103 in 4-cell, miR-292, -182, -34b, -30c 
in 8-cell, miR-140 in morula, and miR-15b, -204, -106a in blastocysts (Viswanathan 
et al., 2009). It is likely that although early embryos do not synthesise their own 
miRNAs, specific stored miRNAs are activated and have roles in different stages of 
development, possibly involved in proliferation, DNA synthesis, cell communication, 
and differentiation. 
Unfortunately, there is limited evidence on the exact roles of miRNAs in 
embryogenesis. MiR-29b facilitates the establishment of gene imprinting at the ZGA 
by downregulation of Dnmt3a/4b – the suppression of methyltransferases at this stage 
safeguards proper DNA demethylation (Zhang et al., 2015). Moreover, miR-29b is 
involved in pluripotency after the morula stage by promoting the expression of Klf4 
and Nanog pluripotency markers (Wang et al., 2016). The miR-290/302 cluster 
facilitates the transition from naive pluripotency to primed pluripotency – a 
prerequisite for lineage commitment in embryos (Gu et al., 2016). Additionally, 9 
miRNAs (miR-297, -96, -214, -125a, -424, -21, -29c, -376a, and let-7) are candidate 
miRNAs involved in trophectoderm specification and maintenance of pluripotency in 
mouse embryos (Viswanathan et al., 2009). 
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1.3.4 miRNAs in spent culture medium 
MiRNAs regulate the expression of thousands of genes, circulate in biological 
fluids and travel in distant organs to exert their regulatory actions, serving thus as 
secretory molecules (Cortez et al., 2011). miRNAs are protected by degradation 
because they are either enclosed in exosomes or bound in proteins, lipids, or apoptotic 
bodies (Xu et al., 2013) and thus they are resistant to repetitive freeze/thaw procedures, 
can be stored for prolonged times in the freezer without degrading, and are also stable 
after pH changes (Xi et al., 2008). Due to these natural characteristics of miRNAs, 
scientists of the reproduction field suggested that these molecules may serve as non-
invasive biomarkers for embryo selection purposes and prediction of clinical outcomes 
in IVF cycles. It was therefore hypothesised that if miRNAs could be isolated and 
detected in spent culture media (SCM) of embryos and specific miRNAs correlated 
with embryo quality and/or clinical outcomes, then miRNA analysis of SCM could be 
a valuable method for increasing IVF success. 
The first results linking miRNAs with ART outcomes come from a study 
conducted by McCallie et al. (2010) that found six miRNAs (let-7a, miR-19a, -19b, -
24, -92, -93) significantly under-expressed in blastocysts produced by infertile patients 
(PCOS or known male factor infertility) compared to fertile donor controls. The 
predicted gene targets of these miRNAs were involved in several processes of pre-
implantation development such as transcription, cell growth, proliferation, and 
differentiation. Further analysis of three selected targets (ARIH2, KHSRP, NFAT5) 
showed that their expression was indeed altered and consistent with the aberrant 
miRNA expression profiles. Importantly, this study was the first to show that 
morphologically similar embryos expressed aberrant miRNA levels relating to 
infertility. The authors further suggested that quality might be impaired in the embryos 
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produced by infertile patients as a result of abnormal miRNA expression (McCallie et 
al., 2010). 
In a later study, 754 miRNAs were assayed in human donated blastocysts and 
the association between their expression with the chromosomal status (euploidy) of 
the embryos was examined (Rosenbluth et al., 2013). It was found that 39 miRNAs 
were differentially expressed between euploid and aneuploid embryos, with four of 
them (miR-141, -27b,, -339-3p, -345) demonstrating an >8-fold difference in 
expression in euploid embryos. Gene target scan analysis showed that these genes 
were all critical for embryo development and differentiation, being involved in cell 
signalling pathways, adhesion, and proliferation. The results of this study highlighted 
the potential use of miRNA analysis for PGT-A assessment in IVF cycles. 
Additionally, it was the first study to report differential expression according to the 
sex of the human embryo, meaning that when miRNA profiling is carried out in 
embryos the result may vary due to the sex (Rosenbluth et al., 2013). 
So the above studies formed a strong basis for further research on miRNA roles 
in assisted reproduction. The next step was to prove that mammalian embryos actually 
release miRNAs in the surrounding micro-environment, which is necessary for using 
miRNA profiling as non-invasive assessment method. Initially Kropp and colleagues 
(2014) examined the presence of 5 miRNAs (miR-25, -302c, -196a1, -181a2, -370) in 
the medium of in vitro-cultured bovine embryos. These miRNAs were specifically 
chosen because of their roles on mammalian embryogenesis. Culture media samples 
were collected from individually-cultured embryos and pooled together depending on 
whether the embryo formed a blastocyst or degenerated. The SCM samples and the 
groups of embryos (blastocysts vs degenerate embryos) were then analysed for the 
presence of miRNAs. Furthermore, SCM samples from human embryos were pooled 
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and analysed for the same miRNAs. The results showed that degenerate embryos 
(those that failed to reach blastocyst stage) expressed (intracellularly) significantly 
higher levels of all miRNAs except miR-370. The SCM analysis found that at least 
one of the miRNAs, miR-25, is released by both bovine and human embryos and thus 
can be quantified in spent medium. Based on these findings the authors further implied 
that quantification of specific miRNAs secreted in embryo culture media could be used 
for non-invasive embryo quality assessment (Kropp et al., 2014). However, this study 
also pinpointed two main problems of miRNA analysis, namely contamination of 
SCM samples (from serum additives and proteins) and the value of single sample 
analysis as pools of samples might not reflect the status of each individual embryo. 
In a parallel study, Rosenbluth et al. (2014) extended their research to associate 
miRNA secretion from human embryos with their chromosomal status (euploidy) and 
clinical outcomes. Donated PN frozen embryos were cultured to the blastocyst stage 
and SCM from Days 4 and 5 were assayed for a panel of 754 miRNAs. The 
chromosomal status was assessed by analysis of Day 5/6 trophectoderm biopsies. It 
was found that miR-372 and miR-191 are released by human embryos and that SCM 
from aneuploid embryos has significantly higher levels of miR-191. Moreover, further 
experiments were carried out to associate the two miRNAs with clinical outcomes. 
Spent media from Days 4 and 5 were analysed and it was found that both miRNAs are 
present in higher levels in SCM of Day 5 embryos that failed to lead to a live birth. 
Based on these results it was therefore suggested that secreted miRNAs have potential 
value as biomarkers of embryo chromosomal status and clinical outcomes (Rosenbluth 
et al., 2014). 
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Later studies focused on the roles of embryo-released miRNAs in implantation 
as it is the first interaction of the embryo with the maternal body that occurs 
immediately after the end of the pre-implantation embryo development period and 
hence any biological effect of secreted miRNAs would be observed at this stage. A 
study by Cuman and colleagues (2015) specifically focused on the relation of miRNAs 
secreted by human blastocysts with their implantation potential, defined as the number 
of pregnancies that were carried to term. The analysis was carried out in pooled spent 
frozen media samples from Days 3-5 of culture. Their findings showed that from the 
47 miRNAs present in SCM, 19 were exclusively secreted by the group of blastocysts 
that implanted whereas 22 were secreted only by the non-implanted group. Of these, 
miR-661 was the most differentially expressed miRNA and further experiments in 
individual SCM samples verified that non-implanted embryos intensively secrete this 
miRNA whereas in the implanted group this miRNA is undetected (Cuman et al., 
2015). 
MiRNA secretion and implantation were also linked by another study in human 
blastocysts that found that miR-20a and miR-30c are differentially secreted in SCM 
from euploid implanted and non-implanted embryos (Capalbo et al., 2016). The 
implanted group secreted significantly higher levels of the two miRNAs and their 
predicted gene targets were found to be involved in implantation-related pathways by 
in silico analysis. In addition, TE analysis showed that >96% of the secreted miRNAs 
were present in TE cells suggesting overall that the blastocyst stage embryo secreted 
factors to the environment for its interaction with the uterine wall and its subsequent 
implantation. Interestingly, culture media from the cleavage and morula stages were 
also analysed and showed similar results with the blank controls suggesting thus that 
only blastocyst media is useful for miRNA profiling, especially for individual sample 
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analysis (Capalbo et al., 2016). This finding is in agreement with the suggestion that 
embryos produce their miRNA machinery after ZGA for cellular functions and they 
become secretory at the later stages (blastocyst) where they package and release 
miRNAs for inter-cellular communication with the endometrium which ultimately 
regulates implantation (Liang et al., 2017). The relevant miRNA studies published so 
far are discussed throughout this thesis and are presented in summary in Table 1.1. 
Further thorough details for each study can be found in Appendix A. 
 
Table 1.1 Summary of studies in relation to miRNAs in spent culture media of embryos 




Reference Species Primary findings 
Kropp et al. (2014) bovine, 
human 
miRNAs are released by human and bovine 
embryos 
Rosenbluth et al. (2014) human miRNAs in SCM are candidate biomarkers of 
aneuploidy and clinical outcomes 
Kropp and Khatib (2015) bovine miRNAs in SCM are candidate biomarkers of 
embryo quality 
Cuman et al. (2015) human miRNAs in SCM are potential predictors of 
implantation outcome 
Capalbo et al (2016) human miRNAs in SCM derive from the TE and may be 
predictive of implantation potential 
Borges et al. (2016) human miRNAs in SCM can predict implantation failure 
Lin et al. (2019) bovine miRNAs in SCM can be used as biomarkers of 
embryo developmental potential 
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1.4 Rationale and hypothesis 
Refined methods for assessing the embryonic quality prior to transfer are needed 
in order to improve IVF success rates worldwide. Choosing the embryo with the higher 
potential to implant and develop further into a healthy foetus will benefit first and 
foremost the thousands of patients undergoing IVF each year, financially, physically, 
and psychologically, as well as national and private healthcare systems that cover to 
costs of IVF. Ideally an embryo assessment method should be quick, easy, safe, 
sensitive, accurate, reproducible, and cost-effective. Collection of the medium in 
which an embryo has developed until the latest pre-implantation stages is safe for the 
embryo (non-invasive) and easy for the embryologist (no training required, no special 
equipment). Further analysis with established biomolecular methods fulfill the 
requirements for sensitivity, accuracy, reproducibility, and cost-effectiveness. 
MicroRNAs are key-factors of gene regulation in mammals, they circulate in 
body fluids and exert secretory functions (-cortez et al., 2011), and they are resistant 
to environmental changes (Mitchell et al., 2008, Xi et al., 2008). As such, miRNAs 
are candidate molecules for non-invasive techniques in research and clinical 
applications. In the last decade, analysis of spent culture medium for the presence of 
miRNAs has emerged as a method for determining the quality of an embryo and 
predicting clinical outcomes (Appendix A). As described in detail in this Chapter, 
miRNAs form complex molecular networks and pathways that have pivotal regulatory 
roles in the specialisation and maturation of mammalian gametes, fertilisation, and 
embryonic growth. However, there is a lack of evidence regarding specific miRNA 
roles in embryo development and there is no deep understanding how miRNAs are 
released by embryos and what is the biological role of miRNAs at the peri-
implantation period. 
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The hypothesis in the present thesis is that mammalian embryos release specific 
miRNAs that are indicative of their developmental potential and quality. For this, 
specific miRNAs were investigated in relation to two processes that are essential for 
normal embryonic growth: developmental dynamics/kinetics and apoptosis. These 
served as measurable outcomes that directly reflect on the potential of an embryo to 
implant and establish a healthy pregnancy. It was moreover suggested that miRNA 
release is triggered by certain processes/cues in a selective manner rather than this 
being a passive and random process. Lastly, it was further hypothesised that embryo-
released miRNAs have secretory functions and cause changes in endometrial cells 
acting as mediators of the embryo-maternal communication. 
1.5 Aims and objectives 
Initially, the aim was to verify that current molecular methods can be employed 
to detect miRNAs in minimum volume of medium from single-cultured embryos. The 
relevant miRNA studies have pooled media samples and grouped them according to 
different criteria (Kropp et al., 2014, Rosenbluth et al., 2014, Capalbo et al., 2016), 
which introduces bias and increases the risk of false positive/negative findings. 
Moreover, the use of miRNAs for non-invasive purposes is only clinically relevant 
when it applies to selection of a single embryo for transfer, meaning that this method 
needs to be refined for SCM deriving from single-cultured embryos. Therefore, the 
use of qPCR technology was firstly attempted to establish a detection protocol for the 
purposes of single embryo assessment. qPCR method was readily available at the time 
and it is a known technology that is highly sensitive and accurate and has been used 
for pre-implantation genetic testing of embryos.  
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After this was achieved, the aim was then to link specific miRNAs with the 
developmental potential of embryos, measured quantitively as duration of stages and 
events using time-lapse monitoring, and the DNA quality, expressed as apoptotic 
index at the blastocyst stage. The morphokinetic properties and apoptotic index served 
thus as measurable outcomes of embryonic quality which directly reflect on the 
potential of embryos to implant and establish a healthy pregnancy. The present study 
therefore explored the potential value of miRNA analysis on assessing the quality of 
embryos, even in cases where this is not phenotypically obvious. The only publication 
regarding miRNAs in SCM and embryo quality grouped the embryos in those that 
reached blastocyst stage and those that degenerated (Kropp et al., 2014), which 
however renders miRNA analysis redundant since degenerate embryos are easily 
detected through the microscope and will of course be excluded for transfer. The 
established protocol and the first study along with the findings are described in detail 
in Chapter 3. 
Where there was an association between apoptosis and miRNA in SCM, the 
mechanism involved was further explored. Usually, miRNA studies transfect miRNA 
mimics in embryos (Kropp and Khatib, 2015, Lin et al., 2019) or use in silico target 
prediction tools to explain their findings (Rosenbluth et al., 2014, Capalbo et al., 
2016). It is a common misconception to assume that miRNA levels in spent medium 
reflect on the intra-cellular content, i.e. the more miRNA you have in SCM the more 
you have inside the blastocyst cells. However, no study has proven yet that extra-
cellular miRNA levels are in concordance with the intra-cellular content. It is 
important to establish the direction of association between miRNA release and 
embryonic quality in order to understand whether miRNAs have functions as secretory 
molecules at the window of implantation or they are randomly released and serve no 
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other actions outside the embryonic cells. In Chapter 4, the direction of association 
was investigated firstly by measuring intra- and extra-cellular miRNA levels in 
individual embryos and running correlation tests and secondly by artificially causing 
apoptosis at the blastocyst stage and then measuring SMC miRNA levels to identify 
any differences. Hence the mechanism of release of specific miRNAs was further 
investigated to understand whether miRNAs are passively and randomly extruded by 
cells or there is an active cellular process involved to miRNA packaging and release 
which suggests a secretory function for these molecules. 
The experiments in Chapters 3 and 4 were carried out using the mouse as a 
model organism to study mammalian pre-implantation embryo development. The 
mouse embryo was initially chosen due to the fact that pre-implantation development 
has many shared events between humans and mice, the genomes between the species 
are ~85% identical, and the mouse has been used extensively in embryo studies in the 
past with detailed information available in the existing literature. Additionally, mouse 
embryos are ideal to study morphokinetic events due to their cytoplasmic appearance 
which is almost transparent making thus observations and annotations quite easy. 
However, some miRNAs that were studied in these chapters were mouse-specific and 
exist in homologue conserved clusters in other mammalian species. Because this thesis 
involves basic scientific research that ultimately aims to form a strong basis for 
applications in humans, it was suggested that the preliminary findings be reproduced 
in another mammalian species with the exact same miRNA sequence as the human. 
Hence in Chapter 5 bovine embryos were cultured and the levels of specific miRNAs 
were measured in SCM in relation to apoptosis. This study confirmed the roles of 
specific miRNAs in relation to embryonic quality and as such it opened the way 
towards the final experiments. 
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Finally, effects mediated by miRNAs in endometrial cells were examined to 
elucidate the biological reason behind embryo-secreted miRNAs at the peri-
implantation period. miRNAs control cell processes in embryonic and uterine cells 
(Liang et al., 2017), are actively released (Kropp et al., 2014, Vilella et al., 2015), and 
internalised by blastocysts and endometrial cells (Vilella et al., 2015, Burns et al., 
2016), meaning that these molecules likely act as mediators of the embryo-maternal 
interactome at the window of implantation. Possibly circulating miRNAs function as 
regulators of implantation by triggering cell signalling cascades and controlling the 
expression of adhesion molecules, inflammatory proteins, and growth factors. 
However, to date there is no published work about miRNA gene targets in endometrial 
cells using large-scale platforms. Therefore, in Chapter 6 the effects of a specific 
miRNA on human endometrial cells were studied using transfections in cell cultures 
and microarray gene profiling. This study concluded the research presented in the 
present thesis and provides a holistic picture of the roles of specific miRNAs in 
mammalian reproduction. 
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2. CHAPTER TWO: METHODOLOGY 
2.1 Mouse embryo culture 
Frozen 1-cell stage mouse embryos (B6C3F-1 × B6D2F-1 strain) were thawed 
in Hepes-buffered medium (Sigma-Aldrich, UK) following the manufacturer’s 
instructions (Embryotech, USA). The embryos were individually placed in micro-
wells of EmbryoSlides™ (Vitrolife, Sweden) previously prepared with 25 µL of 
Embryomax KSOM medium overlaid with 1.4 ml of Embryomax light mineral oil 
(Merck, UK) and equilibrated at 37oC in 5% CO2. The embryos were cultured in the 
EmbryoScope™ time-lapse incubator (Vitrolife, Sweden) at 37oC and 5% CO2 until 
they reached the full blastocyst stage (~80 h post-thaw). 
2.2 Triple blastocyst staining (FITC/TxRed/DAPI) 
All staining steps are performed in glass plates coated with Sigmacote (Sigma-
Aldrich, USA). The blastocysts were separately placed in 4% PFA for 12 min at room 
temperature for fixation. After washing in 2% BSA/PBS, the TritonX100 reagent 
(Sigma-Aldrich, USA) was used at a 0.1% concentration for permeabilising the 
membranes. The embryos were washed and placed in drops containing the primary 
antibody H2AK119Ub (1:200) (Cell Signaling Technology, USA) overnight under 
mineral oil at 4oC. The next day, the blastocysts were incubated with the Anti-Rabbit 
IgG secondary antibody (1:300) (Alexa Fluor 488 FITC-conjugated) under mineral oil 
at room temperature for 1 h. Next, they were washed twice in 2% BSA/PBS and 
stained for apoptosis using the TdT-mediated dUTP-X nick end labelling method 
(TUNEL) with the In Situ Cell Death Detection Kit with TMR red following the 
manufacturer’s instructions (Sigma-Aldrich, USA). Briefly, each embryo was placed 
in a mixture of the Enzyme and Label solutions in a 1 in 10 dilution respectively and 
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the dishes were incubated for 45 min at 37oC. Lastly, the embryos were washed and 
loaded with the Vectashield Mounting Medium containing DAPI (Vector 
Laboratories, USA) in 10-well slides (ThermoFisher, UK) for nuclear staining. 
2.3 Fluorescence imaging 
The embryos were visualised using a Nikon eclipse Ti 90x microscope with an 
adjusted Hamamatsu digital camera (C4742-80-12AG) and the appropriate filters 
corresponding to the maxima excitation and emission wavelengths of the dyes 
(490/525nm Alexa Fluor 488, 596/615nm TxRed, 350/470nm DAPI). The Volocity 
3D imaging software (PerkinElmer Inc., USA) was used to capture images and 
annotate the total cell number (TCN), apoptotic extent, and identify the sex of 
embryos. 
2.4 Time-lapse annotations 
Each embryo was captured with the in-built camera every 15 min at 9 focal 
planes. The EmbryoViewer software (Vitrolife, Sweden) was used to process the data. 
The following morphokinetic events were annotated following previously proposed 
guidelines (Ciray et al., 2014): pronuclei fading (tPNf), first cleavage (t2), division to 
the 3-cell (t3), 4-cell (t4), 5-cell (t5), and 8-cell (t8) stages, start of blastulation (tSB), 
and full blastocyst (tB) stages (Table 2.1). Using this information, the durations of the 
second (ECC2 or t4-t2) and third cell cycle (ECC3 or t8-t4) and the synchronicity of 
the second (s2 or t4-t3) and third cell cycle (s3 or t8-t5), and duration of blastulation 
(dB) were calculated. Additionally, the ratios of the cleavage synchronicities from 2 
to 4 cells (CS2-4), 2 to 8 cells (CS2-8), and 4 to 8 cells (CS4-8) were calculated as 
described previously (Cetinkaya et al., 2015) (Table 2.2). 
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Table 2.1 Exact timings, developmental stage, and criteria used to annotate the time-
lapse parameters of the embryos. 
 
Table 2.2 Calculations of developmental events using the exact timings described above. 
 
 
 Cell stage Criteria 
tPNf Pronuclear fading First frame in which both pronuclei disappear 
t2, t3, t4, t5, t8 2-cell, 3-cell, 4-cell, 5-cell, 8-cell First frame in which the 2, 3, 4, 5, or 8 cells are 
clearly separated by membranes accordingly 
tSB Small blastocoel First sign of blastocoel formation 
tB Blastocyst Last frame before the embryo starts pushing 
against the ZP 
Relative timings Morphodynamic event Calculation 
ECC2 Duration of second cell cycle t4-t2 
ECC3 Duration of third cell cycle t8-t4 
S2 Synchronization of cell divisions t4-t3 
S3 Synchronization of cleavage pattern t8-t5 
CS2-4 2- to 4- cell stage cleavage synchronicity (t4-t3) / (t4-t2) 
CS2-8 2- to 8- cell stage cleavage synchronicity ((t3-t2) + (t5-t4)) / (t8-t2) 
CS4-8 4- to 8- cell stage cleavage synchronicity (t8-t5) / (t8-t4) 
dB Duration of blastulation tB-tSB 
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2.5 miRNA extraction 
2.5.1 miRNA extraction from spent culture media 
When culture was terminated, 20 μL of spent media were collected from each 
embryo, immediately snap-frozen in LN2, and stored at -80
oC. The miRNeasy 
Serum/Plasma Kit by Qiagen (USA) was used for miRNA extraction. The 
manufacturer’s instructions were followed with small alterations to the protocol 
aiming to increase the miRNA concentration (Figure 2.1). The 20 μL samples were 
first diluted 1 in 2 with RNase-free water, 200 μL of the QIAzol Lysis Reagent were 
added, and the homogenate was incubated at room temperature (15-25oC) for 5 min. 
Morover, 3.5 µL of the spike-in control (cel-miR-39-3p, custom-made from 
Invitrogen) concentrated at 10 pmol/µL and 40 µL of choloroform were added and the 
mixture was shaken vigorously and incubated at room temperature for 2-3 min. The 
tubes were centrifuged for 15 min at 12,000 x g at 4oC, 120 µL of the upper aqueous 
phase were transferred to a new collection tube, and 180 µL of 100% ethanol were 
added. The samples were pipetted into RNeasy MinElute spin columns and 
centrifuged at ≥8,000 x g for 15 s, 700 µL of Buffer RWT were then added to the spin 
column and centrifuged for 15 s at ≥8,000 x g. After this, 500 µL Buffer RPE were 
pipetted and the samples were centrifuged for 15 s at ≥8,000 x g. Lastly, 500 µL of 
80% ethanol were added and centrifuged for 2 min at ≥8,000 x g., and the column was 
then centrifuged at full speed for 5 min to dry the membrane. The spin column was 
placed in a new collection tube,  10 µL of RNase-free water were added, and the tube 
was centrifuged for 1 min at full speed to elute the RNA. The samples were stored at 
-80oC until further processing or immediately processed for building cDNA templates. 
 























Figure 2.1 miRNA extraction from culture medium procedure using the miRNeasy 
Serum/Plasma Kit (Qiagen, USA). 
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2.5.2 Total RNA (miRNA + RNA) extraction from blastocysts 
Tubes containing a single blastocyst in 10 µL of RNase-free water were 
immediately immersed in LN2 and stored at -80
oC until extraction. Total RNA was 
extracted using the miRNeasy Micro Kit (Qiagen, USA) (Figure 2.2). Firstly, 700 µL 
of the QIAzol Lysis Reagent were added and the cells were homogenised by vortexing 
for 1 min. The homogenate was incubated at room temperature for 5 min, 3.5 µL of 
the spike-in control (cel-miR-39-3p, custom-made from Invitrogen) concentrated at 
10 pmol/µL and 140 µL of chloroform were added. The samples were shaken 
vigorously for 15 s, incubated at room temperature for 2-3 min, and centrifuged for 15 
min at 12,000 x g at 4oC. Moreover, 350 µL of the upper aqueous phase were collected 
into a new tube and 525 µL of 100% ethanol were added. The samples were pipetted 
into RNeasy MinElute spin columns, centrifuged at at ≥8,000 x g for 15 s at room 
temperature, 700 µL of Buffer RWT were then added to the spin column and 
centrifuged for 15 s at ≥8,000 x g. After this, 500 µL Buffer RPE were pipetted and 
the samples were centrifuged for 15 s at ≥8,000 x g. Lastly, 500 µL of 80% ethanol 
were added and centrifuged for 2 min at ≥8,000 x g., and the column was then 
centrifuged at full speed for 5 min to dry the membrane. The spin column was placed 
in a new collection tube,  14 µL of RNase-free water were added, and the tube was 
centrifuged for 1 min at full speed to elute the RNA. The samples were stored at -80oC 



























Figure 2.2 Total RNA extraction from blastocysts procedure using the miRNeasy Micro 
Kit (Qiagen, USA). 
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2.6 RNA extraction from cells 
The RNease Mini Kit (Qiagen, USA) was used for RNA extraction from 
endometrial stromal cells (Figure 2.3). Firstly, cells were collected in 600 µL RLT 
buffer, 1% β-mercaptoethanol, 1 volume of 70% ethanol was added to the lysate, and 
the samples were loaded onto RNeasy Mini spin clomuns and centrifuged for 15 s at 
≥8000 x g. Then, 700 µL of Buffer RW1 were added and the columns were centrifuged 
for 15 s at ≥8000 x g. The columns were then washed with 500 µL Buffer RPE 
followed by centrifugation at ≥8000 x g for 15 min. This step was repeated with 
extended centrifugation to 2 min. The spin columns were then centrifuged at full speed 
for 1 min to dry the membrane, placed in new collection tubed, and eluted with 20 µL 
of RNase-free water by centrifugated for 1 min at ≥8000 x g. The RNA samples were 
stored at -80oC until further processing. 
2.6.1 RNA clean-up by ethanol precipitation 
This protocol was carried out for the preparation of RNA samples for microarray 
analysis due to the high guanidine salts: RNA concentration ratio which interferes with 
the amplification steps of the microarray protocol. Briefly RNA clean-up was carried 
out using ethanol precipitation, where: RNA sample, 1 µl Glycogen, 1/10th of sample 
volume of 3 M sodium acetate (pH 5.2), and 2 sample volumes of 100% ethanol were 
mixed well and kept at -80oC overnight. The tubes were centrifuged for 15 min, 12.000 
x g at 4oC and the supernatant was discarded. In each sample, 500 µl of cold 70% 
ethanol were added and the tubes were centrifuged for 5 min, 12.000 x g at 4oC – this 
step was carried out twice. Lastly, the pellet was air-dried for ~5 min and the pellet 
was resuspended in appropriate volume of RNase-free H2O (~20 µl/sample) to achieve 
>50 ng/µl RNA concentration. The samples were stored at -80oC until further 
processing. 



























Figure 2.3 Total RNA extraction from cells procedure using the RNeasy Mini Kit 
(Qiagen, USA). 
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2.7 cDNA synthesis from miRNAs 
The TaqMan Advanced miRNA cDNA Synthesis Kit (Applied Biosystems, UK) was 
used for building cDNA libraries from miRNAs. Firstly, the Poly(A) Reaction Mix 
was prepared using the volumes depicted in Table 2.3 for the appropriate number of 
reactions (samples). For each reaction, 1.3  μL of Poly(A) Reaction Mix were mixed 
with 3.7 μL of miRNA eluate. The tubes were placed into the Techne Touchgene 
Gradient Thermal Cycler, model FTGRAD2D (Techne, USA), and incubated 
following the conditions described in Table 2.4. 
 
Table 2.3 Reagents and quantities needed for the poly(A) reaction. 
 
 
Table 2.4 Cycling conditions for the polyadenylation reaction. 
Step Temperature Time 
Polyadenylation 37oC 45 min 
Stop reaction 65oC 10 min 




Component Volume (μL) x 1 
reaction 
10X Poly(A) Buffer 0.5 
ATP 0.5 
Poly(A) Enzyme 0.3 
Total Poly(A) Reaction Mix 1.3 
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The adaptor ligation reaction was then carried out by preparing sufficient Ligation 
Reaction Mix for the required number of reactions according to Table 2.5. For each 
reaction, 10 μL of the mix were added to the 5 μL of the polyadenylated miRNA 
product. The tubes were then incubated following the conditions described in Error! 
Reference source not found.. 
 






















Component Volume (μL) x 1 reaction 
5X DNA Ligase Buffer 3 
50% PEG 8000 4.5 
25X Ligation Adaptor 0.6 
RNA Ligase 1.5 
RNase-free water 0.4 
Total Ligation Reaction Mix  10 
Step Temperature Time 
Ligation 16oC 60 min 
Hold 4oC Hold 
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Moreover, the reverse transcription reaction was carried out by preparing the  
RT Reaction Mix for the required number of reactions according to Table 2.7. In each 
tube containing the adaptor ligation reaction product, 15 μL of the RT mix were added 
and the tubes were incubated following the settings of Table 2.8. 
 
Table 2.7 Reagents and quantities for the reverse transcription reaction. 
Component Volume (μL) x 1 reaction 
5X RT Buffer 6 
dNTP Mix (25mM each) 1.2 
20X Universal RT Primer 1.5 
10X RT Enzyme Mix 3 
RNase-free water 3.3 
Total RT Reaction Mix 15 
 
Table 2.8 Cycling conditions for the reverse transcription reaction. 
Step Temperature Time 
Reverse transcription 42oC 15 min 
Stop reaction 85oC 5 min 
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The miRNA amplification reaction was carried out by preparing miR-Amp 
Reaction Mix for the required number of reactions (Table 2.9). For each sample, 45 
μL of miR-Amp were mixed with 5 μL of the reverse transcription product. The tubes 
were incubated in the thermal cycler following the cycling conditions described in 
Table 2.10. 
 
Table 2.9 Reagents and quantities for the miR-Amp reaction. 
Component Volume (μL) x 1 reaction 
2X miR-Amp Master Mix 25 
20X miR-Amp Primer Mix 2.5 
RNase-free water 17.5 
Total miR-Amp Reaction Mix 45 
 
Table 2.10 Cycling conditions for the miRNA amplification reaction. 
Step Temperature Time Cycles 
Enzyme activation 95oC 5 min 1 
Denature 95oC 3 s 14 
Anneal/Extend 60oC 30 s 
Stop reaction 99oC 10 min 1 
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2.8 cDNA synthesis from RNA 
The High Capacity RNA-to-cDNA kit (Applied Biosystems, UK) was used for 
cDNA synthesis from RNA. The reverse transcription mix was prepared using the 
reagents and quantities described in Table 2.11. A minor modification to the 
manufacturer’s protocol was carried out for blastocyst samples due to the low RNA 
concentration. While 5 μL of RNA product were used for endometrial cellls,  9 μL 
were added for each blastocyst sample. The difference was substituted with nuclease-
free water making up to 20 μL of total mix. Lastly, cDNA libraries were built 
following the cycling conditions of Table 2.12. 








volumes used for a blastocysts (Chapter 4) and b for endometrial cells (Chapter 6) 
 
Table 2.12 Cycling conditions for cDNA library building from RNA. 
Setting Step 1 Step 2 Step 3 
Temperature 37oC 95oC 4oC 
Time 60 min 5 min ∞ 
 
Component Volume (μL) 
2X RT Buffer Mix 10 
20X RT Enzyme Mix 1 
RNA sample 9a or 5b 
Nuclease-free H2O 1a or 4b 
Total RT mix 20 
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2.9 PCR for miRNA amplification 
The TaqMan® Universal PCR Master Mix, no AmpErase UNG (Applied 
Biosystems, UK) and TaqMan® Advanced miRNA Assays (20X) (assay information 
in Appendix B) were used for miRNA amplification. Firstly, the PCR Reaction Mix 
was prepared using the reagents and quantities described in Table 2.13. For each 
reaction, 2.5 μL of the cDNA product were added to 7.5 μL of the mix in each well of 
a 96-well PCR plate. The plates were run in the 7500 Fast Real-Time PCR System 
(Applied Biosystems, UK) setting the cycling conditions of Table 2.14. 
Table 2.13 Reagents and quantities for the PCR for miRNA quantification. 
Component Volume (μL) x 1 reaction 
TaqMan® Universal PCR Master Mix 5 
TaqMan® Advanced miRNA Assay (20X) 0.5 
RNase-free water 2 
Total PCR Reaction Mix 7.5 
 





Step Temperature Time Cycles 
Enzyme activation 95oC 20 s 1 
Denature 95oC 3 s 40 
Anneal/Extend 60oC 30 s 
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2.10 PCR for RNA amplification 
The TaqMan® Universal PCR Master Mix, no AmpErase UNG (Applied 
Biosystems, UK) and the corresponding TaqMan® Gene Expression Assays (20X) 
were used for RNA amplification. Firstly, 1:100 dilutions of the cDNA templates were 
prepared for the samples derived from endometrial cells. The samples coming from 
blastocysts were not diluted due to the low RNA concentration. The manufacturer’s 
protocol was generally followed, with small modifications depending on whether 
simplex or duplex reactions were carried out (Table 2.15). For simplex reactions, 2 μL 
of the cDNA product were added to 3 μL of the PCR Reaction mix in each well of a 
96-well PCR plate. For duplex reactions, 2 μL of the cDNA product were added to 8 
μL of the PCR Reaction mix, making a total volume of 10 μL per well. The plates 
were run in the 7500 Fast Real-Time PCR System (Applied Biosystems, UK) setting 
the cycling conditions of Table 2.16. 
 
Table 2.15 Reagents and quantities for the PCR for RNA quantification. 
Component Volume (μL) x 1 reaction 
TaqMan® Universal PCR Master Mix 2.5a or 5b 
TaqMan® Gene expression Assay (20X) 0.25 assay 1 + 0.25 assay 2 (duplex)a or 0.5b 
Nuclease-free H2O 0a or 2.5b 
Total PCR Reaction mix 3a or 8b 
avolumes used for blastocyst samples in duplex PCR reactions (Chapter 4) 
bvolumes used for endometrial cells with single plex PCR (Chapter 6) 
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Table 2.16 Cycling conditions for the PCR for RNA quantification. 
Stage Temperature Time 
Hold 50oC 2:00 
Hold 95oC 0:20 
Cycle (40 cycles) 95oC 0:03 
60oC 0:30 
 
2.11 Analysis of PCR data 
All data were analysed with the 7500 Software V2.3 (Applied Biosystems, UK) 
using the Ct values as read-outs. miRNAs let-7b and cel-miR-39 spike-in were used 
for normalising the Ct values in the experiments were miRNAs were quantified. 
During the optimisation phase of miRNA analysis, let-7b showed consistent, stable 
expression in all samples and was chosen as a normaliser. The spike-in miR-39 is 
recommended by the manufacturer as it is species-specific (C.elegans) and is therefore 
not expected to amplify in samples from other species. Moreover, Rpl5 was chosen 
for normalising the RNA expression in mouse blastocyst samples whereas 18S was 
used for normalising the Ct values in samples from human endometrial cells. The Ct-
value of 35 was used as cut-off to capture all the potentially valid signals in the miRNA 
experiments. The amplification plots were visually examined, the baseline and 
threshold values adjusted where necessary (threshold~0.1), the Ct values were viewed 
and the ΔCt and ΔΔCt values were calculated based on the recommendations by 
Schmittgen and Livak (2008). 
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3. CHAPTER THREE: MIRNAS IN SPENT MOUSE CULTURE 
MEDIUM AS BIOMARKERS OF DEVELOPMENT AND 
APOPTOSIS 
3.1 Introduction 
MicroRNAs are important regulators of cell processes such as stress signalling, 
cell cycle progression, development, differentiation, and apoptosis (Mendell and 
Olson, 2012). During the differentiation of mammalian gametes and the subsequent 
embryo development miRNAs are dynamically expressed in a tightly controlled and 
time-dependent fashion (Hossain et al., 2012, Tang et al., 2007, Du et al., 2014, Qi et 
al., 2013). As described in detail in Chapter 1, miRNAs control normal growth and 
development of the preimplantation embryo. Embryos also release miRNAs in the 
surrounding micro-environment at the peri-implantation period. Therefore, analysis of 
spent embryo culture medium for miRNAs is a promising method for assessing the 
quality embryos in a non-invasive manner. 
To date there are only two published studies that have investigated the 
association between embryonic quality and miRNA presence in medium. Initially 
Kropp and Khatib (2015) identified and characterised miRNAs in SCM of bovine 
embryos with differing developmental competence. In this experiment the embryos 
were cultured in groups to the morula stage at which point they were placed in 
individual culture up to the blastocyst stage. The SCM were then collected and pooled 
according to the developmental status in SCM from degenerate embryos and SCM 
from blastocysts accordingly. Small RNA sequencing technology was used to analyse 
the samples. It was found that degenerate embryos released significantly higher levels 
of 11 miRNAs compared to blastocysts. Based on these findings the authors suggested 
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that miRNAs in SCM indeed have potential as non-invasive biomarkers of quality 
(Kropp and Khatib, 2015). Nevertheless, this study only provided preliminary 
evidence and had two significant limitations that need to be addressed in the context 
of non-invasive embryo assessment. Firstly, the SCM samples were pooled in groups 
and then analysed which increases the probability of false positive/negative findings 
as it is not known whether all embryos release miRNAs and at which levels. Secondly 
in the clinical application degenerate embryos can easily be detected morphologically 
and would never be transferred to the uterus. Thus, there is no need for molecular 
analysis to distinguish between degenerate and normal-looking embryos. As with all 
molecular assessment methods the aim is to distinguish embryos of similar 
morphology and select the one with the best developmental potential for transfer. 
Moreover, a very recent study in bovine embryos questioned whether miRNAs 
in SCM can be used as biomarkers of developmental competence (Lin et al., 2019). 
For this embryos were cultured individually to the blastocyst stage and they were 
grouped according to the timing of the first cleavage (“slow”, “intermediate”, “fast”) 
and the blastocyst formation competence (degenerate, D and blastocysts, B). The SCM 
were pooled for each group and miRNAs were sequenced. It was found that 2 
miRNAs, namely miR-30c and miR-10b, were highly secreted by “slow” embryos 
compared to “intermediate”, miR-45 was higher in the degenerate group whereas miR-
113 and miR-139 were higher in the blastocyst group. In their bioinformatics analysis 
the differentially expressed miRNAs affected pathways related to embryo 
development and apoptosis amongst others (Lin et al., 2019). Although this study 
provided evidence that possibly the miRNA levels in SCM reflect on the 
developmental competence of embryos, there were also some weak points that call for 
caution when interpreting the results. The SCM samples were once again pooled to 
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achieve the concentration needed for sequencing which increases the risk of false 
findings. Even with pooled samples the miRNA was very low for an accurate analysis 
and some groups were consequently excluded. 
3.2 Rationale and hypothesis 
In this preliminary study the initial hypothesis was that miRNAs can be detected 
in spent culture media deriving from single-cultured embryos using available 
technology. It was further hypothesised that embryos release differential levels of 
miRNAs relating to embryo quality which was assessed through the DNA 
fragmentation index and morphokinetic timings. These were chosen as primary 
outcomes since both DNA quality of the blastomeres and the morphokinetic 
characteristics of embryos reflect on the potential of embryos to implant, grow further, 
and establish a healthy pregnancy. Overall, the hypothesis of this first experiment was 
that miRNA analysis of spent culture medium from single-cultured blastocysts can be 
used as a non-invasive method to identify embryos of different quality and potential. 
If this proves to be true then it could form a strong basis for future research and clinical 
applications in human assisted reproduction technologies. 
3.3 Aims and objectives 
Although miRNAs are intensively studied lately, there is still limited evidence 
regarding the involvement of specific miRNAs on key-processes controlling embryo 
pre-implantation development. Considering the lack of information, the aim of the 
study presented in this chapter was to examine whether embryo-released miRNAs 
reflect on two processes that are essential for embryonic growth: developmental 
dynamics/kinetics and apoptosis. More specifically, it was examined whether certain 
developmental events occurring at the pre-implantation stages are linked to the active 
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release of specific miRNAs. The mouse embryo was used as a model organism in the 
context of this study. 
In this study, the levels of miRNAs in SCM of mouse blastocysts were measured 
and analysed in relation to morphokinetic annotations and extent of apoptosis. For this, 
miR-24, miR-124, miR-291a, and miR-294 were studied as candidate biomarkers 
because they have key actions in proliferation, differentiation, and cell death. For 
instance, miR-24 inhibits proliferation through direct targeting of cell cycle genes 
E2F2 and MYC (Lal et al., 2009) and is additionally involved in apoptosis (Wang et 
al., 2014, Wang and Qian, 2014).  Moreover, miR-124 targets CDK6, an important 
protein for G1/S transition (Lujambio et al., 2007) and induces apoptosis (Yuan et al., 
2017). MiR-290 family members are amongst the earliest miRNAs expressed de-novo 
in embryonic development in mice. MicroRNAs miR-291a and miR-294 promote cell 
divisions by translational regulation of the G1/S factor Cdkn1a. These miRNAs 
promote cell survival by targeting apoptotic mediators Casp2 and Ei24 (Zheng et al., 
2011, Li et al., 2017). Finally, all four miRNAs act on pluripotency factors such as 
Nanog and Oct4 regulating this way cellular differentiation, a process that is crucial 
for normal developmental progress (Marson et al., 2008, Furuta et al., 2010, Lee et al., 
2016).  
For the purposes of this study it was essential to have a detailed picture on the 
association of the miRNAs with development and apoptosis. Therefore, individual 
samples of SCM deriving from single-cultured embryos were analysed - a technical 
approach which has not been reported previously. miRNA data were then associated 
with morphokinetic information and apoptotic percentage for each embryo 
individually. Morphokinetics were assessed using time-lapse incubation technology 
because it allows to continuously monitor the embryos and annotate dynamic events, 
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cleavage patterns, and timings of events and extract detailed descriptive information 
about the development of each embryo individually. Embryo quality was assessed by 
using specific apoptosis detection staining and calculating the percentage of apoptotic 
cells at the blastocyst stage. 
3.4 Methodology 
3.4.1 Embryo culture, morphokinetic annotations, and blastocyst scoring  
Preliminary experiments were firstly carried out to establish the methodology 
and design the experimental procedure. After this, 1-cell stage mouse embryos (N=70) 
(B6C3F-1 x B6D2F-1) were thawed and cultured until Day 5 of development (80 h 
post-thaw) in EmbryoScope in 2 consecutive repetitions of this experiment following 
the protocols described in Section 2.1. Morphokinetic annotations were carried out 
according to the criteria provided in Section 2.4 and the data were processed to 
generate the absolute and relative timings to the various developmental stages using 
the time of pronuclear fading (tPNf) to normalise the values (time O). Moreover, 
fragmentation percentage at the 4- and 8-cell stages, multinucleation at the middle of 
t3-t2 and t5-t4 intervals, and blastomere size at the 2-, 4-, 8-cell stages were noted as 
morphological markers of embryo quality. Lastly, the blastocysts were graded at the 
specific timeframe of 70.0-70.3 h (post-thaw) based on the quality of the 
trophectoderm and inner cell mass (Table 3.1) as good, fair, or poor morphology 
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Table 3.1 ICM and TE characterisation criteria used to score the blastocysts. 
Grade ICM TE 
A Prominent, easily discernible, with many 
cells that are compacted and tightly 
adhered together 
Many cells forming a cohesive 
epithelium 
B Easily discernible, with many cells that 
are loosely grouped together 
Few cells forming a loose epithelium 
C Difficult to discern, with few cells Very few cells 
 







3.4.2 Blastocyst staining 
To exclude sex-related differences in miRNA expression as reported for other 
species (Rosenbluth et al., 2013, Gross et al., 2017b) sexing of embryos was carried 
out. Sex determination was based on the molecular phenomenon of X inactivation 
which happens at the blastocyst stage in female mouse embryos. Histone 2a ubiquitin 
is enriched in the inactive X chromosome (Xi) in females, therefore by immuno-
targeting this protein a Xi patch appears in cells of female embryos. Furthermore, the 
embryos were stained for apoptosis using the TdT-mediated dUTP-X nick end 
labelling method (TUNEL) - a well-established method for apoptosis detection in 
mammalian embryos, including murine (Abdelhafez et al., 2011), bovine (Vichera et 
al., 2014), porcine (Chen et al., 2018), and human embryos (Li et al., 2012). Thus, the 
SART grade Embryo grade (ICM/TE) 
Good AA, AB 
Fair BA, BB, BC 
Poor CB, CC 
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blastocysts were separately stained following the triple staining protocol described in 
section 2.2. The embryos were visualised with fluorescent microscopy (2.3), the sex 
was identified and the apoptotic extent at the blastocyst stage (% apoptotic cells / total 
cell count) was assessed for each embryo. 
3.4.3 miRNA quantification 
Spent culture media were collected from each well of the EmbryoSlides where 
embryos were cultured along with blank media controls from wells not exposed to 
embryo culture. The samples were placed in PCR 0.2 ml microtubes which were 
immediately immersed in LN2 and stored in -80
oC until further processing. miRNAs 
were extracted from each sample according to the protocol provided in Section 2.5.1. 
The products were either stored for a short period of time in -20oC or immediately 
processed further. cDNA libraries were built (2.7) and PCR was carried out (2.9) to 
amplify the miRNA signals and quantify the expression. The probes used in this study 
are listed in the table below (Table 3.3). The data were analysed with the 7500 
Software V2.3 (Applied Biosystems, UK) using the Ct values as read-outs (2.11). The 
let-7b-3p miRNA was used for normalising the Ct values. The Ct-value of 35 was used 
as cut-off to capture all the potentially valid signals. 
Table 3.3 miRNA assays used for amplifying each miRNA. The target miRNA and the 
mature sequence are displayed. 
TaqMan miRNA probes 
Target Assay name MiRBase accession 
number 
Mature miRNA sequence (5’-3’) 
miR-291a mmu-mir-291a-3p MIMAT0000368 AAAGUGCUUCCACUUUGUGUGC 
miR-294 mmu-mir-294-3p MIMAT0000372 AAAGUGCUUCCCUUUUGUGUGU 
miR-24 hsa-miR-24-3p MIMAT0000080 UGGCUCAGUUCAGCAGGAACAG 
miR-124 mmu-mir-124-3p MIMAT0000134 UAAGGCACGCGGUGAAUGCC 
let-7b hsa-let-7b-3p MIMAT0004482 CUAUACAACCUACUGCCUUCCC 
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3.4.4 Statistical analysis 
The Statistics Clinic at the School of Medicine (UoN) was consulted for the 
processing of the data produced throughout the experiments. The SPSS Statistics 26 
software (IBM, USA) was used for data analysis. Data distributions were checked 
using the Shapiro-Wilk test for normality and visual examination of the histograms. 
Values greater than twice the standard deviation for each parameter were considered 
outliers and excluded from further analysis. The Kruskal-Wallis test was performed to 
examine the distribution of apoptosis across the good, fair, and poor morphology 
groups. The 2-ΔCt values were used for all statistical tests using the miRNA data 
(Schmittgen and Livak, 2008). Log transformations were carried out where necessary 
to achieve normal distribution of the values. Independent samples t-tests were carried 
out to examine the expression of miRNAs between the sex groups. Spearman’s and 
Pearson’s correlation coefficients were calculated for examining potential correlations 
between morphokinetics and apoptosis with miRNA levels in SCM. A p value of 
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3.5.1 Embryo development 
From the 70 mouse embryos thawed, 59 (84%) cleaved, formed morulae, and 
reached the blastocyst stage by day 4 of culture. After normalisation of the annotation 
data with the tPNf, the average time ± standard deviation (in hours) for each 
developmental stage were calculated and are presented in Table 3.4 and Table 3.5. 
Table 3.4 Average value and standard deviation for the time in hours to reach each 
developmental stage. 
Absolute timing Average (h) Standard deviation (h) 
t2 1.7 0.4 
t3 22.4 1.2 
t4 23.1 1.4 
t5 33.1 1.8 
t8 34.6 1.9 
tB 59.6 2.8 




Table 3.5 Average value and standard deviation for the interval in hours to complete 






Relative timing Average (h) Standard deviation (h) 
ECC2 21.4 1.3 
ECC3 11.5 1.2 
S2 0.7 0.6 
S3 1.5 0.8 
CS2-4 0.03 0.03 
CS2-8 0.9 0.03 
CS4-8 0.1 0.06 
dB 3.2 1.8 
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3.5.2 miRNA expression in spent culture medium 
The SCM from 59 blastocysts were analysed for the presence and levels of the 
miRNAs. All samples amplified for let-7b that was used for normalising the Ct values 
for the rest of the miRNAs. For miR-24, 17 samples (29%) showed amplification 
below the cut-off Ct value and accordingly 36 samples (61%) were positive for miR-
124, 20 (34%) for miR-291a, and 43 (73%) for miR-294. For miR-24 one sample was 
excluded as an outlier, for miR-124 3 samples were outliers, for miR-291a 1 sample, 
and for  miR-294 1 sample was an outlier. The remaining samples for each miRNA 
were either negative or amplified beyond 35 cycles thus being treated as negative 
samples. Blank samples, namely water and culture media not exposed to embryo 
culture, were also run in parallel and showed no amplification for the miRNAs. The 
average and standard error of mean of the Ct and ΔCt values are shown in Table 3.6. 






miRNA Ct ΔCt 
miR-24 33.3 (± 0.5) 28 (± 2) 
miR-124 32.7 (± 0.3) 27.8 (± 1.5) 
miR-291a 31 (± 0.7) 25.7 (± 3.5) 
miR-294 27.8 (± 0.4) 22.9 (± 2.7) 
let-7b 5 (± 0.8)  
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3.5.3 miRNAs and embryo sex 
 A total of 49 blastocysts were successfully stained for sex assessment. Embryos 
in which the FITC dye was highly concentrated in a genomic region in each cell, 
appearing like a green dot, were easily observed and classified as female whereas in 
embryos where the FITC dye was diffused in each cell were classified as male (Figure 
3.1). Sample size differed between sex groups with 30 male versus 19 female mouse 
embryos. The mean miR-24 ΔCt was 28.1 ± 0.7 (SEM) for male embryos and 27.3 ± 
1 for female embryos. MiR-124 was 27.8 ± 0.4 and 28 ± 0.4, miR-291a was 26.9 ± 
0.9 and 23.5 ± 1.4, and miR-294 was 23 ± 0.6 and 22.7 ± 0.6 for male and female 
blastocysts respectively (Figure 3.2). Mean comparisons showed that miRNA levels 
in SCM were similar between male and female embryos (p>0.05). Therefore, further 












Figure 3.1 Mouse blastocysts x40 magnification after triple staining. The DAPI nuclear dye 
was used to count the TCN and the TxRed dye specifically binds to broken DNA, indicating 
this way cell death. The apoptotic extent was calculated by dividing the apoptotic cells with the 
TCN (%). Gender determination was based on the molecular phenomenon of X inactivation. 
Histone 2a ubiquitin is enriched in the Xi in females, therefore by immuno-targeting this protein 
an Xi patch appears in cells of female embryos. In the first row a female embryo is displayed 
with the characteristic FITC nuclear patch whereas in the male embryo (lower row) the dye is 
diffused since Histone 2a ubiquitin is not concentrated in a genomic region. 
CHAPTER THREE: MIRNAS IN SPENT MOUSE CULTURE MEDIUM AS BIOMARKERS OF 













3.5.4 miRNAs and development 
Data from 59 mouse embryos were analysed to examine the relationship 
between pre-implantation development and miRNA levels in SCM. Thus, for each 
embryo miRNA levels were compared with absolute timings (t2, t3, t4, t5, t8, tSB, tB 
- normalised with tPNf) and relative timings of ECC2, ECC3, s2, s3, dB, CS2-8, CS4-
8, and CS2-4. The miRNA levels were not significantly associated with the duration 
of distinct developmental events for most of the dataset. However, a significant 
correlation was found between miR-124 and the duration of blastulation dB (N=36, 
p<0.001) and further analysis revealed that the direction of the association is negative 
(r=-0.528) (Figure 3.3). Post-hoc power calculation with GPower using the sample 
size and correlation value found that the power of this finding reached 0.57 (Faul et 
al., 2009). 
Figure 3.2 Mean ΔCt for each miRNA in male and female embryos. T-bars depict the 
standard deviation for each variable. 
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3.5.5 Morphology, miRNAs and apoptosis 
No signs of fragmentation and multinucleation were observed in the 59 embryos 
while they were cultured in time-lapse. Blastomere size was uneven for 2 embryos at 
the 2-cell stage, 4 embryos at the 4-cell stage, and 5 embryos at the 8-cell stage. Cell 
lysis was observed in 5 embryos that developed into blastocysts. After assessing the 
morphology of 59 blastocysts, 4 were categorised as good, 42 as fair, and 6 as poor, 
whereas 7 embryos had not reached the full blastocyst stage at the 70.0-73.0 interval 
and were not classified. Moreover, 47 blastocysts were stained for apoptosis and the 
average apoptotic percentage was 12% ranging from 0% up to 56% (Figure 3.4). 
Analysis of variance tests showed that the average extent of apoptosis was similar 
across the three morphology groups (good=21 ± 6%, N=4; fair=15 ± 1%, N=37; 
poor=9 ± 1%, N=6) (p>0.05). The 5 blastocysts with signs of cell lysis did not show 
different expression of miRNAs in the respective spent media samples compared to 
Figure 3.3 Scatter plot of miR-124 in relation to duration of blastulation (dB). The 
variables are transformed using log10 (x*10) to achieve a Gaussian distribution. The 
transformed values are depicted in the x and y axis. MiR-124 and dB are significantly 
correlated (N=36, p<0.001) in a negative relationship (r=-0.528). 
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the rest of the population (p>0.05). The SCM levels of miRNAs -24, -124, and -291a 
were not associated with apoptosis (p>0.05). However, miR-294 was significantly 
correlated with the extent of apoptosis (N=36, p<0.001) with Pearson’s correlation 
coefficient revealing a positive relationship between these variables (r=0.560) (Figure 
3.5). The power of the study was found 0.96 in the post-hoc analysis with GPower 
















Figure 3.4  Mouse blastocysts with different apoptotic indexes (x40 magnification). The 
Tx-Red dye specifically binds to broken DNA, indicating this way cell death. On the 
blastocyst on the left the dye is barely detectable whereas on the blastocyst on the left the dye 
marks almost half of the embryo and is localised exclusively in the embryonic part that 
contains the ICM. 
Figure 3.5 Scatter plot of miR-294 in relation to apoptosis. The variables are transformed 
using log10 (x+10) to achieve a Gaussian distribution. The transformed values are used as 
inputs for the x and y axis. MiR-294 and apoptosis are significantly correlated (N=36, 
p<0.001) in a positive relationship (r=0.560). 
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The present experiment shows that miRNA quantification in SCM from single-
culture embryos is possible and provides preliminary evidence linking specific 
miRNAs with morphokinetics and apoptosis. The main findings are that miR-124 is 
inversely associated with the duration of blastulation and miR-294 is directly 
correlated with the extent of apoptosis in mouse embryos. 
3.6.1 Mouse blastocysts release miR-24, miR-124, and the miR-290 cluster in 
spent culture media 
It was hypothesised that miR-24, miR-124, and the miR-290 cluster would be 
found in SCM of embryos since these miRNAs are expressed in embryonic cells 
(Landgraf et al., 2007, Tang et al., 2007, Rosenbluth et al., 2013, Kropp and Khatib, 
2015), control processes involved in embryonic development such as cell cycle 
progression and differentiation (Grandjean et al., 2009, Zhao et al., 2015, Yuan et al., 
2017), and are found in serum meaning that they are released by cells (Rotkrua et al., 
2013, Meng et al., 2014, Santangelo et al., 2017). 
In contrast to other studies that pool SCM samples using different grouping 
criteria (Rosenbluth et al., 2014, Cuman et al., 2015, Kropp and Khatib, 2015, Gross 
et al., 2017b), in the present study its was shown that it is possible to isolate and 
quantify miRNAs from single-cultured embryos. The significance of single sample 
analysis is highlighted by the finding that not all embryos release miRNAs in 
detectable levels, therefore by grouping samples together false positive/negative 
findings are very likely. Indeed the amplification rate ranged from 29% for miR-24 up 
to 73% for miR-294, even when the reference miRNA let-7b was detected. 
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As expected, the presence of the selected miRNAs was verified in the culture 
media of mouse embryos. This finding agrees with studies showing that mammalian 
blastocyst-stage embryos release microRNAs in their environment. This is known for 
two species –bovine blastocysts (Kropp et al., 2014, Gross et al., 2017b) and human 
embryos (Rosenbluth et al., 2014, Cuman et al., 2015, Capalbo et al., 2016). To date 
there are no publications showing similar findings for the mouse embryo. 
Additionally, from the selected panel miR-24 has been found in bovine SCM (Kropp 
and Khatib, 2015) whereas there are no reports for miR-124 and the miR-290 cluster. 
Taken together, these findings show that miRNA analysis is possible for single 
samples and hence could be further explored as a non-invasive embryo assessment 
method. 
3.6.2 miR-24, miR-124, miR-291a, and miR-294 levels do not differ between 
male and female mouse blastocysts 
In mammals there is a surprisingly high density of miRNA sequences on the X 
chromosome and an almost complete absence of miRNA genes in Y chromosome. 
This feature is highly conserved in mammals including humans and it is also observed 
in lower-level organisms like D.melanogaster and C.elegans (Ghorai and Ghosh, 
2014). It is estimated that approximately 10% of miRNA genes are located on the X 
chromosome which according to the miRBase database (www.mirbase.org) 
corresponds to 118 miRNAs of which 62 are classified with high annotation 
confidence (Di Palo et al., 2020). This sex-specific genomic feature equips females 
with a larger miRNA machinery compared to males and possibly contributes to 
gender-biased functions in organisms. Thus miRNA studies in mammalian species, 
and especially those with human implications, need to take into consideration the sex 
as a potentially confounding factor. 
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 Information on differential miRNA expression in embryos come mainly from 
two studies. Initially, Rosenbluth and colleagues (2013) identified 20 miRNAs that 
differed significantly between female and male human embryos (Rosenbluth et al., 
2013). This study analysed biopsy material to quantify the intra-cellular expression of 
754 miRNAs and found that 20 miRNAs are differentially expressed according to 
embryo sex. Of these, 14 miRNAs were more highly expressed in male embryos and 
6 miRNAs were highly expressed in female embryos (Rosenbluth et al., 2013). 
Interestingly from the 20 differentially-expressed miRNAs only 2 are located in X 
chromosome according to miRBase which begs the question: why is there sexual 
dimorphism in expression of miRNAs located in chromosomes other than the X? The 
answer to this remains unclear, however it could be that since miRNAs are relatively 
newly-discovered molecules the genomic context needs to be further investigated and 
validated. In addition, it is highly likely that biological differences in epigenetic 
patterns and endogenous compounds (hormones, cytokines) are responsible since they 
affect the regulation of miRNA expression (Gulyaeva and Kushlinskiy, 2016). 
 Moreover, a study in bovine embryos analysed the expression of 68 miRNAs 
in media collected from female and male blastocysts (Gross et al., 2017b). It was found 
that at least 8 miRNAs were released in significantly higher levels by female 
blastocysts compared to males. Of these, miR-122, miR-22, and miR-320a were 
further validated and supplemented in bovine endometrial epithelial cells to 
investigate the potential roles of these miRNAs in communication with the maternal 
environment. These miRNAs were uptaken by the endometrium where they caused 
transcriptomic changes in implantation-related genes. Based on these findings, the 
authors therefore suggested that there are dimorphic differences in miRNA secretion 
by blastocysts and these can have further effects in the blastocyst-endometrium 
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crosstalk (Gross et al., 2017b). It must be highlighted that although these findings 
show different expression patterns, none of the 8 differentially-released miRNAs are 
located in X chromosome. Once again it could be that biological differences that 
influence miRNA transcription and/or secretion are responsible for the observed 
differences.  
Considering both studies described above it was therefore decided to carry out 
embryo sexing in this experiment to exclude any bias relating to sex, even though none 
of the studied miRNAs are located on X. More specifically, miR-24 is located in 
chromosome 12, miR-124 in chromosome 2 and the miR-290 cluster in chromosome 
7 – all with high annotation confidence according to miRBase. Indeed, in the present 
study these miRNAs were released in similar levels by female and male mouse 
blastocysts and thus sex was not considered as a confounding factor in the following 
statistical analyses. 
3.6.3 Longer blastulation is negatively associated with miR-24 levels in spent 
media 
Due to the involvement of all chosen miRNAs with cell proliferation and growth 
it was expected that the variable expression of these miRNAs in SCM would associate 
with differences in the timings of morphokinetic events. Development was assessed 
by measuring absolute and relative timings of specific kinetic and dynamic events that 
are characteristic in mammalian preimplantation embryo development. For instance, 
blastomere division cycles and blastocoel formation are events that occur during the 
development of bovine, murine, and human embryos amongst other species. In turn 
morphodynamic events are informative regarding the developmental potential of each 
embryo. Indeed in human embryos specific timings reflect on the ability for blastocyst 
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formation, implantation, and post-implantation potential of embryos (Meseguer et al., 
2011, Dal Canto et al., 2012, Cetinkaya et al., 2015, Motato et al., 2016). 
The main finding comes from the comparison of miR-124 and dB where lower 
miR-124 levels were linked to longer duration of blastulation. This association could 
be a result of miR-124 regulatory actions in cell proliferation and differentiation that 
occur at the dB interval.  For instance, during blastulation the first lineage decision 
separates the cells in the TE and ICM populations and by the late blastocyst the ICM 
differentiates further into the epiblast and primitive endoderm (Zernicka-Goetz et al., 
2009). Interestingly one of the targets of miR-124 is SMYD3, a methyltransferase that 
regulates the transcription of lineage-specific factors that are essential for progression 
to the latest pre-implantation stages (Furuta et al., 2010, Zeng et al., 2012). Because 
of the involvement of this miRNA in cell differentiation it could be that variable miR-
124 levels reflect on the ability of embryos to complete blastulation. It must be noted 
however that miR-124 has more than 1.500 gene targets (www.targetscan.org) and 
therefore alternative pathways cannot be ruled out and further work is needed to 
decipher those exact mechanisms. 
 When the present experiment was designed and carried out there were no 
publications regarding the association of miRNAs in SCM with embryo development. 
Recently some interesting findings were published in this topic. More specifically, Lin 
et al. (2019) carried out an experiment whereby bovine embryos were cultured 
individually to the blastocyst stage and were grouped according to the first cleavage 
pattern in “fast”, “intermediate”, and “slow” embryos (Appendix A). The respective 
SCM samples were pooled and analysed with sequencing for the identification of 
marker miRNAs in each developmental group. Although there were technical 
difficulties with the “fast” group, it was found that miR-30c and miR-10b were highly 
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released by “slow” embryos compared to “intermediate” and this difference was 
statistically significant. Bioinformatics analysis revealed that these miRNAs affected 
pathways relevant to embryo development and signalling and thus the authors further 
suggested that these miRNAs are candidate biomarkers of impaired developmental 
potential (Lin et al., 2019). Despite the key differences of this study with the present 
experiment (pooled samples, no timelapse, bovine vs mouse), the general findings are 
in agreement and further strengthen the suggestion that embryos with different 
developmental potential release miRNAs differentially. 
Regardless of the biological mechanism behind miR-124 release and 
blastulation, the duration of this stage could be a sign of poor developmental potential. 
Indeed, there is evidence to suggest that developmentally compromised embryos 
require longer time to complete blastulation. More specifically, a study in human IVF 
where single euploid blastocysts were transferred showed that shorter blastulation is 
associated with increased ongoing pregnancy rates  (Mumusoglu et al., 2017). 
Although not clear, it seems that the completion of this stage within a specific 
timeframe reflects on the potential of embryos to establish a healthy pregnancy. In the 
present study faster blastulating embryos transport excessive amounts of miR-124 to 
the surrounding micro-environment compared to slower embryos. Since faster dB is a 
sign of superior quality, higher miR-124 levels in SCM could be measured to identify 
embryos with favourable developmental potential. 
Nevertheless, it would be advised that this finding is studied further and 
reproduced in other experiments before investigating its importance. What became 
apparent in the statistical analysis and can be visualised in Figure 3.5 is that the 
distribution of values between 1.3 and 1.5 of dB does not follow the pattern of the 
negative correlation, ie there is a gap of expected miR-124 values in this timeframe. 
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In specific, embryos that completed blastulation within this interval showed a high 
dispersion of miR-124 in SCM. The problem is particularly evident for embryos with 
dB values around 1.4 where, according to the correlation test, the expected miR-124 
values would range between 1.3 and 1.7; however these levels were not detected. 
Evidently there are few datapoints in this specific dB timeframe (only 2) and thus a 
larger sample size could clarify this discrepancy of values. Although the sample size 
in the present study was calculated a priori, 39% of the original population did not 
express miR-124 in SCM which significantly lowered the sample size for the 
correlation test. Possibly miRNA information from more embryos with dB in this 
interval would prove or disprove the correlation, which would make this finding more 
reliable. Indeed a post-hoc calculation of statistical power showed that these findings 
achieved a 0.57 power (Faul et al., 2009) - which was considerably lower from the 
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3.6.4 Extended blastomere apoptosis is positively correlated with miR-294 
release 
Since miR-24, miR-124, and the miR-290-295 cluster are microRNAs that are 
expressed in mouse preimplantation development and they all have roles in DNA 
repair mechanisms (Tulay and Sengupta, 2016), it was hypothesised that the release 
of these miRNAs within culture media would reflect on the apoptotic status of the 
embryos. Perhaps the most interesting finding of the present experiment is that miR-
294 in SCM is strongly associated with apoptosis at the blastocyst stage.  
Although the mechanism behind this association needs to be further studied it is 
possible that the actions of miR-294 on apoptosis regulation  led to the observed 
difference. Target prediction analysis was carried out to identify potential regulatory 
effects of miR-294 on apoptosis-related factors (www.targetscan.org). Interestingly, 
miR-294 is involved in the post-transcriptional regulation of the apoptosis facilitator 
Bcl2l11– a regulatory mechanism which could possibly explain the association. 
Additionally, this miRNA regulates the expression of cyclin-dependent kinases 
Cdkn1a and Cdk2 genes that are key-mediators of DNA damage recognition in the 
p53 signalling pathway which initiates apoptosis in cells. However, it is likely that the 
association of miR-294 and apoptosis is not that simplistic and straightforward as this 
miRNA targets more than 700 genes and therefore complex regulatory networks 
activated through miR-294 could also lead to increased apoptosis in blastomeres.  
Because miR-294 and apoptotic extent are directly associated, it could be that 
higher miRNA levels lead to increased DNA damage in embryonic blastomeres. This 
possibility was recently described for another miRNA in the bovine species. More 
specifically, Lin and colleagues (2019) firstly identified that miR-30c was found in 
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elevated levels in SCM of developmentally compromised embryos. The miR-30c 
mimic was then supplemented in embryo culture and it was found that the up-take of 
miR-30c by embryos significantly increases apoptosis at the blastocyst stage by 8%. 
It was further shown that miR-30c downregulates a gene of the DNA damage response 
pathway (CDK12) which according to the authors was the reason behind the impaired 
blastocyst quality and extended apoptosis (Lin et al., 2019). Although the findings of 
Lin  et al. (2019) are in line with these of the present experiment, the pathways 
involved in release of miRNAs by pre-implantation embryos are not yet understood 
and thus the mechanism of miR-294 release and its association with apoptosis inside 
the embryonic cells needs to be further explored. 
Regardless of this, it must be mentioned that apoptosis is a crucial “rescue” 
mechanism for the normal development of preimplantation embryos as it corrects cell 
abnormalities that occur. Nevertheless, extended apoptosis has negative effects on 
embryo survival which reflects on implantation and pregnancy rates (Ebner et al., 
2001). The extent of apoptosis in embryos cannot always be assessed morphologically 
and to further support this blastocyst scoring was carried out and compared with the 
number of apoptotic cells in each embryo. Additionally, other quality markers such as 
multinucleation at the t3-t2 and t5-t4 intervals, fragmentation at the 4- and 8-cell 
stages, and blastomere symmetry at the 2-, 4-, and 8-cell stages were annotated. No 
associations between these quality markers and apoptosis were found meaning that 
sole morphological assessment has limited value on assessing cellular quality. In 
contrast, this study provides preliminary evidence that miRNA analysis of SCM can 
be used to distinguish highly apoptotic from lower apoptosis embryos.  
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 The findings of the present experiment are limited to mouse embryos and 
caution must be taken for any assumptions for the human or other mammalian species. 
Although miRNAs are highly conserved molecules across evolution, genomic 
differences are found between species. For instance, the miR-290 cluster is mouse-
specific and therefore any follow-up experiments in higher species should be carried 
out with the homologue miR-371-373 cluster. Additionally, the embryos used in this 
experiment were frozen at the 1-cell stage and subsequently thawed and cultured. The 
freezing-thawing procedure might result in altered miRNA profiles compared to fresh 
embryos due to higher cellular stress and damage from cryopreservation. Moreover,   
the oocytes were fertilised with traditional IVF so discrepancies might be found if 
similar experiments are carried out in ICSI-fertilised embryos due to the zona 
pellucida opening in these embryos through which molecules can be passively 
transported to the extra-cellular environment.  
Another limitation was the small panel of miRNAs studied in this experiment. 
Although a total of 14 miRNAs were chosen as candidate molecules (Appendix B), 
preliminary experiments found that either some miRNAs were present in the culture 
medium (possibly from serum albumin contamination) or they were completely absent 
in spent culture media samples (Appendix C). Additionally, because the aim was to 
analyse individual SCM samples there was a very small concentration of total 
miRNAs recovered from each embryo (< 10 ng/μL) which is inevitably limiting for 
the number of reactions/targets. Due to these reasons only four miRNAs (miR-24, 
miR-124, miR-291a, miR-294) were carefully chosen for this study. However, 
because of the numerous biological roles of miRNAs it is expected that other miRNAs 
in spent media are also associated with embryo development and quality. 
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Lastly as described previously for miR-124 and blastulation, the sample size was 
suboptimal for the correlation test and the power of the study was below the aimed 
value which make these results weak and possibly unreliable. Additionally the 
amplification rate varied for all miRNAs and it reached a maximum value of 73% for 
miR-294; however, 100% amplification was not achieved in the present study. This is 
a considerable limitation that  might have hindered any significant findings and that 
lowers the effectiveness of miRNA analysis as a non-invasive method for embryo 
assessment. 
3.8 Conclusions 
In summary, miRNAs are present in SCM and are detectable in minimum 
volume. Extra-cellular miRNAs reflect on pre-implantation development as it has 
been found for miR-124 and the developmental competence of embryos to complete 
blastulation. Additionally, embryo quality reflects on miRNA release since miR-294 
in SCM is directly linked to the apoptotic percentage in mouse blastocysts.  
Overall, this preliminary evidence shows that embryo developmental potential 
and DNA quality are associated with the extra-cellular levels of miRNAs. Since early 
morphokinetics and apoptotic extent at the blastocyst stage have effects on 
implantation and post-implantation outcomes, specific miRNAs could be quantified 
and serve as markers of embryonic potential.  
Nevertheless, the nature of regulation and mechanisms involved need to be 
further explored to understand the biological role behind the release of miRNAs by 
early embryos. Additionally, it is necessary to carry out similar work in other 
mammalian species to understand the degree of conservation of those mechanisms. 
These are the research questions that are investigated further in the following chapters.
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4. CHAPTER FOUR: MIR-294 MECHANISM OF RELEASE BY 
MOUSE BLASTOCYSTS 
4.1 Introduction 
Based on the finding that highly apoptotic embryos intensively release miR-294 
it was decided to extend the research and study the nature of this association and the 
mechanism involved. Two possibilities exist in regards to the association between 
apoptosis and high extra-cellular levels of miR-294. On the one hand it is possible that 
miR-294 is the factor causing cell death in blastomeres and its presence in SCM can 
either be a result of passive release, for example due to membrane damage. On the 
other hand it could be that increased apoptosis is the triggering factor of intense release 
of this miRNA, meaning that poor quality embryos “intentionally” transcribe, 
package, and release miR-294 in the surrounding micro-environment. In this case 
miR-294 could serve secretory functions as a signalling molecule for communication 
with other cell types.  
If miR-294 is the factor causing apoptosis then it is expected that the expression 
of this miRNA is higher inside the blastocyst cells. There it could up- or down-regulate 
genes involved in cell death pathways which would ultimately lead to the observed 
effect. As discussed in the previous chapter, miR-294 has hundreds of targets 
including genes of the Bcl-2 apoptotic pathway. Dysregulation of such genes could 
disrupt molecular networks with downstream effects on DNA fragmentation and 
cellular apoptosis. The abnormally high DNA fragmentation would quickly result in 
degradation of membranes and organelles and ultimately cell death. Molecules 
including small nucleic acids like miRNAs could then “leak” from the damaged 
membranes out to the surrounding micro-environment. 
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If apoptosis in blastomeres (regardless of the causal factor) triggers the 
expression and/or exocytosis of miR-294 then the secreted profile will not necessarily 
reflect the miRNA composition of the cells and moreover the gene targets of miR-294 
will also not be dysregulated. In this case it is the cellular stress that activates miRNA 
secretion mechanisms which results in higher miRNA levels in the medium. Although 
such mechanism has not been described in embryos yet it is worth mentioning that 
stress signalling and miRNA release have been studied extensively in association with 
human diseases. It is now known that in body fluids there are distinct miRNA signature 
profiles relating to several types of cancer and also cardiovascular diseases (Mendell 
and Olson, 2012). miRNA export from cancerous cells is selective and regulated and 
the circulating miRNAs are protected from enzyme degradation due to their carriers 
(see Chapter 1). Specific miRNAs are then enclosed by other cells and exert their 
regulatory actions on mRNA targets. Hence these molecules are part of the inter-
cellular communication network which is related to the onset and progress of various 
diseases (Boon and Vickers, 2013). Although the existing evidence favours the second 
possibility behind the miR-294 mechanism of release in this chapter, since there are 
no studies yet investigating the biological mechanisms behind embryo-released 
miRNAs these possibilities were further explored. 
Initially, a review of the relevant literature was carried out to establish the 
experimental procedures. What was common in miRNA studies was the use miRNA 
mimics to cause the downregulation of in silico predicted targets in order to explain 
their findings. For example in the bovine study by Kropp and Khatib (2015) it was 
reported that degenerate embryos released higher levels of miR-24-3p compared to 
fully-formed blastocysts (amongst 11 other miRNAs). The miR-24 mimic was then 
supplemented in the culture medium of morulae and the embryos were further grown 
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to the blastocyst stage. Up-take of the mimic was verified in the grown blastocysts and 
it was found that addition of the mimic caused 27.3% decline in blastocyst formation. 
Further analysis found that one of the targets CDKN1b was significantly repressed by 
33% in transfected embryos. This gene has important roles in cell cycle progression 
and thus affects cell proliferation and growth.  Based on the above, the authors 
suggested that high expression of miR-24 possibly dysregulated CDKN1b and this in 
turn impaired the developmental potential of embryos and led to their degeneration 
(Kropp and Khatib, 2015). 
Moreover, in the study by Lin et al. (2019) it was found that bovine embryos 
that completed the first cleavage later released more miR-30c in the culture medium. 
More specifically, “slow” embryos had significantly higher levels of miR-30c 
compared to “intermediate” embryos and hence this miRNA was further studied in 
relation to embryo development. The miR-30c mimic was supplemented to embryo 
culture and the embryos were cultured to the blastocyst stage. MiR-30c was up-taken 
by embryos and it caused higher apoptotic extent by 8% at the blastocyst stage. 
Additionally, this miRNA downregulated CDK12, a kinase which alters DNA damage 
response pathways. Based on these findings the authors suggested that elevated miR-
30c possibly disrupts signalling and apoptosis pathways which impair the 
developmental potential and quality of embryos (Lin et al., 2019). 
Therefore in both studies the embryos were transfected with the respective 
miRNAs and then the expression of gene targets was analysed. However, neither of 
these studies showed that in fact the levels of miRNAs inside the blastomeres are in 
concordance with the levels outside of them in the surrounding micro-environment. It 
is a common misconception to assume that miRNA levels in spent culture medium 
reflect on the intra-cellular content, i.e. the more miRNA you have in SCM the more 
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you have inside the blastocyst cells. If this was the case, using mimics is of course an 
acceptable approach, however no study has proven this yet. The next questions were 
therefore: Do embryos that release higher levels of a specific miRNA in SCM have 
increased levels of this miRNA inside their cells? Does the intra-cellular miRNA 
trigger apoptotic pathways? Or do highly apoptotic embryos actively release more 
miRNA extra-cellularly, which could then serve another function such as cell 
signalling? 
4.2 Rationale and hypothesis 
The hypothesis of the present experiment was that when apoptosis in early 
embryonic stages occurs, it triggers molecular pathways associated with miR-294 
transcription, packaging, and release which results in higher levels of this miRNA in 
the extra-cellular environment. This hypothesis is based on previous knowledge that 
miRNAs are actively released by cells rather than non-selective passive release. 
Importantly, no lysis was observed in the preliminary experiments which further 
strengthens the suggestion that this is not a process of passive transport. 
4.3 Aims and objectives 
The aim of this experiment was to study the direction of the association between 
the extended apoptosis and the high levels of miR-294 in SCM of blastocysts. For this 
it was firstly investigated whether the intra-cellular levels of miR-294 correspond with 
the extra-cellular levels. In case there was a concordance between them it is likely this 
miRNA that causes apoptosis; thus miR-294 mimic transfection could be used to 
further study the molecular mechanisms involved. In the same context the expression 
of key-apoptotic targets predicted in silico was also analysed in relation to miR-294 
SCM levels. 
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Furthermore, another experiment was carried out where DNA damage was 
artificially induced in mouse embryos and the SCM was collected at the end of culture 
and analysed for miR-294 levels. If cellular apoptosis triggers miR-294 release, then 
higher levels of this miRNA are expected in the study group compared with control 
embryos. In this case it would mean that apoptosis precedes miR-294 exocytosis, and 
it is in fact the process of apoptosis that triggers the packaging and release of miR-294 
outside the embryonic cells.  
4.4 Methodology 
4.4.1 Intra-cellular miR-294 levels 
Mouse embryos (B6C3F-1 x B6D2F-1) were thawed (N=54) and cultured in 
individual drops of pre-equilibrated Embryomax KSOM medium overlaid with 
EmbryoMax light mineral oil (Merck, UK) (Section 2.1). The embryos were cultured 
to the blastocyst stage at 37oC in 5% CO2. Spent media samples and blastocysts were 
then collected and stored in individual microtubes at -80oC until further processing. 
miRNA extraction, amplification, and quantification were carried out in the SCM 
samples according to the protocols described in Sections 2.5.1, 2.7, and 2.9. The Ct 
values were normalised with the cel-miR-39-3p spike-in control recommended by the 
manufacturer (Qiagen, USA). 
According to the miR-294 values the embryos were divided in 4 groups: null, 
low, medium, and high release groups. Embryos from each group were then 
individually processed for miRNA and total RNA extraction following the respective 
protocol (2.5.2). cDNA templates were built (2.7, 2.8) and the expression patterns of 
miR-294, Bcl2 and Apaf-1 were analysed using TaqMan™ assays and the PCR 
conditions described respectively in 2.9 and 2.10. Duplex reactions were carried out 
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using the Rpl5 gene to normalise the Ct values. The cut-off Ct value of 35 was used to 
filter out fluorescence artefacts. 
4.4.2 DNA damage induction 
Preliminary experiments were carried out to optimise the conditions that would 
cause the level of DNA breakage for the purposes of this study. Mouse 1-cell stage 
embryos (B6C3F-1 x B6D2F-1) were thawed and cultured to the early blastocyst stage 
(~70  h post-thaw). The embryos were exposed to UV radiation by placing them on 
the benchtop UV Transilluminator (UVP, USA) for 5 s (wavelength 302 nm). A 
control group with no UV treatment was also cultured in parallel. The embryos were 
cultured for 16 more hours (in total 86 h post-thaw) to allow for transcriptional and 
translational responses to DNA damage. SCM samples were then collected and 
analysed for miR-294 expression. All blastocysts were collected and stained with 
TUNEL (2.2) to assess DNA breakage. 
4.4.3 Statistical analysis 
The SPSS Statistics 26 software (IBM, USA) was used for data analysis. Data 
distributions were checked using the Shapiro-Wilk test for normality and visual 
examination of the histograms. The ΔCt values were used for all statistical tests using 
the miRNA and RNA data. Log transformations were carried out where necessary to 
achieve normal distribution of the values. ANOVA and Tukey’s post-hoc comparisons 
were performed to detect significant differences in miRNA and RNA expression 
between the null, low, medium, and high miRNA release groups in Experiment A. A 
t-test comparison was carried out to detect significance in miRNA levels between the 
UV-treated and control groups for Experiment B. A p value of <0.05 was considered 
significant for all tests. Graphs were generated using GraphPad PRISM 8. 




From the 54 SCM samples, 13 were null for miR-294 (76% amplification rate) 
and the average Ct from the rest of the samples was 27.9 ± 2.2 (ΔCt 8.9 ± 2.1). By 
calculating the Q1 and Q3 quartiles of the population, the blastocyst samples were 
categorised in null (Ct > 35, zero expression), low (ΔCt 11.6 ± 0.8), medium (ΔCt 9.1 
± 0.6), and high (ΔCt 6 ± 0.9) miR-294 groups, N=10 for each group. The average 
intraceullular ΔCt was 3.2 for null, 3.1 for low, 2.7 for medium, and 4.8 for high 
release groups. After logarithmic normalisation, ANOVA detected significant 
difference in expression between the groups (p<0.001). Post-hoc comparisons showed 
that it was the high group that expressed significantly less miR-294 compared to the 
null (p<0.01, -3.1 FC), low (p<0.001, -3.1 FC), and medium (p<0.001, -4 FC) groups 













Figure 4.1 miR-294 expression in spent culture media samples and in blastocyst cells. 
Corresponding samples for SCM and cells are shown here for each embryo. Thus SCM samples 
are in total 30 (10 had zero expression of miR-294) and blastocyst samples are in total 40. The 
average miR-294 ΔCt was 10.0 for media samples and 4.6 for blastocyst cells. b) Comparison 
of miR-294 levels (log10 (x +10) values) between null, low, medium, and high miR-294/SCM 
groups. The boxplots contain the middle 50% of the values (Q3-Q1) and the median (horizontal 
line) and the whiskers depict the maximum and minimum values for each group. Significant 
differences in expression between the high and the null, low, medium groups are marked with 
asterisks. 
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Furthermore, Bcl2 expression was null for all 40 blastocyst samples. However, 
Apaf-1 was expressed in embryonic cells with an average Ct of 33.4 ± 0.6 (ΔCt 5.3 ± 
0.6) in the null group, 33.7 ± 0.7 (ΔCt 5.4 ± 0.6) in the low group, 32.7 ± 0.7 (ΔCt 5.4 
± 0.5) in the medium, and 33.4 ± 0.7 (ΔCt 4.9 ± 0.4) in the high group. ANOVA testing 

















Figure 4.2 Comparison of intra-cellular Apaf-1 expression between the null, low, 
medium, and high miR-294 release groups. The y axis contains the normalised Ct values 
for Apaf (log10 (Ct) values). Each group consists of N=10 samples. The boxplots contain the 
middle 50% of the values (Q3-Q1) and the median (horizontal line) and the whiskers depict 
the maximum and minimum values for each group. Embryos from the 4 groups expressed 
similar levels of Apaf-1 (p>0.05). 
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For the UV experiment, a total of 15 blastocysts were subjected to UV radiation 
(302 nm) for 5 s and 13 blastocysts were used as control of the study. Using TUNEL 
staining, the direct effects of UV on DNA damage was verified, with the UV group 
showing higher extent of apoptosis and reduced cell proliferation compared to the 







The average miR-294 Ct in the SCM of the UV group was 25.1 ± 1.1 (ΔCt 6.3 
± 1) and in the control group 27.1 ± 1.5 (ΔCt 8.3 ± 1.5). The results from the t-test 
showed that the blastocysts with UV-induced DNA damage released significantly 







Figure 4.3 Induced DNA breakage using UV radiation. On the left image, a control 
blastocyst with few apoptotic cells and on the right image a UV-treated embryo with reduced 
TCN and many apoptotic cells. Embryos from both groups were cultured in parallel and for 
the same period. 
Figure 4.4 Average miR-294 ΔCt between the UV-treated and control embryos. The 
embryos treated with 5 s of UV (N=15) released significantly more miR-294 in the SCM 
compared to the control group (N=13) (p<0.01). T-bars show the standard deviation of 
the values. 




In agreement with the hypothesis, taken together the findings of this study 
indicate that embryonic apoptosis activates mechanisms of miR-294 release which 
results in higher levels of this miRNA in spent culture medium. Notably to date there 
is no published evidence regarding the mechanisms controlling miRNA release by 
embryos. 
4.6.1 Extracellular miR-294 levels are negatively associated with the 
intracellular content 
Unsurprisingly, the average miRNA levels were generally higher in blastocyst 
samples compared to culture media samples. However, when the embryos were 
divided in groups according to their SCM miRNA profiles it was found that embryos 
releasing more miR-294 in SCM had significantly less miR-294 in their cells 
compared to the null, low, and medium release groups. Additionally, the expression 
of Bcl2 (a target of miR-294) was analysed in the same samples but was undetectable. 
Because of this, the apoptotic regulator Apaf-1 which is involved in the same pathway 
as Bcl2 was chosen as an alternative apoptotic marker. Apaf-1 acts as a key-activator 
at the last regulatory level of the Bcl2 apoptotic pathway through direct activation of 
caspases which then degrade cellular components (Bratton and Salvesen, 2010). Apaf-
1 was expressed in detectable levels in all the blastocysts, however its expression was 
similar across the groups. Considering these, no further conclusions could be made 
regarding the specific apoptotic pathway. Nevertheless, these results clearly suggest 
that miRNA levels in SCM, at least for the specific miRNA, are not positively 
correlated with cellular content. Therefore the first possible mechanism that this 
miRNA targets apoptotic genes causing cell death is not supported by these findings. 
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Only one embryo study has analysed the intracellular content for specific 
miRNAs and found corresponding intra- and extra- cellular profiles for miR-30c, miR-
10b, miR-45, miR-113, and miR-139 in bovine blastocysts (Lin et al., 2019). This 
study is described in more detail in Chapter 3; however, in the context of the present 
experiment it is worth mentioning once more that this study grouped embryos and 
hence analysed miRNA profiles in pooled samples. In chapter 3 it was shown that 
there are individual embryos that do not release some miRNAs, i.e.  expression rate is 
not 100% in a random study population. Therefore, by pooling samples it is probable 
to find false positive/negative associations. It is highly likely that the disagreement of 
the present results with those from the study by Lin and colleagues (2019) are due to 
the different study designs - individual versus pooled samples analysis. 
Notably a study in stem cells showed that miRNAs packaging and release in 
microvesicles is a selective organised process rather than a random event (Collino et 
al., 2010). In this study miRNA profiles were compared between cell content and 
microvesicle cargo in human bone marrow stem cells and liver stem cells. 
Interestingly, miRNA expression profiles in microvesicles were shared with the 
patterns in their cells of origin for the majority of the miRNAs. Additionally, selected 
miRNAs were only detectable in circulating microvesicles and were absent within the 
cells (Collino et al., 2010). In the present experiment miR-294 expression in spent 
medium was negatively associated with cellular content. This finding in agreement 
with those of Collino and colleagues (2010) support the theory that miRNAs are 
specifically accumulated, packaged, and secreted by cells rather than them being 
leaked from damaged cells. 
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4.6.2 Induced cellular apoptosis triggers the release of miR-294 by mouse 
blastocysts 
To study whether in fact apoptosis triggers miRNA release, UV radiation was 
used to artificially cause DNA damage in blastocysts. A similar methodology has been 
reported previously for UV-induced apoptosis in sea urchin embryos (Lesser et al., 
2003). The embryos were subjected to UV radiation specifically when they reached 
the early blastocyst stage for two reasons. Firstly, it was important not to compromise 
embryo survival and blastocyst formation because it is mainly the trophectoderm 
population that actively releases miRNAs in the extra-cellular environment (Capalbo 
et al., 2016). Additionally, by UV-treating the embryos at the final stages of 
development, DNA repair mechanisms which are activated in the cells had minimum 
time to reverse the effect (Jaroudi and Sengupta, 2007). On the other hand, it was 
crucial for this study to maintain embryo viability for enough time to allow for 
transcriptional responses to DNA damage and, more specifically, cause enhanced 
transcription, packaging, and release of miR-294. In parallel, it was important to cause 
high damage in order to observe the maximum effect of the treatment. After some 
optimisation steps, it was found that UV radiation for 5 s at 302 nm caused direct DNA 
breakage in the blastocysts without instantly killing them. The increase in DNA breaks 
and cell apoptosis was verified using TUNEL staining and miR-294 in SCM was 
measured. In agreement with the hypothesis, the UV-treated embryos released 
significantly more miR-294 in the media compared to the control group.  
Although the exact process that is triggered by DNA damage to release miRNAs 
is unknown, there is some evidence on the regulation of miRNA expression in DNA 
damage response. For example, DNA damage can regulate miRNA expression at the 
transcriptional level by the p53 damage-induced transcription factor that enhances the 
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transcription of miR-34. This miRNA then targets and downregulates cell cycle genes 
which leads to cell cycle arrest (He et al., 2007). Additionally, post-transcriptional 
processing of miRNAs is also regulated in the DNA damage response.  
Post-transcriptional upregulation of miRNAs including miR-16-1, miR-143, and  
miR-145 following DNA damage changes the expression of miRNA targets and 
decreases the rate of cell proliferation (Wan et al., 2011). Lastly, UV damage promotes 
miRNA expression which are then localised in stress granules and mediate gene 
silencing. This process is believed to be an integral part of the DNA damage response 
in cells (Pothof et al., 2009). 
It is not believed that increased miRNA levels in media result from membrane 
fragmentation or cell lysis but rather it is a result of active release. In Chapters 3 and 
4 cell lysis was recorded and no association was found with miRNA levels. Increasing 
evidence shows that miRNA release is regulated, rather than a result of cell injury, and 
these molecules have hormone-like properties causing autocrine, paracrine, and 
endocrine responses. Although the secretion mechanisms are less clear, intra-cellular 
stress and other pathways possibly induce miRNA release (O'Brien et al., 2018). 
Indeed, Ca2+ stimulates the release of miRNAs from neuroendocrine cells which then 
participate in cell-to-cell communication and function as neuromodulators (Gümürdü 
et al., 2017). Additionally, in prostate cancer cells a stress-induced protein complex 
(including Ago-1 and Ago-2) transports miRNAs to the nucleus to change gene 
expression in response to cellular stress (Castanotto et al., 2018). Considering the 
above and the findings presented so far, it appears that cells respond to stress through 
transporting miRNAs between cellular compartments and outside to the extra-cellular 
environment where these molecules exert functions in inter-cellular communication. 




The findings are limited to mouse blastocysts and the specific miRNA. Further 
validation is needed for assumptions for other species due to sequence differences in 
miRNAs between species. Specifically miR-294 belongs to the miR-290 cluster which 
is mouse-specific whereas the homologue cluster in human and bovine is the miR-370 
cluster. Moreover, although it was aimed to establish the molecular mechanism behind 
miR-294 release unfortunately no conclusions could be made in regards to this. The 
evidence presented in this chapter provide information about the direction of 
association between apoptosis and miR-294 secretion by embryos without however 
establishing the molecular pathways that are involved. Possibly experiments on 
miRNA transporting proteins could elucidate the exact mechanism that is activated by 
apoptosis. 
4.8 Conclusions 
In summary apoptosis triggers the mechanism of miR-294 release by mouse 
blastocysts in the surrounding micro-environment. This conclusion is based on three 
findings presented so far in the thesis. Firstly, no lysis or signs of membrane damage 
were observed in embryos that released high miR-294 levels. Secondly, the spent 
media miR-294 levels were inversely associated with cellular content which 
eliminates the possibility that intra-cellular miR-294 targets apoptotic genes and 
promotes DNA fragmentation. Finally, induced apoptosis with UV radiation led to 
elevated levels of miR-294 in the spent media which proves that the direction of 
association is that apoptosis is the causal factor of high miR-294 release by embryos. 
Possibly this miRNA could be secreted for inter-cellular communication purposes 
which will be explored in a later chapter.




5. CHAPTER FIVE: EMBRYO-RELEASED MIRNAS IN 
RELATION TO BLASTOMERE APOPTOSIS IN BOVINE 
EMBRYOS 
5.1 Introduction 
The experiments presented so far showed that DNA damage in embryonic blastomeres 
increases the release of miR-294 by blastocysts in the extra-cellular environment. At 
the time of writing (January 2021) there are no publications regarding apoptosis-
triggered mechanisms of miRNA release in pre-implantation embryos. Although these 
findings are original, one of the limitations throughout the experiments is that mouse 
embryos were studied as model animal organisms for implications in human 
embryology. Despite the many similarities between mouse and human embryo 
development there are also key-differences in molecular, cellular, and dynamic events 
between the two species (Cockburn and Rossant, 2010).  
Generally, miRNA sequences are highly conserved throughout evolution and 
that is one of the characteristics that makes them ideal molecules for research. 
Nevertheless the miR-290-295 cluster studied in the previous chapters is mouse-
specific and is one of the earliest clusters that is transcribed by the embryo, with rising 
expression levels as early as the zygotic genome activation at the 4-cell stage (Tang et 
al., 2007). This cluster has homologue miRNAs in humans and in specific the five 
miRNAs transcribed share active seed sequences with the miR-371-373 cluster (Wu 
et al., 2014). Therefore theoretically miRNAs miR-371, -372, and -373 are candidate 
matches for further experiments that are based on the mouse cluster miR-290-295. 
 





Interestingly, the human miR-371-373 cluster is highly conserved in the Bos 
taurus species with a conservation score of 91% (Kiezun et al., 2012). The best 
characterised and annotated miRNA of this cluster is the bta-miR-371 which is 
transcribed by a sequence of 23 nucleotides. The only difference between human and 
bovine is found in the 13th base which in humans in a cytosine and in bovine a guanine 
(www.mirbase.org). Considering this high conservation in the sequence, the bovine 
embryo could be a candidate animal model to further investigate and ideally reproduce 
the findings between apoptosis and miRNA release in the mouse embryo.  
Although the mouse model offers many advantages as a study organism in 
embryology, the potential of the bovine as a model organism must not be overlooked. 
Cattle embryos are used widely in studies due to the many similarities in biochemical 
and regulatory processes with the human. For example, polyadenylation of mRNA in 
oocyte maturation, glucose utilisation and amino acid metabolism in early embryos 
are more similar between human and bovine compared to murine embryos (Ménézo 
and Hérubel, 2002). Additionally, histone modification changes and the enrichment 
motif profiles at accessible chromatin sites established at the ZGA stage are 
remarkably similar between cattle and humans, even though the actual timing of ZGA 
occurs earlier in human embryos (Halstead et al., 2020). The reproductive physiology 
of cows is also close to the human especially in the follicular development stages and 
the fact that they are both mono-ovulatory species. Ultimately the choice of the animal 
model to study human reproduction depends on the process under study.  
In regards to miRNA roles there is no firm evidence supporting the use of one 
species over the other for applications in the human. Interestingly, miRNA secretion 
by embryos has only been published for bovine embryos as described in detail in 
Chapter 1. This could be due to the higher genomic conservation in miRNA sequences 





between bovine and human species. The study by Lin and colleagues (2019) is the 
only large-scale genomic study in secreted miRNAs by bovine embryos that found a 
minimum number of 294 miRNAs present in culture media after embryo culture. Two 
previous small-scale studies also found that bovine blastocysts secrete miRNAs in the 
surrounding media (Kropp et al., 2014, Gross et al., 2017b). Specifically for miR-371 
there is no available information about its exact roles in bovine embryo development 
although it is known that blastocysts express miR-371 in their blastomeres suggesting 
thus functions at these stages (Goossens et al., 2013). Nevertheless, there is no 
evidence yet that bovine blastocysts actually release miR-371. This needs to be 
verified in the present study before any associations with embryo quality can be made.  
5.2 Rationale and hypothesis 
Initially it was hypothesised that bovine embryos release miR-371 in spent 
culture media. This was based on previous evidence on miR-371 expression inside 
blastocyst cells and reports that bovine embryos secrete miRNAs. Secondly,  the 
hypothesis was that bovine embryos which have a high degree of DNA fragmentation 
in their blastomeres release significantly higher amounts of miR-371 in the 
surrounding micro-environment. This hypothesis was proposed on the initial findings 
in murine embryos and the existing knowledge that miRNAs are highly conserved 
molecules across evolution, not only in the genomic sequences but also in the actions 
that they serve. Although small, this experiment was designed to bridge the gap 
between the findings in mouse embryos and biological roles of miRNA secretion in 
human embryos. 
 
   





5.3 Aims and objectives 
The aim of the experiment presented here was to reproduce the findings of 
Chapter 3 and more specifically to investigate whether the association between 
extended apoptosis and miRNA release is maintained in other mammalian species. To 
study this, bovine embryos were produced in vitro, cultured to the blastocyst stage, 
stained for apoptosis detection, and the culture media samples were analysed for the 
presence of miR-371. The bovine model was used here to study miR-371 which 
belongs to the homologue cluster of the mouse-specific miR-290-295. This miRNA is 
the most annotated of the cluster in the bovine genome and carries a homology score 
of 91% with only one base replacement compared to the human genome. Definitely 
one of the advantages of the bovine model over the mouse in the presented thesis is 
the higher genomic homology in miRNAs with the human. Ultimately the goal of this 
experiment was to examine whether there is an association between apoptosis with 
this miRNA which is highly conserved to the human genome. If this is found then it 
would set a stronger basis for studying the biological roles behind embryo-released 











5.4.1 Bovine in vitro oocyte maturation, fertilisation, and embryo culture 
Bovine embryos were produced in vitro in two consecutive repetitions. All 
media were purchased by IVF Bioscience, UK unless otherwise stated. Ovaries were 
collected from the local abattoir and transported to the laboratory within 1 h in a 
thermos flask containing Dulbecco’s PBS (Sigma-Aldrich, USA) at 37oC. Cumulus-
oocyte complexes (COCs) were aspirated from follicles (2-10mm diameter) and 
oocytes with ≥3 layers of cumulus cells were collected for in vitro maturation (IVM). 
The COCs were washed three times in Search media (S199) in groups of 45 and 
cultured in 4-well dishes (Nunclon, Denmark) previously prepared with BO-IVM and 
equilibrated at 38.8oC, 6% CO2 for 24 h. Frozen semen from Holstein and Friesian 
bulls (Sexing Technologies, USA) was thawed at 38oC for 10 seconds. Motility and 
concentration were assessed and the sperm was washed twice by centrifugation in 2ml 
of BO-SemenPrep, 200g for 5 minutes. The pellets were re-suspended in 350µl of BO-
IVF and the motility and concentration were determined. The groups of matured 
oocytes were washed three times in oocyte wash medium and once in BO-IVF 
medium. The oocytes were transferred to 4-well dishes previously prepared with 400µl 
of BO-IVF, 38.8oC, 6% CO2. An aliquot of sperm suspension was added to each 
fertilisation well, calculated according to the semen concentration, giving a total 
concentration of 10x106 spermatozoa/ml. The gametes were incubated overnight at 
38.8oC, 6% CO2 in a humidified incubator. The presumptive zygotes were washed in 
BO-Wash, vortexed for 2 min in 1ml of BO-Wash, washed three times in BO-Wash 
and once in BO-IVC. The zygotes were then placed individually in wells of 
Embryoslides™ previously prepared with BO-IVC overlaid with BO-Oil and 
equilibrated at 38.8oC and 6% CO2, 6% O2. Embryo culture was carried out in the 





time-lapse incubator until the embryos reached the full blastocyst stage (~170hrs psi). 
Blastomere lysis was annotated in the time-lapse videos using EmbryoViewer 
(Vitrolife, Sweden). 
5.4.2 Blastocyst staining 
The embryos were cultured individually up to the full blastocyst stage, the 
blastocysts were stained with the triple staining protocol (2.2) and visualised with the 
appropriate filters with fluorescent imaging (2.3). Sex determination with 
H2AK119Ub staining was attempted due to the previously reported sexual 
dimorphism in miRNA secretion in the bovine (Gross et al., 2017b). The degree of 
apoptosis was calculated by dividing the number of apoptotic cells with the total cell 
count and expressed as a percentage. 
5.4.3 Culture media analysis 
From each culture well 20 μL culture media were collected and stored at -80oC 
until further analysis. miRNAs were extracted using the same protocol as with the 
mouse experiment in Chapter 3 with the addition of cel-miR-39 spike-in control for 
normalisation of the Ct values (2.5.1). miRNAs miR-371 and miR-39 were quantified 
with single-tube real-time qPCR (2.7 and 2.9) with the respective miRNA probes 
detailed in Table 5.1. 
Table 5.1 miRNA assays used for amplifying each miRNA. The target miRNA and the 
mature sequence are displayed. 
 
TaqMan miRNA probes 
Target Assay name MiRBase accession number Mature miRNA sequence (5’-3’) 
miR-371 bta-miR-371 MIMAT0009301 AAGUGCCGCCAUGUUUUGAGUGU 
miR-39 cel-miR-39-3p MIMAT0000010 UCACCGGGUGUAAAUCAGCUUG 





5.4.4  Statistical analysis 
All data were analysed using the SPSS Statistics 26 software (IBM, USA) and 
graphs were created with GraphPad PRISM 8. Data distributions were checked using 
the Shapiro-Wilk test for normality and visual examination of the histograms. Values 
greater than twice the standard deviation were considered outliers and excluded from 
further analysis. The normalised miRNA values were converted with the 2-ΔCt method 
(Schmittgen and Livak, 2008) and were tested against time-lapse parameters and 
apoptotic index with Spearman’s or Pearson’s correlation tests. A p value of <0.05 
was considered significant for all tests. 
5.5 Results 
5.5.1 miR-371 expression in spent blastocyst media 
After IVM of 72 bovine oocytes, 60 cleaved (83%), 46 formed morulae and 
developed into blastocysts (64%) by 170 h post-insemination. From the culture media 
collected 36 were successfully processed for miRNA extraction and amplification. 
miR-371 was present in detectable levels in all samples (100% amplification rate) and 
only one sample was assessed as an outlier and excluded. After normalisation with 
miR-39, the average ΔCt value for miR-371 was 6.2 (±1.8). Blank samples, namely 
water and culture media not exposed to embryo culture, were also run in parallel and 
showed no amplification for the miR-371. The average and standard error of mean of 
the raw Ct values are shown in Table 5.2. 




miRNA Ct values 
miR-371 26.5 (±1.4) 
cel-miR-39 20.5 (±0.9) 





5.5.2 Blastocyst staining 
The methods that were successfully applied for embryo staining in mouse 
embryos were also used in this experiment. Unlike mouse embryos, bovine blastocysts 
did not show the characteristic Xi patches of FITC dye in their blastomeres and 
therefore it was impossible to assess embryonic sex through this method. 
Nevertheless, the TUNEL staining worked as expected and it was possible to calculate 
the apoptotic index in each embryo by fluorescent imaging (Figure 5.1). A total of 34 
blastocysts were stained successfully and the average total cell number was 132 cells 














Figure 5.1 Bovine blastocysts with different apoptotic indexes (x40 magnification). DAPI 
nuclear dye was used to count the TCN and the TxRed dye specifically binds to broken DNA, 
indicating this way cell death. The apoptotic extent was calculated by dividing the apoptotic 
cells with the TCN (%). The embryo on the top row consists of 234 cells out of which 2 have 
fragmented DNA whereas the embryo below comprises 58 cells out of which 9 are apoptotic. 





5.5.3 miR-371 and apoptosis 
To exclude the possibility that miR-371 is leaked from damaged cells, the 
embryos were cultured in continuous monitoring equipment (EmbryoScope) and cell 
lysis at any stage of development was annotated. Blastomere lysis was observed in 6 
blastocysts and the SCM samples deriving from these embryos were compared against 
the population average for miR-371 expression (t-test). The average ΔCt for the 
blastocysts with lysed cells was 6.8 ± 2.3 and for the rest of the population (N=30) 6 
± 1.7, which was not significantly different (p>0.05). Therefore, lysis was not 
considered a confounding factor further tests were not adjusted for lysis. Regarding 
the association of miR-371 in SCM and apoptosis, Pearson’s correlation coefficient 
revealed a significant positive relationship between these variables (r=0.555,  
p< 0.001, N=33) (Figure 5.2). The power of the study was found 0.93 in the post-hoc 









 Figure 5.2 Scatter plot of miR-371 in relation to apoptosis. The variables are 
transformed using log10 (x*10) transformations to achieve a Gaussian distribution. The 
transformed values are used as inputs for the x and y axis. MiR-371 and apoptosis are 
significantly correlated (N=33, p<0.001) in a positive relationship (r=0.555). 






Although small this experiment aimed to show that, similarly to mouse embryos, 
bovine blastocysts that are highly apoptotic release specific miRNAs in the 
surrounding environment which can be detected and quantified. In line with the 
hypothesis it was found that bovine embryos secrete miR-371 in increasing levels 
relating to the extent of apoptosis inside their blastomeres. 
5.6.1 Bovine blastocysts release miR-371 in culture media 
Even though there are no reports about the specific miRNA, it was not surprising 
that miRNAs would be present in spent culture media samples. In fact the very first 
report in this topic by Kropp and colleagues (2014) used the bovine species to study 
embryo-secreted miRNAs. This study is described in detail in Chapter 1 and Appendix 
A; however the main implication was that miRNAs are secreted by embryos and they 
can be quantified with potential use as non-invasive biomarkers of embryo quality 
(Kropp et al., 2014). A more recent study in bovine embryos analysed culture media 
samples with the use of large-scale sequencing. The presence of at least 294 miRNAs, 
180 of which were novel, was identified in spent media which implies that these 
molecules possibly have more important roles than previously thought at the peri-
implantation period (Lin et al., 2019). 
 Another interesting finding in this experiment was the high amplification rate 
of miR-371 in culture media samples collected from each embryo. All of the samples 
had detectable levels of this miRNA which translates to 100% amplification rate. Not 
only this, but the Ct values were approximately 1 cycle earlier in bovine samples 
compared to the mouse which means that it is released in higher levels by bovine 
embryos. This could be due to the cellular number that comprises a blastocyst in 





bovine, meaning that more cells secrete higher amounts of miRNAs thus resulting in 
elevated levels in the collected sample. Regardless, the finding that all samples had 
detectable levels of miR-371 and only one was considered an outlier suggests that the 
sensitivity of  SCM miRNA analysis is higher than it was thought based on the mouse 
findings. 
5.6.2 X chromosome inactivation is not identified through histone staining at 
the blastocyst stage in bovine 
The triple staining protocol used in Chapter 3 was also carried out in bovine 
blastocysts to simultaneously identify embryonic sex and assess the apoptotic 
percentage. Although expression of the homologue cluster in mouse did not differ 
between male and female embryos, sexual dimorphic expression and release of 
molecules is known for bovine embryos. Male embryos release more extracellular 
vesicles containing transcription factors NFE2L2, superoxide dismutase 1, and 
NOTCH1 when exposed to oxidative stress compared to female embryos  (Taqi et al., 
2019). Evidence for miRNAs also suggests sexual dimorphism in miRNA secretion, 
with at least 8 miRNAs differentially released by male and female blastocysts (Gross 
et al., 2017b). Unfortunately, H2AK911Ub staining did not work in bovine blastocysts 
with the FITC dye being diffused inside the blastomeres in all embryos stained. Instead 
it was expected that in some of the embryos a nuclear patch of FITC would mark the 
inactivated condensed chromatin, characteristic of the X chromosome inactivation 
(XCI) in female embryos.  
The reason behind this could be the diverse patterns of XCI initiation among 
mammalian embryos. XCI takes place at a later stage in bovine embryos, thus 
antibodies against histone modifications (like H2AK911Ub or H3K27me3) of the 





inactivated chromosome do not bind to their targets. Indeed it is estimated that in 
bovine embryos XCI is partially achieved by the blastocyst stage (Bermejo-Alvarez et 
al., 2010). Although the XIST transcript whose actions lead to X chromosome-wide 
gene silencing is upregulated from the morula stage, its colocalisation with histone 
modifications at the X-inactivated chromosome is first detected in day 7 blastocysts 
(Yu et al., 2020). This is also seen in pig blastocysts (Zou et al., 2019), which further 
highlights the need for tailored protocols according to the species studied. It is also 
possible that molecular mechanisms of XCI differ between murine and bovine and 
thus the protocol used in this chapter was not efficient for the purpose of embryo 
sexing.  
Despite the inability to assess embryonic sex it is not believed that miR-371 
expression and secretion differs between male and female embryos. This assumption 
is based first and foremost on the mouse findings in which all embryos released similar 
levels of the homologue miR-290-295 cluster, as presented in Chapter 3. In addition, 
the miR-371 -373 is located on chromosome 18 in the Bos taurus species and not on 
a sex chromosome, which means it is more likely that this cluster is expressed similarly 
in both male and female embryos. Lastly, array-based studies in human embryos 
comparing a panel of 754 miRNAs found no differences in the expression or secretion 
of miR-371, -372, and -373 between male and female blastocysts (Rosenbluth et al., 










5.6.3 Highly apoptotic bovine blastocysts release high levels of miR-371 into 
the surrounding media 
This experiment was carried out for a very specific reason: to show that the 
correlation between apoptosis and the miR-290-295 cluster is conserved in another 
species with higher miRNA homology with the human genome. In agreement with the 
hypothesis, a significant positive correlation was found in bovine blastocysts. 
Embryos with more apoptotic cells released significantly higher levels of the 
homologue miR-371 in spent media. This miRNA was detectable in all samples 
meaning that it could serve as a marker of poor embryonic quality in a non-invasive 
manner. 
There is very limited evidence on embryo-released miRNAs and their value as 
quality markers – the relevant studies are described in detail in Chapters 1 and 3. 
Briefly, Kropp and Khatib (2015) first showed that degenerate embryos release at least 
11 miRNAs in higher levels compared to blastocysts. Moreover, the study by Lin and 
colleagues (2019) which also used bovine embryos found 2 miRNAs, miR-10b and 
miR-45,  highly released by degenerate embryos. Notably, the two studies were not in 
agreement in regards to the miRNAs that could be used as biomarkers of quality – this 
could be due to different experimental protocols. However, the elevated levels of 
miRNAs in spent media from degenerate embryos could be a result of passive release 
from damaged membranes rather than an active, regulated process. Moreover it is 
important to point out that samples were pooled in both studies and analysed in groups 
which increases the risk of false positive/negative findings (Kropp and Khatib, 2015, 
Lin et al., 2019). In contrast with the above, in the present experiment cell lysis was 
annotated for each embryo and no correlation was found with the levels of miR-371 





in spent media. Additionally, the experiments presented so far were all carried out with 
individual sample analysis in order to generate detailed data and avoid false findings.  
The association behind increased apoptosis and intensive miR-371 release by 
embryos is difficult to interpret. Specifically for this miRNA in pre-implantation 
development, it is known that early bovine blastocysts express detectable levels of this 
miRNA in their blastomeres (Goossens et al., 2013) and human embryos release this 
miRNA, along with miR-372 and miR-373, in the surrounding media (Rosenbluth et 
al., 2014). No studies have assessed embryonic apoptosis in correlation to miRNA 
levels in spent media. The only study using TUNEL for apoptosis assessment in fact 
transfected embryos with a miRNA mimic (miR-30c) and then stained the embryos, 
concluding that increased levels inside the embryonic cells cause apoptosis (Lin et al., 
2019). This approach is the opposite from the one presented here thus making the 
findings incomparable. Nevertheless, considering the positive correlation between 
apoptosis and miR-371 media levels, the lack of association between blastomere lysis 
and miRNA levels, and the findings of Chapters 3 and 4 it seems logical to suggest 
that release of miR-371 by bovine blastocysts is an active process and that apoptosis-











The findings presented in this chapter are limited in bovine embryos produced 
with in vitro maturation protocols and further validation is needed for other species 
including human embryos. For reasons discussed in the previous section, embryo 
sexing was unsuccessful and thus, although unlikely, sexual dimorphism in miRNA 
secretion cannot be ruled out. Lastly, these results are specific for miR-371 although 
it is likely that other miRNAs are also packaged and released by cells in response to 
intra-cellular stress. Experiments using large-scale platforms with high sensitivity 
could provide more information on miRNA profiles in relation to embryo quality.  
5.8 Conclusions 
Bovine blastocysts release elevating levels of miR-371 in response to extended 
blastomere apoptosis. This association was consistent between chapters 3 and 5 
despite key-differences. Not only were the species different, the mouse embryos came 
from inbred strains with genetic uniformity whereas the cattle were outbred from 
heterogenous populations with genetic variance and the embryo production protocols 
were different (hyperstimulation/IVF in mouse IVM/IVP in bovine). Thereby it is 
encouraging to observe the same mechanisms conserved in homologue miRNAs 
across different species. Because the results were reproducible it is also more likely 
that similar associations will be found in other species, with specific focus on human 
embryos and the homologue miR-371-373 cluster. Further experiments will possibly 
decipher the biological roles behind miRNA release at the peri-implantation period. 
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6. CHAPTER SIX: TRANSCRIPTOMIC RESPONSE OF 
HUMAN ENDOMETRIAL CELLS TO MIR-371 
6.1 Introduction 
Implantation of the developing embryo into the maternal endometrium is a 
highly coordinated process that is necessary for the establishment of a successful 
pregnancy. Implantation is achieved through the actions of a plethora of factors acting 
in a spatiotemporal fashion to control this process. Initially, the maternal endometrium 
undergoes major molecular and morphological changes during the so-called window 
of implantation (WOI). These changes are collectively known as decidualisation and 
are initiated by the increase of maternal steroid hormones, namely progesterone and 
oestrogen (Dunn et al., 2003). Decidualisation is initiated regardless of the presence 
of an embryo; however, molecules secreted by the growing blastocyst also guide this 
transformation (e.g. chorionic gonadotropin and interleukin-1β) throughout the 
invasion of the trophoblast to establish implantation (Massimiani et al., 2019).  
As the blastocyst orientates towards the uterine epithelium, it interacts with 
cellular protrusions found on the apical surface of endometrial epithelial cells, known 
as pinopodes. This interaction results in adhesion of the blastocyst and is quickly 
followed by penetration and invasion of the cyncytiotrophoblast through the epithelial 
layer into the stromal cells (Davidson and Coward, 2016). The process of implantation 
is therefore a sequence of distinct events that occur shortly after decidualisation: 
apposition of the blastocyst to the implantation site, adhesion of trophoblast cells to 
the endometrial epithelium, and invasion of the cyncytiotrophoblast to the endometrial 
stroma. 




Collectively these events form the embryo-maternal interaction which is 
necessary for the establishment of a successful pregnancy. Each stage is under the 
regulation of both maternally- and embryo-secreted factors, which are known as the 
embryo-maternal interactome. The molecular interactions at the uterine interface 
create a dynamic equilibrium of factors that promotes or inhibits implantation. For 
this, embryonic and uterine cells produce molecules and release them to the extra-
cellular environment to exert their paracrine (or sometimes autocrine) actions. 
Therefore, the endometrial cells and the embryo also possess receptors of specific 
molecules which upon ligand binding activate a cascade of molecular pathways. 
There is a variety of molecules involved in the embryo-maternal interactome, 
including adhesion molecules, signalling molecules, inflammatory response proteins, 
and growth factors. Initially, a molecular dialogue via chemokines acts for the 
orientation of the blastocyst at the site of adhesion. The embryo and the uterine cells 
produce chemokines and they also express chemokine receptors to enable this 
communication. Moreover, blastocyst adhesion is promoted by cadherins which are 
present in both trophoblast and epithelial cells and are essential for the attachment and 
robust adhesion of the embryo to the uterus. Insuline-like growth factors are involved 
in the communication between the embryo and the endometrium and regulate 
endometrial proliferation and decidualisation as well as trophoblast invasion. 
Additionally, members of the interleukin family are released by the endometrium and 
the embryo to intermediate the inflammatory response which is necessary for a healthy 
implantation (Mourik et al., 2009, Massimiani et al., 2019). 
Although the actions of hormones, proteins, and growth factors at the embryo-
maternal interactome have been studied in the past, there is very limited information 
to date regarding the role of miRNAs in implantation. Limited data (mainly from two 




studies; one in humans the other in cattle) indicate that miRNAs have a role in embryo-
maternal communication. 
In the study of Cuman and colleagues (2015), high levels of miR-661 SCM were 
linked to implantation failure in humans. In silico predicted targets, namely PVRL1, 
MTA, and EPHB2, were identified as potential targets of miR-661 in endometrial 
epithelial cells (EECs) using qPCR. Indeed, the expression of these genes was altered 
by miR-661 and these authors reported that the adhesion process of implantation is 
affected by reduced levels of PVRL1 (Cuman et al., 2015). 
In a later study, 68 miRNAs were differentially expressed according to 
embryonic sex in cattle. Gene regulation of the progesterone receptor (PGR) by three 
of these miRNAs was investigated by qPCR in endometrial cells. Both miR-122 and 
miR-320a altered the expression of PGR, and these authors suggested a sex-specific 
transcriptomic response of the uterine cells in the presence of a blastocyst. By 
dysregulating the progesterone receptor it was suggested that these miRNAs influence 
implantation, as progesterone is a key-hormone regulating the receptivity of the 
endometrium at the WOI (Gross et al., 2017b).  
Although the findings of the above studies are encouraging, to date there is no 
information about miRNA gene targets in endometrial cells using large-scale 
platforms. In addition, there are currently no publications identifying specific embryo-
secreted miRNAs in relation to DNA quality which in turn regulate uterine factors and 
the implantation of the embryo itself. This experiment was based on previous findings 
and aimed to provide complete information about miRNA roles in embryo-maternal 
communication.  




6.2 Rationale and hypothesis 
This experiment was carried out to investigate if embryo-released miRNAs have 
active roles in the implantation of the embryo. Indeed, it is logical to assume that 
miRNAs are part of the embryo-maternal interactome. Firstly because, as described in 
Chapter 1, miRNAs are released by mammalian embryos and studies reported 
associations of the presence/absence and/or levels of specific miRNAs with embryo 
quality and reproductive outcomes. Secondly, because miRNAs share similar 
characteristics with other cell signalling molecules, for example they regulate the 
expression of numerous genes, they are packaged into extra-cellular vehicles or are 
bound to proteins or lipids, and they are actively released by cells and travel within 
biological fluids to other parts of the body. Thirdly, because the actual process of 
miRNA packaging and release is energy-demanding, there must be therefore a 
biological reason behind their release by embryos. Indeed, for a biological system like 
the mammalian embryo, energy resources are limited and every process is under tight 
regulation until the embryo implants and the maternal nutritional support begins.  
This experiment investigated whether there is a biological reason that miR-371 
is released by apoptotic embryos. Based on previous findings with bovine embryos 
(Chapter 5) it was proposed that miR-371 impairs the implantation of such embryos, 
perhaps in order to save energy investment required for establishing a pregnancy with 
a low-survival embryo. Overall, it was hypothesised that miR-371a changes the 
transcriptome of endometrial cells which results in molecular and phenotypic changes 
that are consistent with a non-receptive endometrium and impaired implantation. 




6.3 Aims and objectives 
The aim of this experiment was to investigate whether there is a biological 
reason that poor quality embryos release specific miRNAs extra-cellularly. Based on 
the previous findings that extended apoptosis triggers the release of miR-294/371 in 
culture medium of mammalian embryos (Makri et al., 2020), the experiment presented 
here investigated the transcriptomic changes in endometrial cells caused by this 
specific miRNA. Specifically, a human endometrial cell line was chosen to study the 
actions of the specific miRNA in human cells, which could provide preliminary 
information for human implantation. For this, the miR-371a mimic was transfected in 
human endometrial stromal cells. The miR-371a sequence in the human genome 
corresponds to the miR-371 in bovine with only one base difference between the two 
species and these miRNAs are homologue to the mouse-specific miR-290-295 cluster 
studied in Chapter 3. 
Endometrial stromal cells were chosen for transfection instead of epithelial cells 
or tissue for two reasons. Firstly, because stromal cells are involved in all stages of 
implantation except adhesion, which means that more information about the whole 
implantation process will come from studying these cells. Secondly tissue culture was 
avoided in order to study the direct actions of miR-371a in the absence of factors 
normally present in vivo that might hinder our ability to interpret such actions. 
Moreover, gene profiles were analysed with microarray technology followed by 
bioinformatic analysis. Large-scale analysis was chosen to analyse gene changes at 
the whole genome level. miRNAs are regulatory molecules and a single miRNA can 
have thousands of gene targets, which in turn interact with each other in complex 
networks. This is the reason why some in silico predicted gene targets are in fact not 




altered in mimic experiments. Therefore, large-scale gene analysis followed by 
bioinformatics was carried out to study miR-371a actions in endometrial cells. 
6.4 Methodology 
6.4.1 Endometrial Stromal Cells Culture 
Human endometrial stromal cells (CRL-4003) were purchased and cultivated in 
T-75 flasks according to manufacturer’s recommendations (ATCC, USA). All 
medium components were purchased from Sigma-Aldrich (USA), unless otherwise 
stated. The cells were cultured in complete growth medium comprising a 1:1 mixture 
of Dulbecco’s modified Eagle’s medium and Ham’s F-12 medium with 3.1 g/L 
glucose and 1 mM sodium pyruvate without phenol red supplemented with 1.5 g/L 
sodium bicarbonate, 1% ITS + Premix, 500 ng/ml puromycin, 90%; charcoal/dextran 
treated foetal bovine serum, 10%. The medium was renewed every 2-3 days and sub-
culturing was carried out every 5-6 days at a ratio of 1:6. After 8 consecutive passages, 
the transfection procedure was carried out. 
6.4.2 miRNA transfection 
The Lipofectamine RNAiMAX Transfection Reagent (ThermoFisher, UK) was 
used for delivery of the mirVana hsa-miR-371a-3p mimic (Invitrogen, UK) in the 
endometrial cells. The mirVana miR-1 Positive Control (Invitrogen, UK) was used to 
monitor the transfection efficiency, as recommended by the manufacturer. 
Optimisation was required to establish the following: cell confluency at the time of 
transfection, lipofectamine concentration, miRNA mimic concentration, and optimal 
transfection period. Additionally any deleterious effects of Lipofectamine,  
Opti-MEM, or the mimic (combined or separately) were investigated in preparation 
of the experiment and no apparent phenotypic changes were found in the cells. Based 




on the proliferation speed and population growth, the optimal cell confluency for 
transfection in this study was strictly 25-30%. Firstly, the cells were seeded in 24-well 
plates in a concentration of approximately 20% and allowed to settle and attach 
overnight. The next day the plates were checked to assess the attachment and 
confluency and the growth medium was renewed with 450 µl of fresh medium. The 
miRNA-lipofectamine complexes were then formed in preparation for transfection. 
For this, the miRNA mimic and lipofectamine were separately diluted in Opti-MEM 
medium with reduced FBS (ThermoFisher, UK) and then mixed at a 1:1 ratio and 
incubated at 37oC for 15-20 min. The optimal concentrations and volumes for 24-well 
plate transfections are found in Table 6.1. 




Steps Component 24-well plate 
Seed cells one day before transfection Adherent cells 25-30% confluency 
Dilute Lipofectamine RNAiMAX in 
Opti-MEM Medium 
Opti-MEM Medium 25 µl 
Lipofectamine 1.5 µl 
Dilute miRNA mimic in Opti-MEM 
Medium 
Opti-MeM Medium 25 µl 
miRNA mimic (10 µM) 1.5 µl (15 pmol) 
Mix diluted miRNA with diluted 
Lipofectamine (1:1 ratio) 
Diluted Lipofectamine 25 µl 
Diluted miRNA mimic 25 µl 
Incubate Incubate 15-20mins, 37oC 
 
Add miRNA-lipid complexes to cells 
miRNA-lipid complex per well 50 µl 
Final miRNA/well 15 pmol (30 nM) 
Final Lipofectamine/well 1.5 µl 
Culture cells Incubate for 72hrs at 37oC 




The miRNA-lipid complexes were then added in individual wells of the plate 
(50 µl/well – total volume = 500 µl, mimic concentration = 30 nM) and the cells were 
incubated at 37oC for 72 h without changing the growth medium. Each plate contained 
miR-371a-3p-transfected wells, positive control wells (miR-1), and two types of 
negative controls (type 1: cells in 450 µl growth medium + 50 µl Opti-MEM,  
type 2: cells and growth medium, 500 µl). Transfections were carried out in 4 
consecutive repetitions, in triplicate plates. For each repetition, a plate with ECs was 
run in parallel in which the cells were transfected with fluorescently-tagged 
transfection efficiency controls. Cells were transfected with 30nM of Cy3™ Dye-
Labeled Pre-miR Negative Control, and 30nm of BLOCK-iT™ Fluorescent Oligo 
Alexa Fluor Red and FITC transfection efficiency controls (ThermoFisher, USA). 
Every 24 h the wells were examined under the microscope to assess cell survival and 
proliferation. 
6.4.3 Cell collection, RNA extraction, RNA clean-up, cDNA libraries 
Culture medium was removed from the wells and a mix of 1% β-
mercaptoethanol in RLT buffer was added in each well (200 µl) and left for 1 min. 
The cells were mechanically disrupted using the pipet and the RLT mix containing the 
cells were moved in sterile tubes. To achieve enough RNA concentration for the 
microarray, 3 wells with the same culture conditions were combined in a single tube. 
The tubes were stored at -80oC until extraction. RNA extraction was carried out using 
the RNeasy Mini Kit according to the protocol provided (Qiagen, USA) with a minor 
modification at the final step where 20 µl of H2O were used for elution (2.6). An extra 
procedure for RNA clean-up was carried out due to the high guanidine salts: RNA 
concentration ratio which interferes with the amplification steps of the microarray 
protocol (Section 2.6.1). After RNA extraction and clean-up, the positive and negative 




control samples were processed to produce cDNA libraries using the High-Capacity 
RNA-to-cDNA kit (Applied Biosystems, USA) following the protocol provided in 
Section 2.8. 
6.4.4 Transfection efficiency 
The transfection efficiency was assessed by transfecting a positive miRNA 
mimic control under the same experimental conditions. Downregulation of the 
expected targets for the specific miRNA was then examined to assess the mimic 
delivery efficiency. As recommended by the manufacturer (Invitrogen, UK), miR-1 
was delivered to stromal cells as described above and the expression of predicted target 
TWF1 was examined. The PCR plates were prepared for analysis using the following 
volumes per well: 5 µl TaqMan Universal PCR Master Mix (no AmpErase  UNG), 0.5 
µl TaqMan Gene Expression Assay (ThermoFisher, USA), 2.5 µl H2O, and 2 µl cDNA 
product in triplicates for each sample. The assay for TWF1 was used for checking the 
transfection efficiency and 18S ribosomal RNA was used as a normaliser. The 96-well 
plates were run following the protocol described in Section 2.10. The amplification 
plots were visually examined and the TWF1 Ct values were normalised against 18S 
using the ΔCt method (2.11). The percentage of downregulation in the positive control 
samples compared to the negative controls was then calculated. 
Transfection efficiency was also assessed qualitatively with fluorescent 
microscopy, by verifying the uptake of the Cy3-tagged pre-miR mimic negative 
control, which does not cause any identifiable molecular effects upon miRNA 
transfection, and the BLOCK-iT Alexa Fluor Red and FITC fluorescent controls that 
are specifically designed to monitor lipid-mediated transfection efficiency. After 72 
hours of transfection, the supernatant was removed and 500 µl of 70% ethanol were 




added in each well. The plate was kept in the fridge for 3-4 hours, the ethanol was 
removed and mounting medium containing DAPI (Vectashield, USA) was added until 
it covered the surface of each well. After 30 min, the cells were mechanically detached 
from the surface using rigorous pipetting and a small amount of PBS solution. The 
cells were placed in microscope slides for fluorescent microscopy. The settings 
described previously were adjusted for detecting the fluorescent signals with the 
appropriate filters for each dye (542/620 nm TRITC, 475/530 nm FITC, 559/630 
TxRed, 350/470 DAPI).  
6.4.5 Microarray analysis 
Total RNA was isolated from endometrial cells using the RNeasy Mini Kit, as 
described above. The quality and integrity of the total RNA were evaluated on the 
Agilent-2100 Bioanalyzer system. Only samples surpassing the minimal quality 
threshold (RIN > 8.0) were used in the subsequent transcriptomic assessment. cDNA 
was prepared from 50 ng/µl of total RNA as per the GeneChip™ WT-PLUS Reagents 
(ThermoFisher Scientific/Affymetrix, UK) and followed by in vitro transcription to 
produce cRNA, end-labelled and hybridised for 16 h at 45oC to Clariom™ S Human 
Arrays (ThermoFisher Scientific/Affymetrix, UK). Washing and staining steps were 
performed by a GeneChip Fluidics station 450 and scanning was done using ™ 
Scanner 3000 7G System (ThermoFisher Scientific/Affymetrix, UK) according to 
manufacturer’s instructions at the Nottingham Arabidopsis Stock Centre (NASC), 
School of Biosciences, University of Nottingham. The raw CEL files were normalised 
using RMA background correction with quantile normalisation, log base 2 
transformation with adjustment for GC content. Differentially expressed genes were 
considered significant when p-value was <0.05, false discovery rate, FDR ≤ 0.05 with 
Benjamini-Hochberg correction, and fold-change of >1.0 or < -1.0. 




6.4.6 In vitro validation 
For each sample that was analysed by microarray, an appropriate volume of 
RNA product was stored at -80oC to be used for validation of the microarray results. 
cDNA templates were created and PCR was carried out as described above.  The Ct 
values were normalised with 18S, the ΔCt values were used for group comparisons 
and the ΔΔCt values were used for calculating the fold changes between control and 
transfected samples (Schmittgen and Livak, 2008). T-tests were used for comparing 
the expression of each gene across the two groups. Fold change values from the 
microarray and PCR were input in a correlation test to determine the consistency 
between the two amplification methods. For all tests a p value of <0.05 was considered 
significant. 
6.4.7 Gene Set Enrichment Analysis (GSEA) 
The top gene list contained only 45 genes, thus it was not possible to run a robust 
enrichment analysis with this low number. After consultation with the 
bioinformatician, GSEA analysis of the genes that differed significantly (p<0.05) was 
carried out using WebGestalt 2019 version (Liao et al., 2019). Gene ontology (GO, 
Biological Process noRedundant) and pathway (KEGG) analyses were carried out 
using the following parameters: minimum number of genes for a category = 3, 
Significance level = TOP 10, Number of Permutations = 1000, Collapse Method = 
Mean. GSEA was also carried out using a second bioinformatics tool to ensure that no 
significant categories are missed due to access in online databases. Therefore, the gene 
list was analysed using Enrichr to generate GO and pathway lists (Chen et al., 2013), 
and the results are represented in graphs using combined information from both 
WebGestalt and Enrichr. Lastly, Mammalian Phenotype (MP) analysis was carried out 
to identify phenotypic changes relevant to implantation caused by miR-371a addition. 





6.5.1 Transfection efficiency 
After optimisation, the protocol for miRNA transfection was established and the 
experiment was carried out. Endometrial cells were examined on a daily basis to assess 
cell survival and proliferation and also observe if any adverse effects caused by the 
treatment occurred (e.g. precipitation in the medium, abnormal cell morphology and 
clumping). As shown in the picture below, no such effects were apparent. However, 
macroscopically it was observed that cell confluency in the transfection wells differed 
from the control wells. More specifically, at 72 h the transfection wells were confluent 















Figure 6.1 Human endometrial cells at 24, 48, and 72 hours (h) post-transfection. The 
images on the upper row are from wells that were transfected with 15 pmol of mimic and the 
images on the lower row are negative control wells with no added lipofectamine or mimic. 
The pictures were taken at a 10X magnification. 




Furthermore, transfection efficiency was assessed by determining the 
downregulation of miR-1 target, TWF1, in the positive and negative control samples. 
According to the manufacturer, downregulation of the target for >75% is required for 
successful transfection experiments. From the 4 repetitions of the transfection 
experiment, repetition number 3 was the one where transfection efficiency was 
acceptable and therefore samples from this repetition were used for microarray 
analysis. All samples were positive and amplified at the same PCR cycle for the 
reference gene 18S, and more specifically the positive controls amplified at 14.1 
cycles and the negative controls at 14.5 cycles. Moreover, the positive controls 
amplified for TWF1 at 30.1 cycles and the negative samples at 27.8 cycles. The ΔCt 
and 2-ΔCt values were calculated and the percentage of downregulation of the target 
was determined using the following formula: 
% 𝑑𝑜𝑤𝑛𝑟𝑒𝑔𝑢𝑙𝑎𝑡𝑖𝑜𝑛 = (
(𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 2−𝛥𝐶𝑡 –  negative control 2−𝛥𝐶𝑡)
𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 2−𝛥𝐶𝑡
) x 100  
Target downregulation was verified in each cell culture plate. On average, 
TWF1 was downregulated by 82% in the miR-1 transfected wells compared to the 









Figure 6.2 Amplification plot of the positive and negative controls. The x axis contains the 
number of PCR cycles and the y axis the log ΔRn values (ΔRn: reporter fluorescent 
signal/baseline). The threshold line is shown in green. The dark blue lines represent the 
amplification of the fluorescent signals from the negative control and the light blue lines are 
from the positive control (triplicates). All samples are amplifying for 18S (reference gene) at 
the same cycle (~14 cycles). For TWF1, the negative controls amplify earlier (~28 cycles) than 
the positive controls (~30cycles). 




In agreement with the PCR results, fluorescent microscopy also verified the 
transfection efficiency. The Cy3, Alexa Fluor Red, and FITC signals were clearly 
visible inside the endometrial cells (Figure 6.3) and therefore samples from repetition 






6.5.2 Quality control 
The RNA products achieved a concentration of >50 ng RNA/µL, with 
acceptable 260/280 and 260/230 purity values (all close to 2) when measured with 
NanoDrop™ 1000 Spectrophotometer (ThermoFisher, USA). All samples had RIN 
scores of 10 which allowed the use of the 3 mimic and 3 control samples for further 
analysis.  
6.5.3 Partek analysis 
The first step for interpreting the microarray results was to visually examine the 
principal components analysis (PCA) plot. A PCA plot containing 6 samples in total 
(3 transfected, 3 control) was generated (Figure 6.4). 3D concentration ellipsoids were 
fitted to the graph enabling the visualisation of the homo- and hetero-geneity of 
expression profiles within and between the groups. The two ellipsoids are clearly 
separated (not intermingled) and distanced in the graph, which means that there is a 
prominent difference in gene expression between the two groups. The dots within each 
Figure 6.3 Endometrial cells observed with fluorescent microscopy (x40 magnification) 
with the appropriate filters for each dye. Transfection efficiency was verified by detecting 
fluorescence inside the cells. Scale bars (10.00 nm) are added on the top right corner of each 
picture. 




ellipsoid (samples within each group) are tightly concentrated which means that these 
samples have similar expression profiles and should therefore be included in the 
downstream analysis. Regarding the transfected samples, this is an additional 









Moreover, a volcano plot was generated to identify the data points (genes) which 
display large magnitude changes that are also statistically significant (Figure 6.5). The 
volcano plot represents each gene with a dot and combines a measure of statistical 
significance from a statistical test, in this case a 3-way ANOVA between transfected 
and control samples, with the magnitude of the fold change. In the following figure, 
numerous genes are either significantly downregulated or significantly upregulated in 
the transfected samples compared to the controls. In particular 4.760 genes differed 
significantly (p<0.05) between the control and the transfected cells. The p values 
varied from <0.001 to ≤0.05 and the FC from -3.7 to 4 across the 4.760 genes. 
Furthermore, the top gene list was generated using Partek. In total 45 genes were 
differentially expressed between the groups with stricted criteria applied (Figure 6.6). 
Figure 6.4 PCA plot of the samples analysed with microarray. Each sample is represented 
by a dot and each colour represents a group. The red dots and ellipsoid represent 3 control 
samples while the blue dots and ellipsoid represent miR-371a-3p mimic-transfected samples. 






















Figure 6.5 Volcano plot of 21.448 genes analysed with the microarray chip. The fold 
change (FC) is displayed on the x axis and the p-value calculated with 3-way ANOVA is 
given on the y axis. The calculations are given for the transfected samples compared to the 
controls (baseline). Each gene is represented with a dot. The genes that are further apart on 
the x axis and on the top of the y axis are the ones that are significantly differentially expressed 
between transfected and control samples. Manually drawn purple ellipsoids enclose candidate 
top differentially expressed genes. 
Figure 6.6 Heatmap of the top differentially expressed genes. Mimic and control samples 
are clustered in the 6 rows of the map. The gene names are given for every column. Over-
expressed genes are displayed in read and under-expressed genes in green. The genes are 
clustered based on the FC values. 




6.5.4 In vitro validation 
Six genes of interest were chosen for in vitro validation based on the 
mechanisms involved and the fold change values. Specifically, downregulated genes 
CDH2, PCDH10, and SOX4 and upregulated genes E2F7, G0S2, and TNFRSF10 were 
examined in the same samples with PCR. The expression of all genes was significantly 
different between control and transfected groups (p<0.001 for all). Moreover, 
Pearson’s correlation test revealed a statistically significant positive association of the 
fold change values generated by microarray and by PCR (r=0.985, p<0.001). These 
results show consistency across microarray and PCR for the specific genes which 
implies that the findings are accurate, reliable, and reproducible. Table 6.2 summarises 
the expression profiles and fold change values for the 6 genes as generated by 
Affymetrix and the validation in vitro by PCR. 
 
Table 6.2 List of the selected genes for validation of the microarray results with PCR. 
The nature of regulation and fold change difference is given for the microarray in comparison 
to the PCR values. The p values from t-test comparisons for each gene between the two 
methods are also given. 









CDH2 Down Down -1.78 -1.17 
SOX4 Down Down -1.99 -1.34 
PCDH10 Down Down -2.31 -1.65 
TNFRSF10 Up Up 2.28 3.75 
G0S2 Up Up 2.01 5.02 
E2F7 Up Up 2.36 5.30 
 




6.5.5 Gene Set Enrichment Analysis (GSEA) 
GO analysis was carried out for the 4.760 differentially expressed genes 
(noRedundant). Firstly, the genes were categorised based on their biological, cellular, 
and molecular functions. Figure 6.7, Figure 6.8, and Figure 6.9 are slim summaries of 
these analyses and contain combined results from WebGestalt and Enrichr. 
Reproduction was one of the biological processes affected by miR-371a 
transfection with 356 affected genes in this category. Other affected biological 
processes which are likely involved in normal endometrial functions and implantation 
are: response to stimulus (2.124 genes), cell communication (1.501 genes), cell 












Figure 6.7 Gene ontology biological process summary for the differentially expressed genes. 
The height of the bar represents the number of genes in each process and the exact number of 
genes involved is given above each bar. 




Moreover, the membrane was the anatomical cellular part which was mostly 
altered by miR-371a, with 2.112 gene alterations post-transfection. Other cellular 
components relevant to implantation were affected, including nucleus (1.915 genes), 

















Figure 6.8 Gene ontology cellular component summary for the differentially expressed genes. 
The height of the bar represents the number of genes in each process and the exact number of genes 
involved is given above each bar. 




The majority of molecular function changes were related to binding activities, 
with the mostly affected category being protein binding (2.967 genes) followed by 
other relevant categories like ion binding (1.513 genes) and nucleic acid binding 
(1.067 genes), lipid binding (174 genes), kinase binding (135 genes), and cadherin 
binding (111 genes). Enzyme activity changes were also prominent, with hydrolase 
(688 genes), transferase (620 genes), and ATPase (71 genes) activities significantly 


















Figure 6.9 Gene ontology molecular function summary for the differentially expressed 
genes. The height of the bar represents the number of genes in each process and the exact 
number of genes involved is given above each bar. 




From the original input list containing genes that differed significantly (p<0.05), 
3.646 genes were annotated to selected functional categories by WebGestalt and were 
used for the gene set enrichment analysis. Based on the parameters set for analysis, 
114 positive related and 45 negative related categories were identified as enriched 
categories. A bar chart was generated, in which the enriched biological processes were 
ranked using the normalised enrichment scores (NES) calculated by WebGestalt 
(Figure 6.10). In relation to normal endometrial cell functions, processes such as RNA 
catabolism (3.1 NES), negative cell cycle regulation (3 NES), apoptotic signalling (2.5 
NES), proteolysis (2 NES), and cycle arrest (1.9 NES) were upregulated in 
endometrial cells whereas cell proliferation (-2.1 NES), cellular component 
maintenance (-2.1 NES), cell adhesion (-2 and -2.1 NES), immune and inflammatory 





































Figure 6.10 Bar chart of the GSEA. The x axis shows the normalised enrichment score given by 
WebGestalt. Blue bars represent biological process enhanced in the miRNA-transfected samples and yellow 
bars represent processes downregulated compared to the control samples. FDR was ≤0.05 for all categories. 
The figure above has been edited to contain processes relevant to the subject of the present experiment. 




6.5.6 Pathway analysis 
The Kyoto Encyclopaedia of Genes and Genomes (KEGG) 2019 was used as a 
database for pathway analysis. The differentially expressed genes were involved in 
305 pathways in total including pathways relevant to endometrial functions such as 
signalling pathways (MAPK, chemokine, p53, Wnt, TNF, and oestrogen), cell cycle 
(54 genes), apoptosis (52 genes), cytokine interactions (58 genes), and cell adhesion 













Figure 6.11 KEGG pathways in the miRNA-transfected cells. The height of the bar 
represents the number of genes in each process and the exact number of genes involved is 
also given above each bar. 




6.5.7 Mammalian Phenotype 
Input of the differentially expressed genes in MP ontology analysis showed that 
4.818 phenotypes were affected by miR-371a transfection. From these, 13 phenotypes 
have direct effects in human implantation are described in Figure 6.12. The phenotype 
affected the most from miR-371a presence was the decreased endometrial cell 
proliferation (58 gene changes), followed by increased apoptosis (48 genes), failure of 
embryo implantation (7 genes), abnormal decidualisation (5 genes), and abnormal 















Figure 6.12 Mammalian phenotypes affected by miR-371a. The length of the bar represents 
the number of genes in each process and the exact number of genes involved is also given next 
to each bar. 




6.5.8  Implantation-related genes 
Furthermore, a thorough literature review discovered that numerous genes 
altered by miR-371a are involved in all processes of embryo implantation. More 
specifically, genes regulating decidualisation of the stromal cells, uterine cell 
communication, embryo orientation, adhesion, invasion, and establishment of the 
implantation site were dysregulated by miR-371a. The following tables 6.3-6.6 list the 
affected genes according to the process involved. The literature sources are given in 
discussion where gene regulation is described in detail. 
 
 
Table 6.3 Decidualisation-related genes that were altered by miR-371a. The gene family 




 Upregulated Downregulated 
Prolactin PRLR PRLH 
Progesterone  PGR 
Vascular Endothelial Growth Factors (VEGF)  VEGFA;VEGFB 
Cluster of Differentiation antigens (CD)  CD44 
Insulin Growth Factors (IGF) IGF2;IGFBP4 IGF1;IRS2 
Vimentin  VIM 
Snail  SNAI2 
Catenins CTNNB1  
Intermediate filaments DES  




Table 6.4 Genes regulating the stroma-epithelium communication at the window of 
implantation. The gene family and the gene symbols are given for each gene along with the 




















 Upregulated Downregulated 
Hand And Neural crest 
Derivatives (HAND) 
 HAND2 
Progesterone  PGR 
Fibroblast Growth Factors (FGF) FGF2 FGF-1;-5;-7;-9;-17;-20 
Insulin Growth Factors (IGF)  IGF1 




Table 6.5 Genes controlling the adhesion phase of embryo implantation. The gene family 




 Upregulated Downregulated 
Cadherins (CDH, PCDH) PCDH20 PCDH-7;-B8;-9;-B9;-10;-11X;-B11;-B14;-18;-19 
CDH-2;-3;-4;-6;-16 
Integrins (ITG) ITGA3;ITGB3BP ITGB5;ITGB1BP2;ITGBL1 
Cell Adhesion Molecules (CAMs)  ICAM3;NCAM2 
Connexins   GJB6 
Catenins CTNNB1  
Tight Junction (TJ) TJP2;TJAP1  
Desmocollins  DSC2 
Cluster of Differentiation antigens 
(CD) 
CD166 (ALCAM) CD44 
Trophinin TRO  
Galectins  LGALS7B;LGALS9C;LGALS9B 
Proteases ADAM-9;-17;-32;-TS1;-TS12 ADAM-7;-19;-22;-30;-TS7;-TS13;-TS19;-TSL4;-TSL5 
Wingless/Int-1 (WNT)  WNT9B 
SRY-related HMG-box (SOX)  SOX-2 ;-4 ;-5 ;-12;-18 
Epidermal Growth Factors (EGF) HBEGF;ERBB2IP EGFL6;ERBB2 
Fibroblast growth factors (FGF) FGF2 FGF-1;-5;-7;-9;-17;-20 
Progesterone receptor  PGR 
Homeobox (HOX) HOXC8 HOX-A2;-A11;-A-AS3;-C13;-D3;-D11 
B-Cell Lymphoma (BCL) BCL-2L1;-2L12;-11A;-AF1 BCL-7A;-2L14 
Cyclooxygenase (COX) COX-7C ;-7A2L ;-X17 
SYNJ2BP-COX16 
COX1;COX7A1 
Neurogenic locus Notch Homologue 
(NOTCH) 
 NOTCH3 
Thyroid Hormone THRA;THRAP3  
Interferons (IFN)  IFNL1 
Leukemia inhibitory factors (LIF) LIFR  




Table 6.6 Genes involved in the invasion of the trophoblast to the uterine lining. The gene 
family and the gene symbols are given for each gene along with the nature of dysregulation 










 Upregulated Downregulated 
Integrins (ITG) ITGA3;ITGB3BP ITGB5;ITGB1BP2;ITGBL1 
Interleukins (IL) IL-1R1;-F2;-4R;-13RA1;-15 IL-20RA;-34;-16;-3RA;-31;-9R;-2RB;-10;-5;-33 
Epidermal growth factors 
(EGF) 
 EGFL6;ERBB2 
Cytokines/Chemokines  CXCL-6;-8;-12;-16,CLCF1,CCL-2;-13,LEP 
Vascular Endothelial Growth 
Factors (VEGFs) 
 VEGFB 
Insulin Growth Factors (IGFs) IGF2BP2 IGF-1;-2;-BP3;-BP4;-BP5;-BP6;-BP7 





Mucins (MUC)  MUC4;MUC16 
Cell Adhesion Molecules 
(CAMs) 
 ICAM3 
Prolactin PRLR PRLH 
Dickkopf (Wnt signalling)  DKK1 
Leukaemia inhibitory factors 
(LIF) 
LIFR  





The aim of this experiment was to investigate whether miR-371a causes 
molecular changes in human endometrial cells that could have an impact on 
implantation. Since this miRNA is released by both mouse and bovine embryos that 
have extended apoptosis in their blastomeres (Makri et al., 2020), it was hypothesised 
that miR-371a might act as a messenger molecule to interact with endometrial cells 
and inhibit implantation of the incoming embryo. The hypothesis was based on 
existing knowledge regarding the embryo-maternal communication via a plethora of 
molecules that regulate implantation in the mouse and human species (Massimiani et 
al., 2019). As described in detail in the introduction, limited information on miRNA 
actions on human and bovine endometrial cells were also used as preliminary evidence 
for the completion of the present study (Cuman et al., 2015, Gross et al., 2017b). In 
agreement with the hypothesis, the main findings of the present experiment are that 
miR-371a dysregulated the expression of genes in human endometrial cells and this 
dysregulation is overall consistent with impaired implantation of the embryo. 
6.6.1 miR-371a is predicted to cause biological, cellular, and molecular 
changes in human endometrial cells 
Biological processes that are generally involved in cell survival were predicted 
to be altered by miR-371a. These include metabolic processes, cell communication, 
and protein modification and translation. Reproduction-relevant processes in 
endometrial cells such as cell proliferation, response to stimulus, growth, and 
development were also predicted to be altered in transfected cells. Moreover, miR-
371a was predicted to cause changes in a number of cellular components with the most 
enriched group being the membrane followed by changes in the nucleus, cytoskeleton, 
extracellular matrix, focal adhesion, ribosome, and spindle amongst others. 




Additionally, many molecular processes were predicted to be affected by miR-371a 
with leading category the protein binding functions followed by cadherin, ion, nucleic 
acid, lipid, and chromatin binding and enzyme activities such as hydrolase, 
transferase, and ATPase and enzyme regulation. 
Further analysis found numerous enriched categories in endometrial cells after 
miR-371a addition. Many of these have essential roles in implantation, such as the 
cell-cell adhesion, cell proliferation, cytokine production, immune and inflammatory 
responses, and detection of chemical stimulus (Mourik et al., 2009) and all of these 
processes were negatively enriched by miR-371a. Positively enriched processes 
included the negative regulation of cell cycle, cell cycle arrest, p53-mediated 
signalling pathway, apoptotic signalling pathway, response to DNA damage, and 
enhanced proteolysis. These are processes which are generally associated with 
impaired cellular functions and low survival. 
KEGG analysis identified additional pathways predicted to be affected including 
cytokine signalling, RNA degradation, WNT signalling, and oestrogen signalling 
pathways. These pathways are important in all stages of implantation. For example, 
oestrogen signalling is necessary to prepare the endometrium to gain a receptive state 
(Young, 2013). Embryo-maternal communication via cytokine signalling is essential 
for the orientation of the blastocyst towards the site of implantation at the uterine 
epithelium (Dominguez et al., 2005). Moreover, WNT signalling activates factors in 
the trophoblast cells which promote invasion of the blastocyst cells into the 
endometrium (Chen et al., 2009). Taken together these findings reveal that while 
processes that are essential for implantation are predicted to be downregulated, other 
pathways that impair signalling and promote degradation and cell death are predicted 
to be enhanced by miR-371a. 




6.6.2 miR-371a is predicted to induce phenotypic alterations in endometrial 
stromal cells consistent with impaired implantation 
The MP analysis revealed 13 predicted phenotypic changes related to 
implantation that were caused by aberrant gene expression due to miR-371a addition. 
The most affected category was proliferation in which 58 genes were identified that 
cause decreased cellular proliferation. Stromal cell proliferation is essential during the 
initial stages of decidualisation when intense cell proliferation is followed by 
morphophysical changes of the stroma cells (Pan-Castillo et al., 2018). Indeed, 
decreased cell numbers and increased number of dead cells were observed under the 
microscope while this experiment was carried out (Figure 6.1). This is also in 
agreement with the second most affected phenotype predicted, increased apoptosis, 
which was a result of 48 genes being dysregulated. Another predicted altered 
phenotype was abnormal decidualisation of the stromal cells which has deleterious 
effects on embryo implantation as the uterine cells cannot adequately support the 
establishment of an embryo-maternal interface at the invasion part of implantation 
(Pan-Castillo et al., 2018). Overall, impaired implantation and failure of implantation 
were predicted for miR-371a regulation which is in agreement with the hypothesis of 
the present study. 
6.6.3 Effects on stroma cell decidualisation 
In vivo, endometrial stromal cells undergo a series of morphological, cellular, 
and molecular changes at the WOI, collectively known as decidualisation. 
Endometrial remodelling is a prerequisite for successful invasion of trophoblast cells, 
establishment of implantation, and normal growth of the embryo throughout 
pregnancy. Any disturbance in this process could impair endometrial receptivity, 
implantation, and pregnancy (Jeeyeon et al., 2012, Pan-Castillo et al., 2018). 




Decidualisation is initially triggered by progesterone which exerts its actions via 
binding to the progesterone receptor (PGR). Upon binding the receptors undergo 
conformational changes and gain affinity for various transcription factors causing 
overall changes in gene transcription. In the present study the PGR gene was 
downregulated in stromal cells (by 1.9 FC). It is therefore possible that while the 
blastocyst invades through the epithelial layer, secreted miR-371a causes 
downregulation of PGR expression in the underlying stromal cells which could impair 
their cellular transition. 
Another molecular pathway that could affect decidua competence to establish 
implantation is the Hyaluronan (HA) – CD44 interaction. Decidualised stromal cells 
(DSCs) continuously synthesise and secrete HA and express its receptor CD44 on their 
cell surface membranes. Upon HA binding to CD44, activation of PI3K and MAPK 
signalling pathways promote DSC proliferation while inhibiting apoptosis, both of 
which are thought to be beneficial for maintaining normal pregnancy. Indeed, human 
decidua coming from patients with miscarriages have significantly decreased CD44 
levels compared to normal pregnancy controls (Zhu et al., 2013). Interestingly, miR-
371a significantly downregulated CD44 expression by 1.1 FC in human stromal cells 
in the current experiment. Possibly increased miR-371a levels at the embryo 
attachment site could diminish the ability of stromal cells to respond to HA via 
reduction of CD44 binding sites on the cell surface membranes. 
Maintenance and proliferation of DSCs are partly regulated by the insulin-like 
growth factor (IGF) network. The expression of these factors and their binding 
proteins alters upon endometrial differentiation. For example, IGF-2, IGFBP-4, and 
the insulin receptor IRS-2 are highly expressed after decidualisation (Ganeff et al., 
2009). Notably, supressed expression of IGF-2, IGFBP-4, and IRS-2 was caused by 




miR-371a (-1.1, -1.1, and -1.7 FC respectively). Dysregulation of this particular 
pathway at the site of implantation could have negative effects on the competence of 
DSCs to establish a healthy foetal-maternal interface. 
6.6.4 Effects on stromal-epithelial communication 
Equally important is the stromal-epithelial crosstalk which prepares the uterine 
cells to accept an invading embryo. Oestrogen and progesterone together with growth 
factors trigger and coordinate the stroma-epithelium communication. Dysregulation 
of  mediators of the stroma-epithelial crosstalk often leads to pregnancy loss and 
infertility, highlighting thus the importance of inter-cellular communication for 
implantation (Hantak et al., 2014).  
As in decidualisation, PGR plays a pivotal role in the luminal-stromal 
communication. Progesterone receptors are found in both epithelial and stromal cells; 
however, PGR expression is higher in the latter cell type at the WOI (Kurita et al., 
1998). These receptors are transcription factors that are found in the cytoplasm in 
absence of progesterone. Upon binding, these receptors translocate to the nucleus 
where they bind to specific genomic sites to activate or repress the expression of genes. 
Additionally, PGR regulate gene expression via targeting other transcription factors 
(Hantak et al., 2014). With regards to epithelial-stromal communication, the stromal 
PGR mediates the inhibitory effect of progesterone on epithelial DNA synthesis and 
proliferation (Kurita et al., 1998). Moreover, lactoferrin and Pgr expression in mouse 
epithelial cells is also mediated via PGR in the stromal cells in response to 
progesterone (Kurita et al., 2000). Interestingly, in mice stromal PGR are necessary 
and sufficient to mediate the increase of Indian Hedgehog (IHH), a cell signalling 
protein, in epithelial cells whereas PGR in the epithelium play no role in Ihh induction 




upon progesterone activation (Simon et al., 2009). Considering the above, it is 
probable that miR-371a affects PGR-mediated molecular pathways involved in 
stromal-epithelial communication. This could have deleterious effects in the healthy 
cooperation of the uterine cell populations to establish a pregnancy. 
Stroma-derived growth factors also regulate epithelial functions. For instance, 
members of the fibroblastic growth factor (FGF) family are important for the 
activation of kinases in signalling cascades. FGF expression in human stroma cells is 
partly induced by elevating levels of oestrogen at the WOI and FGFs are then released 
and bind to FGF receptors at the surface of epithelial cells (Hantak et al., 2014). This 
binding activates extracellular signal-regulated kinases 1 and 2 (ERK1/2) signalling 
cascade in the cytoplasm of epithelial cells (Eswarakumar et al., 2005) that overall 
promotes epithelial proliferation (Li et al., 2011). Specifically, FGF-1, -2, -9, and -18 
are produced in stromal cells and trigger signalling cascades in EECs which enhances 
epithelial proliferation (Li et al., 2011, Tsai et al., 2002). In the present experiment, 
the expression of seven FGF genes was altered by miR-371a addition, with FGF-1, -
5, -7, -9, -17, -20 being significantly downregulated and FGF-2 upregulated. 
IGF-1 is another factor which mediates the stromal-epithelial communication. 
In humans, elevating oestrogen enhances the transcription of IGF-1 in stromal cells 
which is then released and binds to the respective receptor (IGF-1R) at the surface of 
epithelial cells (Hantak et al., 2014). Upon binding, it triggers the phosphatidylinositol 
3-kinase/Akt (PI3K/Akt) signalling pathway which stimulates cell cycle progression 
in EECs acting thus as a paracrine factor to enhance epithelial proliferation (Zhu and 
Pollard, 2007, Walker et al., 2010). MiR-371a in the present study lowered IGF-1 
expression in stromal cells by 1.2 FC which could disturb the paracrine regulation of 
the luminal epithelium with effects on implantation. 




A tight temporal interplay of oestrogen and progesterone regulates the uterine 
environment during pregnancy. While oestrogen enhances epithelial proliferation 
during the first two days of pregnancy, elevating levels of progesterone counteract and 
sustain proliferation on day 4 of pregnancy. A key-player of this exit from the cell 
cycle is the heart and neural crest derivatives-expressed protein 2 (HAND2). HAND2 
is a progesterone-driven factor that is induced in stroma by day 3 of pregnancy while 
it is absent in the epithelium (Huyen and Bany, 2011). HAND2 directly inhibits the 
actions of FGFs which trigger signalling cascades that promote proliferation (Li et al, 
2011). More specifically, the ERK1/2 pathway is directly affected by HAND2 which 
leads to cessation of proliferation (Li et al., 2011). Whereas FGF expression is 
necessary for the first days of implantation, their levels need to be sustained after day 
3 to slow down epithelial proliferation and promote cellular differentiation. Indeed 
Hand2 knockout mice show persistent epithelial proliferation with uteri failing to 
achieve a receptive state compared to controls (Li et al., 2011). Notably, miR-371a 
significantly decreased HAND2 expression by 1.3 FC in stromal cells which could 
directly affect the FGF crosstalk with the uterine epithelium and impair implantation 
in vivo. 
6.6.5 Effects on embryo attachment and adhesion 
Although stromal cells were transfected in the present study, it is likely that 
similar gene expression changes are observed in endometrial epithelial cells; therefore, 
effects on the process of embryo adhesion are briefly discussed. The initial analysis 
showed that membrane structure was the cellular component mostly affected by miR-
371a and moreover cell adhesion processes were downregulated. Additionally, key-
genes involved in embryo attachment and adhesion were generally dysregulated by 
miR-371a. 




As the embryo approaches the uterine wall, a level of polarity orientates the 
blastocyst in relation to the uterine epithelium. In humans, the ICM is directed at the 
site of attachment (Lee and Demayo, 2004) through a chemokine gradient (Dominguez 
et al., 2005). Chemokines and their receptors are found in both uterus and the 
blastocyst, suggesting a bi-directional communication via chemokines at this stage 
(Hannan et al., 2006). Interestingly, KEGG analysis found that the chemokine 
signalling pathway was significantly altered by miR-371a and 5 chemokines (CCL-2, 
-13 and CXCL-6, -12, -16) were significantly downregulated. While the roles of these 
molecules in embryo attachment is not yet established, they all serve chemoattractant 
properties in human cells (www.uniprot.org) and are thus mentioned within this 
context. 
Furthermore, cell adhesion molecules (CAMs) and junctional complexes at the 
epithelium are responsible for binding with other cells or with the extracellular matrix 
(ECM) during implantation. Cadherins (CDH) and protocadherins (PCDH) are 
transmembrane glycoproteins that form adherens junctions with the embryo (Singh 
and Aplin, 2009, Dey et al., 2004), whereas connexins form gap junctions between 
cells and create channels which allow the cytoplasmic exchange of molecules 
(Grummer and Winterhager, 2011). Furthermore, immunoglobulin CAMs (NCAMs, 
ICAMs, CCAMs) form non-classical junctions between cells (Singh and Aplin, 2009). 
ICAMs additionally act as ligands for integrins; transmembrane receptors that mediate 
cell-ECM adhesion and trigger signalling cascades for cell cycle regulation and 
cytoskeleton organisation (Kimber and Spanswick, 2000). Another important cell 
surface receptor is CD44, the receptor for hyaluronan (HA). The interaction between 
CD44 and HA is important for the initial docking of the embryo to the uterus (Berneau 
et al., 2019). Lastly, galectins (LGALS) are secreted by cells and act via cross-linking 




carbohydrate chains on cells surfaces and the ECM, thus having functional roles in 
embryo adhesion (Aplin and Singh, 2008, Smalley and Ley, 2005, Shimizu et al., 
2008). In the present experiment, miR-371a caused downregulation of 5 CDH genes 
(CDH-2, -3, -4, -6, -16) and 10 PCDHs (PCDH-7, -B8, -9, -B9, -10, -B11, -11X, -B14, 
-18, -19) and upregulation of PCDH-20. Moreover, KEGG analysis showed 
significant alteration of CAMs actions in endometrial cells and expression of 
connexin-30 (Cx-30) and ICAM-3 and NCAM-2 were downregulated. Integrin family 
members ITG-B5, -B1BP2, -L1 were downregulated and ITG-A3 and ITG-B3BP 
upregulated. Furthermore, CD44 and LGALS-7B, -9C, 9B were downregulated. 
Signalling molecules that mediate embryo adhesion were also dysregulated. The 
epidermal growth factor family (EGF) members mediate signalling with matrix 
metalloproteinases MMPs and ADAMs (Qiu et al., 2004, Gee and Knowlden, 2003), 
which are responsible for molecule assembly and degradation at the embryo-uterine 
interface to facilitate adhesion (Singh and Aplin, 2009). Additionally, EGFs interfere 
with the expression of the neurogenic locus notch proteins (Notch) (Massimiani et al., 
2019) which mediate signalling networks involved in cell proliferation, invasion, 
adhesion, apoptosis, and differentiation (Bray, 2006). Lastly, EGF and WNT members 
form signalling cascades (Civenni et al., 2003) which are important for embryo 
orientation at the site of apposition (Goad et al., 2017). Regarding miR-371a 
regulation, signalling pathways were generally affected including MAPK and Wnt 
signalling. Moreover, EGF-L6, the EGF receptor ERBB-2, ADAM-7, -19, -22, -30, -
TSL4, -TSL5, -TS7, -TS13, -TS19, MMP-3, -12, -14, Notch-3, and Wnt-9B were all 
significantly downregulated whereas ADAM-9, -17, -32, -TS1, -TS12 were 
upregulated.  




Lastly, increasing levels of progesterone at the WOI cause structural and 
molecular changes to the uterine epithelium in order to achieve a receptive state. In 
adhesion, progesterone upregulates the expression of MUC-1 at the apical surface of 
uterine epithelia (Meseguer et al., 2001) which acts as a ligand for selectins expressed 
by human blastocysts at the time of adhesion (Carson et al., 2006). Progesterone also 
controls the expression of cadherins in the luminal epithelium which are essential 
CAMs for embryo adhesion as described above (Jha et al., 2006). In the present 
experiment miR-371a significantly decreased the expression of the progesterone 
receptor PGR which could cause reduced response of the epithelial cells to 
progesterone stimulus. 
6.6.6 Effects on trophoblast invasion, inflammatory response, and 
establishment of the implantation site 
In humans, embryo invasion triggers an inflammatory response which needs to 
be controlled in order for the semi-allogeneic embryo to be accepted by the maternal 
endometrium. The balance between pro- and anti-inflammation is key to establish a 
healthy pregnancy. Immune cells are necessary to promote tolerance of the invading 
blastocyst and these cells in synergy with the endometrial cells produce cytokines and 
growth factors which are essential for the maternal acceptance of the embryo (Sharma 
et al., 2016, Mourik et al., 2009). In regards to this experiment, miR-371a generally 
impaired immune response and acute inflammatory response processes in endometrial 
cells. 
Interleukins (ILs) are key-players of the inflammatory response in implantation. 
In human decidua IL-1, IL-6, and IL-11 form complex signalling networks with other 
cytokines and factors to regulate implantation (Dimitriadis et al., 2005). Knockout 




experiments for these ILs show reduced implantation or complete implantation failure 
in mice (Sakurai et al., 2012). Interestingly, miR-371a changed the expression of eight 
ILs with upregulation of IL-15 and downregulation of IL-34, -33, -31, -16, -10, -8, and 
-5. Although the roles of these interleukins are not yet clear in relation to implantation, 
this does not mean that these molecules have no functions. For example, IL-5, IL-8, 
and IL-10 are all secreted in high levels by decidualised cells (Sharma et al., 2016, 
Robb et al., 1998) and IL-5, IL-10 have anti-inflammatory roles promoting 
immunotolerance in other cell types (Hara et al., 2001, Tran et al., 2012). Additionally, 
IL-8 acts as a pro-inflammatory chemokine and also enhances angiogenesis (David et 
al., 2016). Downregulation of these interleukins might impair the ability of the 
maternal tissue to tolerate the invading embryo. 
Chemokines control the migration and positioning of immune cells in tissues 
having as such pivotal roles in immune response. Several chemokines and chemokine 
receptors are expressed at the embryo-maternal interface to regulate the inflammatory 
response in implantation (Dimitriadis et al., 2005). In this study, miR-371a 
downregulated the expression of five chemokines, CCL2, CCL13, CXCL6, CXCL12, 
and CXCL16. Of these, it is known that CXCL6 and CXCL16 are expressed highly by 
human decidua (Red-Horse et al., 2001, Jones et al., 2004). Disturbance of the 
chemokine signalling network could affect the ability of the decidua to trigger an 
inflammatory response.  
Another pro-inflammatory protein involved in implantation is leptin (LEP). 
Leptin is expressed in human endometrial stroma cells and exerts its actions mainly as 
a modulator of the expression of immune factors (Gonzalez et al., 2003). In vitro, LEP 
upregulates components of the IL-1 family (IL-1β, IL-1Ra, IL-1R1) (Gonzalez and 
Leavis, 2001, Gonzalez et al., 2004). In addition, LEP enhances the expression of the 




leukaemia inhibitory factor (LIF) in stromal cells which is critical for the invasion of 
the trophoblast in the endometrium (Song et al., 2000, Robb et al., 2002). Low LIF 
expression in endometrium is associated with implantation failure in humans (Wu et 
al., 2013) and Lif-deficient mice are unable to establish implantation (Song et al., 
2000). Leptin also enhances the production of integrin β3 (ITGB3) by endometrial 
cells, a transmembrane adhesion receptor that mediates cell-cell and cell-extracellular 
matrix adhesion and induces bidirectional signalling (Gonzalez and Leavis, 2001). 
ITGB3 is important for maintaining the physical interaction and cellular 
communication during the invasion of the trophoblast. Endometrial tissues from 
women with unexplained infertility have low ITGB3 levels (Dorostghoal et al., 2017) 
and Itgb3-knockout mice show reduced implantation sites (Illera et al., 2000). 
Considering all, the decreased expression of LEP in this experiment could suggest an 
inhibitory role of miR-371a on implantation through disturbance of the trophoblast 
invasion.  
Moreover, the IGF signalling networks are essential for establishing the immune 
response balance by stimulating and limiting inflammation. IGFBP-1 is expressed by 
stromal cells and has a major role in implantation, specifically through regulation of 
invasion via IGF-2 communication of the trophoblast cells (Fazleabas et al., 2004). 
The roles of other IGF family members in implantation is not clear yet; however it is 
likely that IGFs form complex molecular pathways mediating the embryo-maternal 
crosstalk (Mourik et al., 2009). With regards to miR-371a effects, the expression of 
IGF2BP-2 was upregulated whereas IGFBP-3, -4, -5, -6, -7 and IGF-1, -2 were 
significantly downregulated. Disruption of the IGF network could have effects on the 
ability of the cells to balance the immune response during invasion. 




Lastly, a plethora of growth factors at the WOI are essential for the establishment 
of a nutrient supply system. Members of the vascular endothelial growth factor family 
(VEGF) possibly act at the last stages of trophoblast invasion to stimulate the 
formation of blood vessels (angiogenesis) which will establish placentation and 
support an ongoing pregnancy. Ligands and receptors of VEGF members are found in 
trophoblast and endometrial cells, suggesting a bidirectional embryo-maternal 
communication via VEGF signalling (Sharma et al., 2016, Matsui et al., 2004). 
Additionally, VEGFs are increasingly produced and released by endometrial cells 
during decidualisation (Sharma et al., 2016) and the expression is also influenced by 
the site of implantation which implies a specific role of VEGF regulation in 
implantation (Hayashi et al., 2019). The mode of VEGF regulation in implantation is 
not clear yet; although VEGFs promote vascular permeability and endothelial cell 
proliferation and migration through the extracellular matrix, they inhibit trophoblast 
cell invasiveness in in vitro experiments (Fitzpatrick et al., 2003). The existing 
literature suggests that VEGFs are anti-invasive factors that are however expressed in 
high levels to balance the pro-invasive actions of other molecules and establish an 
equilibrium for trophoblast invasion. Regarding the present experiment, VEGFB in 
stromal cells was significantly downregulated by miR-371a (-1.3 FC), which could 






























Figure 6.13 Summary of predicted genes altered by miR-371. A highly apoptotic embryo 
releases miR-371 which is uptaken by epithelial cells, possibly changing the expression of 
genes responsible for embryo attachment and adhesion. Levels of this miRNA could then 
reach the stromal layer and alter the expression of genes involved in stroma-epithelium 
communication, invasion of the trophoblast, inflammation response and establishment of 
the implantation site. 





These findings are limited to the actions of miR-371a in human endometrial 
stromal cells. Possibly other miRNAs released by embryos interact with proteins, 
transcription factors, and RNAs and form molecular networks which regulate 
implantation. Additional experiments using epithelial cells could confirm the 
predicted actions of miR-371a in embryo attachment and adhesion. In this sense, 
embryo adhesion assays could be performed in cells transfected with miR-371a to 
confirm the phenotypic changes in embryo adhesion. Moreover, co-cultures with 
endometrial cells and trophoblast cells could be carried out to observe any changes in 
trophoblast invasion. Experiments where endometrial tissue is transfected with this 
miRNA could provide evidence on the transcriptomic changes at the tissue level. 
Finally, although literature suggests that miRNAs are taken up by the 
endometrium, this was not proven for the specific miRNA as transfection was carried 
out with chemical reagents. It is worth noting that experiments addressing these points 
were already under way before the labs shut down due to Covid-19 lockdown 
restrictions.  
6.8 Conclusions 
The findings strongly support the hypothesis that miR-371a changes the 
expression of genes in uterine cells with possible effects on implantation. The major 
transcriptomic changes suggest that miRNAs may have important roles as mediators 
of the embryo-maternal communication. This study has generated the first large-scale 
evidence of miRNA involvement in embryo-maternal communication. Although it is 
focused on miR-371a, other miRNAs likely exert similar actions and form complex 
networks with other molecules to control embryo implantation. 
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7. CHAPTER SEVEN: GENERAL DISCUSSION AND 
CONCLUSIONS 
The present thesis focused on the roles of microRNAs in the pre-implantation 
embryo. miRNAs are relatively newly-discovered RNAs with distinct characteristics 
that make them ideal molecules for study. Nevertheless, the actions of miRNAs in the 
early life stages are not yet clear which is why this topic was chosen. Initially a 
literature review was conducted to set the specific objectives of the thesis and establish 
the technical approach for the studies. Thereafter a series of experiments were carried 
out to test the hypotheses. Each consecutive experiment was designed based on the 
findings of the previous experiment in order to direct the research towards providing 
a in-depth analyses of the subject. 
Although this thesis initially explored the potential of miRNA analysis for 
embryo assessment, the focus shifted towards developing our basic understanding of 
the role of miRNAs released by embryos during the peri-implantation period. Firstly, 
we investigated whether miRNAs released from individual embryos into the 
surrounding media can be detected and quantified. After some trials, protocols were 
optimised, and it was shown that this is possible. We then investigated whether the 
levels of miRNAs are indicative of the developmental competence and DNA quality 
of the embryos. Strong evidence for the latter was found for a specific miRNA. The 
mechanism of release of this miRNA was then investigated to understand the reason 
behind this phenomenon. Lastly, the effects of the specific miRNA on uterine cells 
were examined in order to elucidate whether microRNAs are part of the embryo-
maternal interactome during the peri-implantation window. 
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The findings reported in this thesis are novel and form a strong basis for future 
research on mammalian embryo development and pregnancy establishment. The main 
findings and conclusions are listed below: 
1. Mouse embryos release microRNAs into the surrounding micro-environment. 
Thus the mouse could be a useful as a model organism for relevant studies. 
2. MicroRNAs in culture media of single-cultured embryos are detectable and 
quantifiable using current PCR technology. 
3. The levels of specific miRNAs in spent media are informative of the 
embryonic competence. Evidence presented in Chapter 3 linked miR-124 
levels with blastulation duration, although these results were overall 
considered weak. 
4. Specific miRNAs could be used as biomarkers of DNA quality. As presented 
in Chapter 3, the levels of miR-294 are directly correlated with the extent of 
apoptosis in the embryonic blastomeres of mouse embryos. 
5. The release of miRNAs by embryos is likely an active process which is 
triggered as a downstream cellular response to a stimulus. It was shown in 
Chapter 4 that extended apoptosis triggers the release of miR-294 by mouse 
embryos and passive release was rejected as a mechanism for this specific 
miRNA. 
6. Bovine embryos also release miRNAs from the homologue cluster in response 
to a high apoptotic index. The same association is conserved across different 
mammalian species and it is possible that it is maintained in human embryos 
due to the high homology of miRNA sequences in bovine and human; although 
this remains to be determined. 
7. MicroRNAs in the uterine environment change the endometrial transcriptome 
and can promote or inhibit embryo implantation. Gene expression changes can 
be significant due to the numerous targets of miRNAs. 
8. In keeping with other molecules, miRNAs are part of the embryo-maternal 
interactome and form complex regulatory networks to control implantation-
related processes. miRNAs exert secretory and inter-cellular communication 
actions at the peri-implantation period. 
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The original findings that mouse and bovine embryos release higher levels of 
specific miRNAs in direct correlation with the extent of DNA fragmentation in their 
blastomeres can form a strong basis for future research on non-invasive embryo 
assessment methods. The use of available technology for analysing miRNAs in media 
from single-cultured embryos further strengthens the suggestion that these molecules 
could be valuable biomarkers for embryo (de-)selection purposes. Indeed, these results 
were peer-reviewed and published recently in a reproduction-focused journal (Makri 
et al., 2020). It is likely that, in future, miRNA analysis could be integrated in  
multi-omics platforms to score embryos based on the molecular profile of culture 
media.  
One of the noteworthy findings of this thesis was that embryo-released miRNAs 
can have adverse effects on implantation. To date there is limited evidence on the 
involvement of miRNAs in implantation-related processes. However it is recognised 
that as regulatory molecules miRNAs are pivotal for the normal development of the 
early embryo, its viability and, by extension, its potential to robustly adhere to and 
invade into the uterine wall (Liang et al., 2017). Interestingly, an in vitro study in 
mouse peri-implantation embryos found that those with potential to implant 
(outgrowth embryos) expressed at least 10 miRNAs differentially compared to those 
with no implantation potential (non-outgrowth embryos) and blastocysts (control). 
According to the authors, these miRNAs are likely involved in embryo attachment and 
the interaction between the embryo and the endometrium which are necessary for the 
implantation of the incoming embryo (Kim et al., 2019). 
Moreover, there is limited knowledge regarding the association of extra-cellular 
miRNA profiles with implantation outcomes. Initially, the study by Cuman and 
colleagues (2015) found distinct profiles for at least 19 miRNAs released by implanted 
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embryos and 22 miRNAs exclusively released by non-implanted embryos. Thus it was 
suggested that specific miRNAs could be used as predictors of implantation in human 
assisted reproduction cycles (Cuman et al., 2015). Moreover, a small study by Borges 
et al. (2016) found that embryos that failed to implant had significantly higher levels 
of miR-142-3p in the spent culture media. It was therefore proposed that this miRNA 
could be a biomarker of implantation failure (Borges et al., 2016). Therefore, taken 
together, these two studies showed that quantification of miRNAs in spent media 
could be of clinical value for predicting implantation outcomes in humans. Even more 
interesting was the preliminary evidence they provided on the roles of extra-cellular 
miRNAs on implantation. 
During the last few years the biological functions of microRNAs at the embryo-
maternal interface have been studied. It is known that these molecules circulate in 
biological fluids where they are protected by their carriers and can exert secretory 
functions in other cell types (Boon and Vickers, 2013). Exosomes are the main carriers 
of miRNAs and these vesicles are released by both uterine and embryonic cells, which 
indicated the existence of an inter-cellular communication network via miRNAs 
(Saadeldin et al., 2015). This suggestion is further supported by evidence that extra-
cellular vesicles (EVs) with miRNA cargoes are internalised by embryos and 
endometrial cells.  
In early pregnancy in sheep EVs mediate conceptus-maternal interactions. When 
vesicles purified from uterine luminal fluid are fluorescently tagged and infused back 
to the lumen of pregnant sheep, after some days these EVs are located in the conceptus 
trophectoderm. Inversely, EVs released by conceptuses are rich in proteins and RNAs 
and are uptaken by uterine cells (Burns et al., 2016). Moreover, human endometrial 
epithelium specifically releases at least 6 miRNAs during the window of implantation, 
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with miR-30d being the most differentially-released. This miRNA is in exosomes and 
is internalised by embryos (tested with in vitro mouse assays) either exosome-bound 
or in a free form via the trophectoderm. There it causes overexpression of genes 
encoding for adhesion molecules like integrins and cadherins. Embryo adhesion is 
notably increased in an embryo adhesion assay with miR-30d supplementation (Vilella 
et al., 2015). 
On the other hand, when bound-free miRNAs are added to culture media at the 
morula stage they are uptaken by embryos. Kropp and Khatib (2015) tested this with 
the miR-24 mimic in bovine embryos and not only found significantly elevated levels 
in the blastocyst cells (by 44 FC) but this uptake was associated with repression of the 
CDKN1b gene which could have effects on embryonic development and implantation 
competence. Moreover, in the study of Cuman and colleagues (2015), human 
trophoblast cells were transfected with a tagged miRNA mimic, the refreshed 
conditioned media was collected after 24 hours and transferred to cultures of 
endometrial epithelial cells. Interestingly, the endometrial cells contained significantly 
higher levels of the specific miRNA (Cuman et al., 2015). This protocol mimicked as 
closely as possible the in vivo conditions where miRNAs are bound by trophectoderm 
cells in complexes or enclosed in EVs which are then internalised by other cell types. 
Thus it enabled trophoblast cells to package and release miRNAs which were later 
recognised and uptaken “naturally” (i.e., without transfection reagents), by 
endometrial cells. Inside the endometrial cells the miRNA reduced the levels of MTA2 
and PVRL1 proteins which blocked embryo adhesion, an effect which was also 
verified with an adhesion assay (Cuman et al., 2015). 
 In agreement with the above studies, miRNA-mediated transcriptomic changes 
in human endometrium were also found in the experiment presented in Chapter 6. In 
CHAPTER SEVEN: GENERAL DISCUSSION AND CONCLUSIONS 
169 
 
this experiment miR-371a transfection in endometrial cells caused major 
dysregulation in gene expression. Changes in biological and cellular processes, as well 
as predicted phenotypic changes associated with disruption of the implantation 
process, were caused by the embryo-secreted miR-371a. Additionally, a plethora of 
key-genes regulating decidualisation, stroma-epithelium communication, adhesion, 
trophoblast invasion, and inflammatory response were affected by this miRNA. 
Considering all the above it is evident that small RNAs released by embryos 
exert inter-cellular communication actions by regulating gene expression inside the 
endometrial cells. These changes can directly inhibit or promote implantation of the 
blastocyst. These findings are interesting because cytokines and growth factors were 
until recently considered the predominant regulators of implantation. However, as 
more and more information becomes available, miRNAs have now been 
acknowledged as key-mediators of embryo implantation, with roles in uterine 
receptivity, embryonic competence, adhesion, trophoblast invasion, and beyond 
(Gross et al., 2017a, Liang et al., 2017). 
Undoubtedly the most interesting suggestion of this thesis is that embryos of 
poor quality could impair their implantation via secreted miRNAs. As discussed 
previously miRNA expression, packaging, and exocytosis is an active and energy-
demanding process. The embryo has limited resources at the very early stages of 
development and therefore there must be a biological reason why apoptotic embryos 
release intensely miR-371. Moreover, the transfection experiment in endometrial cells 
demonstrated that implantation is impaired after addition of this miRNA. Thus, it is 
logical to suggest that miR-371a interacts with the endometrium to reject an embryo 
with low probability of survival. Signalling the endometrium to reject a defective 
embryo saves the maternal energy investment required for implantation. 
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Mechanisms contributing to active de-selection of human embryos at 
implantation have been described. For example, arresting human embryos trigger a 
strong response in decidual secretory profiles characterised by selective inhibition of 
IL-1β, -6, -10, -17, -18, eotaxin, and HB-EGF secretion. The decidualising 
endometrial cells selectively recognise the presence of a developmentally impaired 
embryo and respond by inhibiting the secretion of key implantation mediators and 
immunomodulators (Teklenburg et al., 2010). The authors here suggest that this could 
be a mechanism evolved to avoid the energy investment from the maternal side to 
establish a pregnancy with an embryo that has reduced probabilities of survival and 
instead promote the beginning of a new menstrual cycle in which a good quality 
embryo will implant resulting in a healthy live birth (Teklenburg et al., 2010). 
Moreover, low-quality embryos cause a heightened and prolonged Ca2+ 
response in endometrial epithelial cells. A stress response is also observed when 
mouse uteri are exposed in vivo to culture medium conditioned by poor-quality 
embryos. Conversely, developmentally competent human embryos trigger a short-
lived Ca2+ response fluxes and conditioned media from these embryos activate a 
focused gene network enriched in metabolic enzyme and implantation factors  
(Brosens et al., 2014). 
Thus, enhancing and inhibiting mechanisms activated by embryo-derived 
signals contribute to active selection at implantation. It is clear that the embryo-
maternal dialogue is essential for the initiation of implantation and the state of the 
blastocyst influences the success of implantation (Zhang et al., 2013b). Nevertheless, 
the roles of miRNAs as factors of this interactome are not yet clear. Although there is 
a lack of published literature regarding this topic, the actions of extra-cellular vesicles 
with  RNA cargoes in cell signalling receive more and more attention in reproductive 
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science and preliminary findings are already presented in international conferences. 
So far it seems that EVs are key-mediators not only during the peri-implantation period 
but furthermore to the conceptus-maternal communication. 
Interestingly, supporting evidence for embryo selection mechanisms triggered 
by miRNAs came to light only recently. In the study by Berkhout and colleagues 
(2020), human ICSI-fertilised embryos were cultured to Day 4, media samples were 
pooled according to the morphological quality (high-quality: ≤20% fragmentation, 
low-quality: >20% fragmentation), and analysed for miRNA profiles using a  
PCR-array. It was found that high-quality embryos exclusively secreted miR-320a 
whereas low-quality embryos exclusively secreted miR-19b-3p and miR-19a-3p. 
Mimics and inhibitors of these miRNAs were transfected into decidualised human 
endometrial stromal cells to identify phenotypical changes caused by them. It was 
found that miR-320a significantly enhances endometrial cell migration and further 
experiments on the gene targets of this miRNA showed changes in 223 genes. Gene 
ontology analysis identified effects on cell adhesion, regulation of cytoskeleton 
organisation, and cell migration caused by miR-320a presence. As a conclusion the 
authors suggested that by secreting miR-320a, high-quality embryos directly influence 
endometrial cells to prime the endometrium at the implantation site for successful 
implantation (Berkhout et al., 2020). 
The results described above are in good agreement with the findings of the 
present thesis, that embryos with different quality cause gene changes in neighbouring 
endometrial cells through secreted miRNAs, and these changes can affect the ability 
of the endometrium to establish implantation. Although the effect of miR-371a was 
not verified in a clinical study here, Cuman and colleagues (2015) detected the 
presence of this miRNA exclusively in samples deriving from embryos that failed to 
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implant. Considering the findings of the present thesis and the available literature it 
seems that the embryo-secreted miR-371a has a signalling role in the implantation 
period. 
During the peri-implantation period the decidualised endometrium acts as a 
sensor of embryonic quality. To be reproductively successful, the endometrium must 
be receptive as well as selective. This is proposed as a maternal strategy that has 
evolved to prevent inappropriate investment in poorly viable embryos (Macklon and 
Brosens, 2014). Regarding reproduction-related processes, as increasingly more 
evidence becomes available it is expected that the roles of miRNAs as triggering 
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7.1 General conclusions 
In conclusion, mammalian pre-implantation embryos express, package, and 
release miRNAs to the surrounding micro-environment. There are specific miRNAs 
released by embryos of differing developmental competence and DNA quality which 
can be quantified in spent culture media derived from single-cultured embryos. 
Analysis of spent media for miRNAs could be of clinical value for embryo  
(de-)selection purposes, alongside other -omics platforms that are currently developed. 
 High DNA fragmentation triggers the release of specific miRNAs belonging 
to the miR-290-295 cluster by murine embryos and the release of the homologue  
miR-371-373 cluster by bovine blastocysts. MiR-371a triggers major transcriptomic 
changes in human endometrial cells which are overall consistent with impaired 
implantation. Human studies show a link between miR-371a release and implantation 
failure. Overall, it is suggested that miR-371a acts as a mediator to prevent 
implantation of an abnormal embryo with low chance of survival. 
 The novel findings presented here show secretory functions of miRNAs at the 
embryo-maternal interface. As further research is carried out it is expected that 
miRNAs will be acknowledged as important mediators of implantation. Implantation 
success depends on the complex interplay between a receptive endometrium and a 
competent embryo. Implantation-related processes remain largely unknown making 
implantation a true “black box” in developmental biology. Future research on 
molecules mediating the first dialogue between the embryo and the mother is 
necessary to shed light on the mechanisms controlling implantation. This will enrich 






ABD EL NABY, W. S., HAGOS, T. H., HOSSAIN, M. M., SALILEW-WONDIM, D., GAD, 
A. Y., RINGS, F., CINAR, M. U., THOLEN, E., LOOFT, C., SCHELLANDER, K., 
HOELKER, M. & TESFAYE, D. 2013. Expression analysis of regulatory 
microRNAs in bovine cumulus oocyte complex and preimplantation embryos. Zygote, 
21, 31-51. 
ABDELHAFEZ, F., XU, J., GOLDBERG, J. & DESAI, N. 2011. Vitrification in open and 
closed carriers at different cell stages: assessment of embryo survival, development, 
DNA integrity and stability during vapor phase storage for transport. BMC 
Biotechnology, 11, 29. 
AHMED, K., LAPIERRE, M. P., GASSER, E., DENZLER, R., YANG, Y., RUELICKE, T., 
KERO, J., LATREILLE, M. & STOFFEL, M. 2017. Loss of microRNA-7a2 induces 
hypogonadotropic hypogonadism and infertility. Journal of Clinical Investigation, 
127, 1061-1074. 
ALLES, J., FEHLMANN, T., FISCHER, U., BACKES, C., GALATA, V., MINET, M., 
HART, M., ABU-HALIMA, M., GRÄSSER, F. A., LENHOF, H.-P., KELLER, A. 
& MEESE, E. 2019. An estimate of the total number of true human miRNAs. Nucleic 
Acids Research, 47, 3353-3364. 
ALVES, M. B. R., DE ARRUDA, R. P., DE BEM, T. H. C., FLOREZ-RODRIGUEZ, S. A., 
SÁ FILHO, M. F., BELLEANNÉE, C., MEIRELLES, F. V., DA SILVEIRA, J. C., 
PERECIN, F. & CELEGHINI, E. C. C. 2019. Sperm-borne miR-216b modulates cell 
proliferation during early embryo development via K-RAS. Scientific Reports, 9. 
AMANAI, M., BRAHMAJOSYULA, M. & PERRY, C. F. A. 2006. A restricted role for 
sperm-borne microRNAs in mammalian fertilization. Biology of Reproduction, 75, 
877-884. 
APLIN, J. D. & SINGH, H. 2008. Bioinformatics and transcriptomics studies of early 
implantation. Assessment Of Human Reproductive Function, 1127, 116-120. 
ARROYO, J. D., CHEVILLET, J. R., KROH, E. M., RUF, I. K., PRITCHARD, C. C., 
GIBSON, D. F., MITCHELL, P. S., BENNETT, C. F., POGOSOVA-
AGADJANYAN, E. L., STIREWALT, D. L., TAIT, J. F. & TEWARI, M. 2011. 
Argonaute2 complexes carry a population of circulating microRNAs independent of 
vesicles in human plasma. Proceedings of the National Academy of Sciences - PNAS, 
108, 5003-5008. 
BALABAN, B., BRISON, D., CALDERÓN, G., CATT, J., CONAGHAN, J., COWAN, L., 
EBNER, T., GARDNER, D., HARDARSON, T., LUNDIN, K., CRISTINA MAGLI, 
M., MORTIMER, D., MORTIMER, S., MUNNÉ, S., ROYERE, D., SCOTT, L., 
SMITZ, J., THORNHILL, A., VAN BLERKOM, J. & VAN DEN ABBEEL, E. 2011. 
† The Istanbul consensus workshop on embryo assessment: proceedings of an expert 
meeting †. Human Reproduction, 26, 1270-1283. 
BAO, J., LI, D., WANG, L., WU, J., HU, Y., WANG, Z., CHEN, Y., CAO, X., JIANG, C., 
YAN, W. & XU, C. 2012. MicroRNA-449 and microRNA-34b/c function 
redundantly in murine testes by targeting E2F transcription factor-retinoblastoma 
protein (E2F-pRb) pathway. The Journal of Biological Chemistry, 287, 21686. 
BARRIE, A., HOMBURG, R., MCDOWELL, G., BROWN, J., KINGSLAND, C. & TROUP, 
S. 2017. Examining the efficacy of six published time-lapse imaging embryo selection 
algorithms to predict implantation to demonstrate the need for the development of 
specific, in-house morphokinetic selection algorithms. Fertility and Sterility, 107, 
613-621. 
BASHIRI, A., HALPER, K. I. & ORVIETO, R. 2018. Recurrent Implantation Failure-update 
overview on etiology, diagnosis, treatment and future directions. Reproductive 
Biology and Endocrinology, 16, 121-18.  
BEHM-ANSMANT, I., REHWINKEL, J., DOERKS, T., STARK, A., BORK, P. & 




CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes & 
Development, 20, 1885-1898. 
BELLEANNÉE, C., CALVO, E., THIMON, V., CYR, D. G., LÉGARÉ, C., GARNEAU, L. 
& SULLIVAN, R. 2012. Role of MicroRNAs in Controlling Gene Expression in 
Different Segments of the Human Epididymis (Region-Specific miRNA Signatures 
in the Epididymis). PLoS ONE, 7, e34996. 
BERKHOUT, R. P., KEIJSER, R., REPPING, S., LAMBALK, C. B., AFINK, G. B., 
MASTENBROEK, S. & HAMER, G. 2020. High-quality human preimplantation 
embryos stimulate endometrial stromal cell migration via secretion of microRNA hsa-
miR-320a. Human Reproduction (Oxford), 35, 1797-1807. 
BERMEJO-ALVAREZ, P., RIZOS, D., RATH, D., LONERGAN, P., GUTIERREZ-ADAN, 
A. & SEIDEL, G. 2010. Sex Determines the Expression Level of One Third of the 
Actively Expressed Genes in Bovine Blastocysts. Proceedings of the National 
Academy of Sciences - PNAS, 107, 3394-3399. 
BERNEAU, S. C., RUANE, P. T., BRISON, D. R., KIMBER, S. J., WESTWOOD, M. & 
APLIN, J. D. 2019. Investigating the role of CD44 and hyaluronate in embryo-
epithelial interaction using an in vitro model. Molecular Human Reproduction, 25, 
265-273. 
BERNSTEIN, E., KIM, S. Y., CARMELL, M. A., MURCHISON, E. P., ALCORN, H., LI, 
M. Z., MILLS, A. A., ELLEDGE, S. J., ANDERSON, K. V. & HANNON, G. J. 2003. 
Dicer is essential for mouse development. Nature Genetics, 35, 215-217. 
BOON, R. A. & VICKERS, K. C. 2013. Intercellular Transport of MicroRNAs. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 186-192. 
BORGES, E., SETTI, A. S., BRAGA, D., GERALDO, M. V., FIGUEIRA, R. D. S. & 
IACONELLI, A. 2016. miR-142-3p as a biomarker of blastocyst implantation failure 
A pilot study. Jornal Brasileiro De Reproducao Assistida, 20, 200-205. 
BOSCH, E., LABARTA, E., KOLIBIANAKIS, E., ROSEN, M. & MELDRUM, D. 2016. 
Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertility 
and Sterility, 105, 560-570. 
BRATTON, S. B.  & SALVESEN, G. S. 2010. Regulation of the Apaf-1-caspace-9 
apoptosome. Journal of Cell Sciene, 123, 3209-3214. 
BRAUN, J. E., TRUFFAULT, V., BOLAND, A., HUNTZINGER, E., CHANG, C.-T., 
HAAS, G., WEICHENRIEDER, O., COLES, M. & IZAURRALDE, E. 2012. A 
direct interaction between DCP1 and XRN1 couples mNRA decapping to 5′ 
exonucleolytic degradation. Nature Structural & Molecular Biology, 19, 1324-1331. 
BRAY, S. J. 2006. Notch signalling: a simple pathway becomes complex. Nature Reviews 
Molecular Cell Biology, 7, 678-689. 
BROSENS, J. J., SALKER, M. S., TEKLENBURG, G., NAUTIYAL, J., SALTER, S., 
LUCAS, E. S., STEEL, J. H., CHRISTIAN, M., CHAN, Y.-W., BOOMSMA, C. M., 
MOORE, J. D., HARTSHORNE, G. M., ŠUĆUROVIĆ, S., MULAC-JERICEVIC, 
B., HEIJNEN, C. J., QUENBY, S., GROOT KOERKAMP, M. J., HOLSTEGE, F. C. 
P., SHMYGOL, A. & MACKLON, N. S. 2014. Uterine Selection of Human Embryos 
at Implantation. Scientific Reports, 4, 3894. 
BURNS, G. W., BROOKS, K. E. & SPENCER, T. E. 2016. Extracellular Vesicles Originate 
from the Conceptus and Uterus During Early Pregnancy in Sheep. Biology of 
Reproduction, 94, 56. 
BUTLER, A. E., RAMACHANDRAN, V., HAYAT, S., DARGHAM, S. R., 
CUNNINGHAM, T. K., BENURWAR, M., SATHYAPALAN, T., NAJAFI-
SHOUSHTARI, S. H. & ATKIN, S. L. 2019. Expression of microRNA in follicular 
fluid in women with and without PCOS. Scientific Reports, 9, 1-9. 
CAMPBELL, A., FISHEL, S., BOWMAN, N., DUFFY, S., SEDLER, M. & HICKMAN, C. 
F. L. 2013. Modelling a risk classification of aneuploidy in human embryos using 




CAO, R., WU, W. J., ZHOU, X. L., XIAO, P., WANG, Y. & LIU, H. L. 2015. Expression 
and preliminary functional profiling of the let-7 family during porcine ovary follicle 
atresia. Molecules and Cells, 38, 304. 
CAPALBO, A., RIENZI, L., CIMADOMO, D., MAGGIULLI, R., ELLIOTT, T., WRIGHT, 
G., NAGY, Z. P. & UBALDI, F. M. 2014. Correlation between standard blastocyst 
morphology, euploidy and implantation: an observational study in two centers 
involving 956 screened blastocysts. Human Reproduction, 29, 1173-1181. 
CAPALBO, A., UBALDI, F. M., CIMADOMO, D., NOLI, L., KHALAF, Y., FARCOMENI, 
A., ILIC, D. & RIENZI, L. 2016. MicroRNAs in spent blastocyst culture medium are 
derived from trophectoderm cells and can be explored for human 
embryo reproductive competence assessment. Fertility and Sterility, 105, 225-235.e3. 
CARLETTI, M. Z., FIEDLER, S. D. & CHRISTENSON, L. K. 2010. MicroRNA 21 blocks 
apoptosis in mouse periovulatory granulosa cells. Biology of Reproduction, 83, 286. 
CERNILOGAR, F. M., ONORATI, M.C., KOTHE, G. O., BURROUGHS, A. M., PARSI, K. 
M., BREILING, A., LO SARDO, F., SAXENA, A., MIYOSHI, K., SIOMI, M. C., 
CARNINCI, P., GILMOUR, D. S., CORONA, D. F. V. & ORLANDO, V. 2011. 
Chromatin-associated RNA interference components contribute to transcriptional 
regulation in Drosophila. Nature, 480, 391-395. 
CARSON, D. D., JULIAN, J., LESSEY, B. A., PRAKOBPHOL, A. & FISHER, S. J. 2006. 
MUC1 is a scaffold for selectin ligands in the human uterus. Frontiers in Bioscience, 
11, 2903-2908. 
CASTANOTTO, D., ZHANG, X., ALLUIN, J., ZHANG, X., RÜGER, J., ARMSTRONG, 
B., ROSSI, J., RIGGS, A. & STEIN, C. A. 2018. A stress-induced response complex 
(SIRC) shuttles miRNAs, siRNAs, and oligonucleotides to the nucleus. Proceedings 
of the National Academy of Sciences - PNAS, 115, E5756-E5765. 
CASTILLO, C. M., HARPER, J., ROBERTS, S. A., O’NEILL, H. C., JOHNSTONE, E. D. 
& BRISON, D. R. 2020. The impact of selected embryo culture conditions on ART 
treatment cycle outcomes: a UK national study. Human Reproduction Open, 2020, 
hoz031. 
CETINKAYA, M., PIRKEVI, C., YELKE, H., COLAKOGLU, Y., ATAYURT, Z. & 
KAHRAMAN, S. 2015. Relative kinetic expressions defining cleavage synchronicity 
are better predictors of blastocyst formation and quality than absolute time points. 
Official Publication of ALPHA, Scientists in Reproductive Medicine, 32, 27-35. 
CHAPUIS, A., GALA, A., FERRIÈRES-HOA, A., MULLET, T., BRINGER-DEUTSCH, S., 
VINTEJOUX, E., TORRE, A. & HAMAMAH, S. 2017. Sperm quality and paternal 
age: effect on blastocyst formation and pregnancy rates. Basic and Clinical 
Andrology, 27, 2. 
CHEN, E. Y., TAN, C. M., KOU, Y., DUAN, Q., WANG, Z., MEIRELLES, G. V., CLARK, 
N. R. & MA’AYAN, A. 2013. Enrichr: interactive and collaborative HTML5 gene 
list enrichment analysis tool. BMC Bioinformatics, 14, 128. 
CHEN, Q., ZHANG, Y., LU, J., WANG, Q., WANG, S., CAO, Y., WANG, H. & DUAN, E. 
2009. Embryo–uterine cross-talk during implantation: the role of Wnt signaling †. 
Molecular Human Reproduction, 15, 215-221. 
CHEN, X., LI, X., GUO, J., ZHANG, P. & ZENG, W. 2017. The roles of microRNAs in 
regulation of mammalian spermatogenesis. Journal of Animal Science and 
Biotechnology, 8, 779-786. 
CHEN, X., XIE, M., LIU, D. & SHI, K. 2015. Downregulation of microRNA‑146a inhibits 
ovarian granulosa cell apoptosis by simultaneously targeting interleukin‑1 
receptor‑associated kinase and tumor necrosis factor receptor‑associated factor 6. 
Molecular Medicine Reports, 12, 5155-5162. 
CHEN, Y.-N., DAI, J.-J., WU, C.-F., ZHANG, S.-S., SUN, L.-W. & ZHANG, D.-F. 2018. 
Apoptosis and developmental capacity of vitrified parthenogenetic pig blastocysts. 
Animal Reproduction Science, 198, 137-144. 
CHRISTIE, M., BOLAND, A., HUNTZINGER, E., WEICHENRIEDER, O. & 




interactions with the PAN2 deadenylase and the GW182 proteins. Molecular Cell, 51, 
360-373. 
CIMADOMO, D., CAPALBO, A., UBALDI, F. M., SCARICA, C., PALAGIANO, A., 
CANIPARI, R. & RIENZI, L. 2016. The Impact of Biopsy on Human Embryo 
Developmental Potential during Preimplantation Genetic Diagnosis. BioMed 
Research International, 2016, 7193075-10. 
CIMADOMO, D., FABOZZI, G., VAIARELLI, A., UBALDI, N., UBALDI, F. M. & 
RIENZI, L. 2018. Impact of Maternal Age on Oocyte and Embryo Competence. 
Frontiers in Endocrinology, 9, 327. 
CIRAY, H. N., CAMPBELL, A., AGERHOLM, I. E., AGUILAR, J., CHAMAYOU, S., 
ESBERT, M. & SAYED, S. 2014. Proposed guidelines on the nomenclature and 
annotation of dynamic human embryo monitoring by a time-lapse user group. Human 
Reproduction, 29, 2650-2660. 
CIVENNI, G., HOLBRO, T. & HYNES, N. E. 2003. Wnt1 and Wnt5a induce cyclin D1 
expression through ErbB1 transactivation in HC11 mammary epithelial cells. EMBO 
Reports, 4, 166-171. 
COCKBURN, K. & ROSSANT, J. 2010. Making the blastocyst: lessons from the mouse. The 
Journal of Clinical Investigation, 120, 995-1003. 
COLLINO, F., DEREGIBUS, M. C., BRUNO, S., STERPONE, L., AGHEMO, G., 
VILTONO, L., TETTA, C. & CAMUSSI, G. 2010. Microvesicles Derived from Adult 
Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected 
Pattern of miRNAs. PloS One, 5, e11803-e11803. 
CONDORELLI, G., LATRONICO, M. V. G. & CAVARRETTA, E. 2014. microRNAs in 
Cardiovascular Diseases: Current Knowledge and the Road Ahead: Current 
Knowledge and the Road Ahead. Journal of the American College of Cardiology, 63, 
2177-2187. 
CORRAL-VAZQUEZ, C., SALAS-HUETOS, A., BLANCO, J., VIDAL, F., SARRATE, Z. 
& ANTON, E. 2019. Sperm microRNA pairs: new perspectives in the search for male 
fertility biomarkers. Fertility and Sterility, 112, 831-841. 
CORTEZ, M. A., BUESO-RAMOS, C., FERDIN, J., LOPEZ-BERESTEIN, G., SOOD, A. 
K. & CALIN, G. A. 2011. MicroRNAs in body fluids—the mix of hormones and 
biomarkers. Nature Reviews Clinical Oncology, 8, 467-477. 
CRUZ, M., GARRIDO, N., HERRERO, J., PÉREZ-CANO, I., MUÑOZ, M. & MESEGUER, 
M. 2012. Timing of cell division in human cleavage-stage embryos is linked with 
blastocyst formation and quality. Reproductive BioMedicine Online, 25, 371-381. 
CUI, L., FANG, L., SHI, B., QIU, S. & YE, Y. 2015. Spermatozoa micro ribonucleic acid–
34c level is correlated with intracytoplasmic sperm injection outcomes. Fertility and 
Sterility, 104, 312-317.e1. 
CUMAN, C., VAN SINDEREN, M., GANTIER, M. P., RAINCZUK, K., SORBY, K., 
ROMBAUTS, L., OSIANLIS, T. & DIMITRIADIS, E. 2015. Human Blastocyst 
Secreted microRNA Regulate Endometrial Epithelial Cell Adhesion. EBioMedicine, 
2, 1528-1535. 
DA SILVEIRA, J. C., DE ANDRADE, G. M., NOGUEIRA, M. F. G., MEIRELLES, F. V. & 
PERECIN, F. 2015. Involvement of miRNAs and Cell-Secreted Vesicles in 
Mammalian Ovarian Antral Follicle Development. Reproductive Sciences, 22, 1474-
1483. 
DAL CANTO, M., COTICCHIO, G., MIGNINI RENZINI, M., DE PONTI, E., NOVARA, 
P. V., BRAMBILLASCA, F., COMI, R. & FADINI, R. 2012. Cleavage kinetics 
analysis of human embryos predicts development to blastocyst and implantation. 
Reproductive BioMedicine Online, 25, 474-480. 
DAVID, J. M., DOMINGUEZ, C., HAMILTON, D. H., PALENA, C. & WHITESIDE, T. L. 
2016. The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance. Vaccines, 
4, 22. 
DAVIDSON, L. M. & COWARD, K. 2016. Molecular mechanisms of membrane interaction 




DE MATEO, S. & SASSONE-CORSI, P. 2014. Regulation of spermatogenesis by small non-
coding RNAs: Role of the germ granule. Seminars in Cell and Developmental 
Biology, 29, 84-92. 
DEY, S. K., LIM, H., DAS, S. K., REESE, J., PARIA, B. C., DAIKOKU, T. & WANG, H. 
2004. Molecular cues to implantation. Endocrine Reviews, 25, 341-373. 
DI PALO, A., SINISCALCHI, C., SALERNO, M., RUSSO, A., GRAVHOLT, C. H. & 
POTENZA, N. 2020. What microRNAs could tell us about the human X chromosome. 
Cellular and Molecular Life Sciences : CMLS, 77, 4069-4080. 
DIMITRIADIS, E., WHITE, C. A., JONES, R. L. & SALAMONSEN, L. A. 2005. Cytokines, 
chemokines and growth factors in endometrium related to implantation. Human 
Reproduction Update, 11, 613-630. 
DOMINGUEZ, F., YÁÑEZ‐MÓ, M., SANCHEZ‐MADRID, F. & SIMÓN, C. 2005. 
Embryonic implantation and leukocyte transendothelial migration: different processes 
with similar players? FASEB Journal, 19, 1056-1060. 
DONADEU, F. X., MOHAMMED, B. T. & IOANNIDIS, J. 2017. A miRNA target network 
putatively involved in follicular atresia. Domestic Animal Endocrinology, 58, 76-83. 
DOROSTGHOAL, M., GHAFFARI, H. O. A., SHAHBAZIAN, N. & MIRANI, M. 2017. 
Endometrial expression of β3 integrin, calcitonin and plexin-B1 in the window of 
implantation in women with unexplained infertility. International Journal of 
Reproductive BioMedicine, 15, 33-40. 
DU, Y., WANG, X., WANG, B., CHEN, W., HE, R., ZHANG, L., XING, X., SU, J., WANG, 
Y. & ZHANG, Y. 2014. Deep sequencing analysis of microRNAs in bovine sperm. 
Molecular Reproduction and Development, 81, 1042-1052. 
DUNN, C. L., KELLY, R. W. & CRITCHLEY, H. O. 2003. Decidualization of the human 
endometrial stromal cell: an enigmatic transformation. Reproductive BioMedicine 
Online, 7, 151-161. 
EBNER, T., YAMAN, C., MOSER, M., SOMMERGRUBER, M., PÖLZ, W. & TEWS, G. 
2001. Embryo fragmentation in vitro and its impact on treatment and pregnancy 
outcome. Fertility and Sterility, 76, 281-285. 
EGEA, R., ESCRIVÁ, M., PUCHALT, N. & VARGHESE, A. 2014. OMICS: Current and 
future perspectives in reproductive medicine and technology. Journal of Human 
Reproductive Sciences, 7, 73-92. 
ESHRE. 2020. ART fact sheet. 
ESWARAKUMAR, V. P., LAX, I. & SCHLESSINGER, J. 2005. Cellular signaling by 
fibroblast growth factor receptors. Cytokine and Growth Factor Reviews, 16, 139-
149. 
FAUL, F., ERDFELDER, E., BUCHNER, A. & LANG, A.-G. 2009. Statistical power 
analyses using GPower 3.1: Tests for correlation and regression analyses. Behavior 
Research Methods, 41, 1149-1160. 
FAZLEABAS, A. T., KIM, J. J. & STRAKOVA, Z. 2004. Implantation: embryonic signals 
and the modulation of the uterine environment--a review. Placenta, 25 Suppl A, S26-
31. 
FIEDLER, S. D., CARLETTI, M. Z., HONG, X. & CHRISTENSON, L. K. 2008. Hormonal 
regulation of MicroRNA expression in periovulatory mouse mural granulosa cells. 
Biology of Reproduction, 79, 1030-1037. 
FIGUEIRA, R. C. S., SETTI, A. S., BRAGA, D. P. A. F., FERREIRA, R. C., IACONELLI, 
A. & BORGES, E. 2012. Blastocyst morphology holds clues concerning the 
chromosomal status of the embryo. International Journal of Fertility & Sterility, 98, 
215-220. 
FISHEL, S., CAMPBELL, A., MONTGOMERY, S., SMITH, R., NICE, L., DUFFY, S., 
JENNER, L., BERRISFORD, K., KELLAM, L., SMITH, R., AMP, APOS, CRUZ, I. 
& BECCLES, A. 2017. Live births after embryo selection using morphokinetics 





FITZPATRICK, T. E., LASH, G. E., YANAIHARA, A., CHARNOCK-JONES, D. S., 
MACDONALD-GOODFELLOW, S. K. & GRAHAM, C. H. 2003. Inhibition of 
breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth 
factor. Experimental Cell Research, 283, 247-255. 
FORMAN, J. J., LEGESSE-MILLER, A. & COLLER, H. A. 2008. A search for conserved 
sequences in coding regions reveals that the let-7 microRNA targets Dicer within its 
coding sequence. Proceedings of the National Academy of Sciences of the United 
States of America, 105, 14879-14884. 
FU, J., QU, R.-G., ZHANG, Y.-J., GU, R.-H., LI, X., SUN, Y.-J., WANG, L., SANG, Q. & 
SUN, X.-X. 2018. Screening of miRNAs in human follicular fluid reveals an inverse 
relationship between microRNA-663b expression and blastocyst formation. 
Reproductive BioMedicine Online, 37, 25-32. 
FURUTA, M., KOZAKI, K.-I., TANAKA, S., ARII, S., IMOTO, I. & INAZAWA, J. 2010. 
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in 
hepatocellular carcinoma. Carcinogenesis, 31, 766-776. 
GANEFF, C., CHATEL, G., MUNAUT, C., FRANKENNE, F., FOIDART, J. M. & 
WINKLER, R. 2009. The IGF system in in-vitro human decidualization. Molecular 
Human Reproduction, 15, 27-38. 
GARCÍA-LÓPEZ, J., ALONSO, L., CÁRDENAS, D. B., ARTAZA-ALVAREZ, H., 
HOURCADE, J. D. D., MARTÍNEZ, S., BRIEÑO-ENRÍQUEZ, M. A. & DEL 
MAZO, J. 2015. Diversity and functional convergence of small noncoding RNAs in 
male germ cell differentiation and fertilization. RNA, 21, 946-962. 
GARCÍA-LÓPEZ, J. & DEL MAZO, J. 2012. Expression dynamics of microRNA biogenesis 
during preimplantation mouse development. Gene Regulatory Mechanisms, 1819, 
847-854. 
GARDNER, D. K. & BALABAN, B. 2016. Assessment of human embryo development using 
morphological criteria in an era of time-lapse, algorithms and ‘OMICS’: is looking 
good still important? Molecular Human Reproduction, 22, 704-718. 
GARDNER, D. K., LANE, M., STEVENS, J., SCHLENKER, T. & SCHOOLCRAFT, W. B. 
2000. Blastocyst score affects implantation and pregnancy outcome: towards a single 
blastocyst transfer. Fertility and Sterility, 73, 1155-1158. 
GARDNER, D. K. & SCHOOLCRAFT, W. B. 1999. In vitro culture of human blastocysts. 
In: GARDNER, D. K., SCHOOLCRAFT, W. B., JANSEN, R. & MORTIMER, D. 
(eds.) Toward Reproductive Certainty: Fertility and Genetics Beyond. London: 
London Parthenon Publishing, 378-388. 
GEE, J. M. W. & KNOWLDEN, J. M. 2003. ADAM metalloproteases and EGFR signalling. 
Breast Cancer Research, 5, 223-224. 
GHORAI, A. & GHOSH, U. 2014. miRNA gene counts in chromosomes vary widely in a 
species and biogenesis of miRNA largely depends on transcription or post-
transcriptional processing of coding genes. Frontiers in Genetics, 5, 100-100. 
GILAD, S., MEIRI, E., YOGEV, Y., BENJAMIN, S., LEBANONY, D., YERUSHALMI, N., 
BENJAMIN, H., KUSHNIR, M., CHOLAKH, H., MELAMED, N., BENTWICH, Z., 
HOD, M., GOREN, Y. & CHAJUT, A. 2008. Serum MicroRNAs Are Promising 
Novel Biomarkers. PloS One, 3, e3148. 
GOAD, J., KO, Y.-A., KUMAR, M., SYED, S. M. & TANWAR, P. S. 2017. Differential Wnt 
signaling activity limits epithelial gland development to the anti-mesometrial side of 
the mouse uterus. Developmental Biology, 423, 138-151. 
GONZALEZ, R. R., LEARY, K., PETROZZA, J. C. & LEAVIS, P. C. 2003. Leptin regulation 
of the interleukin1 system in human endometrial cells. Molecular Human 
Reproduction, 9, 151-158. 
GONZALEZ, R. R. & LEAVIS, P. 2001. Leptin upregulates beta3-integrin expression and 
interleukin-1beta, upregulates leptin and leptin receptor expression in human 
endometrial epithelial cell cultures. Endocrine, 16, 21-28. 
GONZALEZ, R. R., RUEDA, B. R., RAMOS, M. P., LITTELL, R. D., GLASSER, S. & 




receptor by human endometrium is partially mediated by interleukin 1 receptor 
signaling. Endocrinology, 145, 3850-3857. 
GOODMAN, L. R., GOLDBERG, J., FALCONE, T., AUSTIN, C. & DESAI, N. 2016. Does 
the addition of time-lapse morphokinetics in the selection of embryos for transfer 
improve pregnancy rates? A randomized controlled trial. Fertility and Sterility, 105, 
275-285.e10. 
GOOSSENS, K., MESTDAGH, P., LEFEVER, S., VAN POUCKE, M., VAN ZEVEREN, 
A., VAN SOOM, A., VANDESOMPELE, J. & PEELMAN, L. 2013. Regulatory 
microRNA Network Identification in Bovine Blastocyst Development. Stem Cells and 
Development, 22, 1907-1920. 
GRADY, R., ALAVI, N., VALE, R., KHANDWALA, M. & MCDONALD, S. D. 2012. 
Elective single embryo transfer and perinatal outcomes: a systematic review and 
meta-analysis. Fertility and Sterility, 97, 324-331. 
GRAHAM, J., HAN, T., PORTER, R., LEVY, M., STILLMAN, R. & TUCKER, M. J. 2000. 
Day 3 morphology is a poor predictor of blastocyst quality in extended culture. 
Fertility and Sterility, 74, 495-497. 
GRANDJEAN, V., GOUNON, P., WAGNER, N., MARTIN, L., WAGNER, K. D., 
BERNEX, F., CUZIN, F. & RASSOULZADEGAN, M. 2009. The miR-124-Sox9 
paramutation: RNA-mediated epigenetic control of embryonic and adult growth. 
Development, 136, 3647-3655. 
GROSS, N., KROPP, J. & KHATIB, H. 2017a. MicroRNA Signaling in Embryo 
Development. Biology, 6, 34. 
GROSS, N., KROPP, J. & KHATIB, H. 2017b. Sexual Dimorphism of miRNAs Secreted by 
Bovine In vitro-produced Embryos. Frontiers in Genetics, 8, 39. 
GRUMMER, R. & WINTERHAGER, E. 2011. Blastocyst-mediated induction of endometrial 
connexins: an inflammatory response? Journal Of Reproductive Immunology, 90, 9-
13. 
GU, K. L., ZHANG, Q., YAN, Y., LI, T. T., DUAN, F. F., HAO, J., WANG, X. W., SHI, M., 
WU, D. R., GUO, W. T. & WANG, Y. M. 2016. Pluripotency-associated miR-
290/302 family of microRNAs promote the dismantling of naive pluripotency. Cell 
Research, 26, 350-366. 
GUAN, Y., LIANG, G., HAWKEN, P. A. R., MALECKI, I. A., COZENS, G., VERCOE, P., 
E, MARTIN, G. B. & GUAN, L. L. 2015. Roles of small RNAs in the effects of 
nutrition on apoptosis and spermatogenesis in the adult testis. Scientific Reports, 5, 
10372. 
GULYAEVA, L. F. & KUSHLINSKIY, N. E. 2016. Regulatory mechanisms of microRNA 
expression. Journal of Translational Medicine, 14, 143. 
GÜMÜRDÜ, A., YILDIZ, R., EREN, E., KARAKÜLAH, G., ÜNVER, T., GENÇ, Ş. & 
PARK, Y. 2017. MicroRNA exocytosis by large dense-core vesicle fusion. Scientific 
Reports, 7, 45661-45661. 
HA, M. & KIM, V. N. 2014a. Regulation of microRNA biogenesis. Nature Reviews Molecular 
Cell Biology, 15, 509. 
HA, M. & KIM, V. N. 2014b. Regulation of microRNA biogenesis. Nature Reviews 
Molecular Cell Biology, 15, 509-524. 
HALSTEAD, M. M., MA, X., ZHOU, C., SCHULTZ, R. M. & ROSS, P. J. 2020. Chromatin 
remodeling in bovine embryos indicates species-specific regulation of genome 
activation. Nature Communications, 11, 4654-4654. 
HANNAN, N. J., JONES, R. L., WHITE, C. A. & SALAMONSEN, L. A. 2006. The 
chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at 
the feto-maternal interface. Biology of Reproduction, 74, 896-904. 
HANTAK, A. M., BAGCHI, I. C. & BAGCHI, M. K. 2014. Role of Uterine Stromal-
Epithelial Crosstalk in Embryo Implantation. International Journal of Developmental 
Biology, 58, 139-46. 
HARA, M., KINGSLEY, C. I., NIIMI, M., READ, S., TURVEY, S. E., BUSHELL, A. R., 




T cells to mediate tolerance to alloantigens in vivo. Journal of Immunology, 166, 
3789-3796. 
HARDARSON, T., VAN LANDUYT, L. & JONES, G. 2012. The blastocyst. Human 
Reproduction, 27, i72-i91. 
HARPER, J., JACKSON, E., SERMON, K., AITKEN, R. J., HARBOTTLE, S., MOCANU, 
E., HARDARSON, T., MATHUR, R., VIVILLE, S., VAIL, A. & LUNDIN, K. 2017. 
Adjuncts in the IVF laboratory: where is the evidence for ‘add-on’ interventions? 
Human Reproduction, 32, 485-491. 
HASUWA, H., UEDA, J., IKAWA, M. & OKABE, M. 2013. miR-200b and miR-429 
function in mouse ovulation and are essential for female fertility. Science, 341, 71-73. 
HAYASHI, K.-G., HOSOE, M., FUJII, S., KANAHARA, H. & SAKUMOTO, R. 2019. 
Temporal expression and localization of vascular endothelial growth factor family 
members in the bovine uterus during peri-implantation period. Theriogenology, 133, 
56-64. 
HE, L., HE, X. Y., LIM, L. P., DE STANCHINA, E., XUAN, Z. Y., LIANG, Y., XUE, W., 
ZENDER, L., MAGNUS, J., RIDZON, D., JACKSON, A. L., LINSLEY, P. S., 
CHEN, C. F., LOWE, S. W., CLEARY, M. A. & HANNON, G. J. 2007. A microRNA 
component of the p53 tumour suppressor network. Nature, 447, 1130-1134. 
HE, Z., JIANG, J., KOKKINAKI, M., TANG, L., ZENG, W., GALLICANO, I., 
DOBRINSKI, I. & DYM, M. 2013. MiRNA‐20 and mirna‐106a regulate 
spermatogonial stem cell renewal at the post‐transcriptional level via targeting STAT3 
and Ccnd1. Stem Cells, 31, 2205-2217. 
HE, Z., KOKKINAKI, M., PANT, D., GALLICANO, G. I. & DYM, M. 2009. Small RNA 
molecules in the regulation of spermatogenesis. Reproduction, 137, 901-911. 
HEITMANN, R., HILL, M., RICHTER, K., DECHERNEY, A. & WIDRA, E. 2013. The 
simplified SART embryo scoring system is highly correlated to implantation and live 
birth in single blastocyst transfers. Journal of Assisted Reproduction and Genetics, 
30, 563-567. 
HFEA. 2021. Code of Practice. 8th edition. 
HODES-WERTZ, B., LEE, H. L., ADLER, A., AMPELOQUIO, E., CLARKE-WILLIAMS, 
M. & GRIFO, J. A. 2013. Single euploid embryo transfer improves IVF pregnancy, 
miscarriage, and multiple gestation outcomes compared to national society for 
assisted reproductive technology database (SART) outcomes. Fertility and Sterility, 
100, S209. 
HOSSAIN, M. M., SALILEW-WONDIM, D., SCHELLANDER, K. & TESFAYE, D. 2012. 
The role of microRNAs in mammalian oocytes and embryos. Animal Reproduction 
Science, 134, 36-44. 
HUSZAR, J. M. & PAYNE, C. J. 2013. MicroRNA 146 (Mir146) modulates spermatogonial 
differentiation by retinoic acid in mice. Biology of Reproduction, 88, 15. 
HUYEN, D. V., BANY, B. M. 2011. Evidence for a conserved function of heart and neural 
crest derivatives expressed transcript 2 in mouse and human decidualization. 
Reproduction, 142, 353-368. 
ILLERA, M. J., CULLINAN, E., GUI, Y., YUAN, L., BEYLER, S. A. & LESSEY, B. A. 
2000. Blockade of the alpha(v)beta(3) integrin adversely affects implantation in the 
mouse. Biology of Reproduction, 62, 1285-1290. 
IPSARRO, J. J., & JOSHUA-TOR, L. 2015. From guide to target: molecular insights into 
eukaryotic  RNA-interference machinery. Nature Structural & Molecular Biology, 
22, 20-28. 
JAROUDI, S. & SENGUPTA, S. 2007. DNA repair in mammalian embryos. Mutation 
Research, 635, 53-77. 
JEEYEON, C., XIAOFEI, S. & SUDHANSU, K. D. 2012. Mechanisms of implantation: 
strategies for successful pregnancy. Nature Medicine, 18, 1754-1767. 
JHA, R. K., TITUS, S., SAXENA, D., KUMAR, P. G. & LALORAYA, M. 2006. Profiling 
of E-cadherin, β-catenin and Ca 2+ in embryo–uterine interactions at implantation. 




JONES, L. R., HANNAN, J. N., KAITU’U, J. T. U., ZHANG, A. J. & SALAMONSEN, A. 
L. 2004. Identification of Chemokines Important for Leukocyte Recruitment to the 
Human Endometrium at the Times of Embryo Implantation and Menstruation. The 
Journal of Clinical Endocrinology & Metabolism, 89, 6155-6167. 
JONAS, S. & IZAURRALDE, E. 2015. Towards a moleular understanding of microRNA-
mediated gene silencing. Nature Review Genetics, 16, 421-433. 
KAHRAMAN, S., SAHIN, Y., YELKE, H., KUMTEPE, Y., TUFEKCI, M. A., YAPAN, C. 
C., YESIL, M. & CETINKAYA, M. 2020. High rates of aneuploidy, mosaicism and 
abnormal morphokinetic development in cases with low sperm concentration. Journal 
of Assisted Reproduction and Genetics, 37, 629-640. 
KIEZUN, A., ARTZI, S., MODAI, S., VOLK, N., ISAKOV, O. & SHOMRON, N. 2012. 
miRviewer: a multispecies microRNA homologous viewer. BMC Research Notes, 5, 
92. 
KIM, J., LEE, J. & JUN, J. H. 2019. Identification of differentially expressed microRNAs in 
outgrowth embryos compared with blastocysts and non-outgrowth embryos in mice. 
Reproduction, Fertility and Development, 31, 645-657. 
KIMBER, S. J. & SPANSWICK, C. 2000. Blastocyst implantation: the adhesion cascade. 
Seminars in Cell and Developmental Biology, 11, 77-92. 
KIRKEGAARD, K., AGERHOLM, I. E. & INGERSLEV, H. J. 2012. Time-lapse monitoring 
as a tool for clinical embryo assessment. Human Reproduction, 27, 1277-1285. 
KROPP, J. & KHATIB, H. 2015. Characterization of microRNA in bovine in vitro culture 
media associated with embryo quality and development. Journal of Dairy Science, 
98, 6552-6563. 
KROPP, J., KHATIB, H. & SALIH, S. M. 2014. Expression of microRNAs in bovine and 
human pre-implantation embryo culture media. Frontiers in Genetics, 5, 91. 
KUMAR, P., DEZSO, Z., MACKENZIE, C., OESTREICHER, J., AGOULNIK, S., BYRNE, 
M., BERNIER, F., YANAGIMACHI, M., AOSHIMA, K. & ODA, Y. Circulating 
miRNA biomarkers for Alzheimer's disease. PLoS One, 8, e69807. 
KURITA, T., LEE, K., COOKE, P. S., LYDON, J. P. & CUNHA, G. R. 2000. Paracrine 
regulation of epithelial progesterone receptor and lactoferrin by progesterone in the 
mouse uterus. Biology of Reproduction, 62, 831-838. 
KURITA, T., YOUNG, P., BRODY, J. R., LYDON, J. P., O'MALLEY, B. W. & CUNHA, 
G. R. 1998. Stromal progesterone receptors mediate the inhibitory effects of 
progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid 
synthesis. Endocrinology, 139, 4708-4713. 
LAL, A., NAVARRO, F., MAHER, C. A., MALISZEWSKI, L. E., YAN, N., AMP, AMP, 
APOS, DAY, E., CHOWDHURY, D., DYKXHOORN, D. M., TSAI, P., 
HOFMANN, O., BECKER, K. G., GOROSPE, M., HIDE, W. & LIEBERMAN, J. 
2009. miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-
Cycle Genes via Binding to ''Seedless'' 3′UTR MicroRNA Recognition Elements. 
Molecular Cell, 35, 610-625. 
LANDGRAF, P., RUSU, M., SHERIDAN, R., SEWER, A., IOVINO, N., ARAVIN, A., 
PFEFFER, S., RICE, A., KAMPHORST, A. O., LANDTHALER, M., LIN, C., 
SOCCI, N. D., HERMIDA, L., FULCI, V., CHIARETTI, S., FOÀ, R., SCHLIWKA, 
J., FUCHS, U., NOVOSEL, A., MÜLLER, R.-U., SCHERMER, B., BISSELS, U., 
INMAN, J., PHAN, Q., CHIEN, M., WEIR, D. B., CHOKSI, R., DE VITA, G., 
FREZZETTI, D., TROMPETER, H.-I., HORNUNG, V., TENG, G., HARTMANN, 
G., PALKOVITS, M., DI LAURO, R., WERNET, P., MACINO, G., ROGLER, C. 
E., NAGLE, J. W., JU, J., PAPAVASILIOU, F. N., BENZING, T., LICHTER, P., 
TAM, W., BROWNSTEIN, M. J., BOSIO, A., BORKHARDT, A., RUSSO, J. J., 
SANDER, C., ZAVOLAN, M. & TUSCHL, T. 2007. A Mammalian microRNA 
Expression Atlas Based on Small RNA Library Sequencing. Cell, 129, 1401-1414. 





LEE, S.-H., CHEN, T.-Y., DHAR, S. S., GU, B., CHEN, K., KIM, Y. Z., LI, W. & LEE, M. 
G. 2016. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, 
Nanog, Klf4 and c-Myc to regulate stemness. Nucleic Acids Research, 44, 10603-
10618. 
LEI, L., JIN, S., GONZALEZ, G., BEHRINGER, R. R. & WOODRUFF, T. K. 2010. The 
regulatory role of Dicer in folliculogenesis in mice. Molecular and Cellular 
Endocrinology, 315, 63-73. 
LESSER, M. P., KRUSE, V. A. & BARRY, T. M. 2003. Exposure to ultraviolet radiation 
causes apoptosis in developing sea urchin embryos. Journal of Experimental Biology, 
206, 4097-4103. 
LI, C., CHEN, C., CHEN, L., CHEN, S., LI, H., ZHAO, Y., RAO, J. & ZHOU, X. 2016a. 
BDNF-induced expansion of cumulus-oocyte complexes in pigs was mediated by 
microRNA-205. Theriogenology, 85, 1476-1482. 
LI, C., CHEN, S., LI, H., CHEN, L., ZHAO, Y., JIANG, Y., LIU, Z., LIU, Y., GAO, S., 
WANG, F., YU, J., WANG, H., RAO, J. & ZHOU, X. 2016b. MicroRNA-16 
Modulates Melatonin-Induced Cell Growth in the Mouse-Derived Spermatogonia 
Cell Line GC-1 spg Cells by Targeting Ccnd1. Biology of Reproduction, 95, 57. 
LI, L., ZHANG, X., ZHAO, L., XIA, X. & WANG, W. 2012. Comparison of DNA apoptosis 
in mouse and human blastocysts after vitrification and slow freezing. Molecular 
Reproduction and Development, 79, 229-236. 
LI, Q., KANNAN, A., DEMAYO, F. J., LYDON, J. P., COOKE, P. S., YAMAGISHI, H., 
SRIVASTAVA, D., BAGCHI, M. K. & BAGCHI, I. C. 2011. The antiproliferative 
action of progesterone in uterine epithelium is mediated by Hand2. Science, 331, 912-
916. 
LI, Y., SHAN, Z., LIU, C., YANG, D., WU, J., MEN, C. & XU, Y. 2017. MicroRNA-294 
Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT 
Pathways by Upregulation of NRAS in Bladder Cancer. Biochemistry (Mosc), 82, 
474-482. 
LIAN, J., TIAN, H., LIU, L., ZHANG, X. S., LI, W. Q., DENG, Y. M., YAO, G. D., YIN, M. 
M. & SUN, F. 2010. Downregulation of microRNA-383 is associated with male 
infertility and promotes testicular embryonal carcinoma cell proliferation by targeting 
IRF1. Cell Death & Disease, 1, e94. 
LIANG, J., WANG, S. & WANG, Z. 2017. Role of microRNAs in embryo implantation. 
Reproductive Biology and Endocrinology, 15, 90. 
LIAO, Y., WANG, J., JAEHNIG, E. J., SHI, Z. & ZHANG, B. 2019. WebGestalt 2019: gene 
set analysis toolkit with revamped UIs and APIs. Nucleic Acids Research, 47, W199-
W205. 
LIN, F., LI, R., PAN, Z. X., ZHOU, B., YU, D. B., WANG, X. G., MA, X. S., HAN, J., SHEN, 
M. & LIU, H. L. 2012. miR-26b promotes granulosa cell apoptosis by targeting ATM 
during follicular atresia in porcine ovary. PloS One, 7, e38640. 
LIN, X., BECKERS, E., MC CAFFERTY, S., GANSEMANS, Y., JOANNA SZYMAŃSKA, 
K., CHAITANYA PAVANI, K., CATANI, J. P., VAN NIEUWERBURGH, F., 
DEFORCE, D., DE SUTTER, P., VAN SOOM, A. & PEELMAN, L. 2019. Bovine 
Embryo-Secreted microRNA-30c Is a Potential Non-invasive Biomarker for 
Hampered Preimplantation Developmental Competence. Frontiers in Genetics, 10, 
315. 
LIU, W.-M., PANG, T. K. R., CHIU, C. N. P., WONG, P. C. B., LAO, K., LEE, K.-F. & 
YEUNG, S. B. W. 2012. Sperm-borne microRNA-34c is required for the first 
cleavage division in mouse. Proceedings of the National Academy of Sciences, 109, 
490-494. 
LUJAMBIO, A., ROPERO, S., BALLESTAR, E., FRAGA, M. F., CERRATO, C., SETIÉN, 
F., CASADO, S., SUAREZ-GAUTHIER, A., SANCHEZ-CESPEDES, M., GIT, A., 
GITT, A., SPITERI, I., DAS, P. P., CALDAS, C., MISKA, E. & ESTELLER, M. 
2007. Genetic unmasking of an epigenetically silenced microRNA in human cancer 




LUO, Z., LIU, Y., CHEN, L., ELLIS, M., LI, M., WANG, J., ZHANG, Y., FU, P., WANG, 
K., LI, X. & WANG, L. 2015. microRNA profiling in three main stages during 
porcine spermatogenesis. Journal of Assisted Reproduction and Genetics, 32, 451-
460. 
MA, T., JIANG, H., GAO, Y., ZHAO, Y., DAI, L., XIONG, Q., XU, Y., ZHAO, Z. & 
ZHANG, J. 2011. Microarray analysis of differentially expressed microRNAs in non-
regressed and regressed bovine corpus luteum tissue; microRNA-378 may suppress 
luteal cell apoptosis by targeting the interferon gamma receptor 1 gene. Journal of 
Applied Genetics, 52, 481-486. 
MACKLON, N. S. & BROSENS, J. J. 2014. The human endometrium as a sensor of embryo 
quality. Biology of Reproduction, 91, 98. 
MAKRI, D., EFSTATHIOU, P., MICHAILIDOU, E. & MAALOUF, W. E. 2020. Apoptosis 
triggers the release of microRNA miR-294 in spent culture media of blastocysts. 
Journal of Assisted Reproduction and Genetics, 37, 1685-1694. 
MARSON, A., LEVINE, S. S., COLE, M. F., FRAMPTON, G. M., BRAMBRINK, T., 
JOHNSTONE, S., GUENTHER, M. G., JOHNSTON, W. K., WERNIG, M., 
NEWMAN, J., CALABRESE, J. M., DENNIS, L. M., VOLKERT, T. L., GUPTA, 
S., LOVE, J., HANNETT, N., SHARP, P. A., BARTEL, D. P., JAENISCH, R. & 
YOUNG, R. A. 2008. Connecting microRNA Genes to the Core Transcriptional 
Regulatory Circuitry of Embryonic Stem Cells. Cell, 134, 521-533. 
MARTINEZ, R. M., LIANG, L., RACOWSKY, C., DIONI, L., MANSUR, A., ADIR, M., 
BOLLATI, V., BACCARELLI, A. A., HAUSER, R. & MACHTINGER, R. 2018. 
Extracellular microRNAs profile in human follicular fluid and IVF outcomes. 
Scientific Reports, 8, 1-10. 
MASSIMIANI, M., LACCONI, V., LA CIVITA, F., TICCONI, C., RAGO, R. & 
CAMPAGNOLO, L. 2019. Molecular Signaling Regulating Endometrium-Blastocyst 
Crosstalk. International Journal of Molecular Sciences, 21, 23. 
MATSUI, N., KAWANO, Y., NAKAMURA, S. & MIYAKAWA, I. 2004. Changes in 
vascular endothelial growth factor production associated with decidualization by 
human endometrial stromal cells in vitro. Acta Obstetricia et Gynecologica 
Scandinavica, 83, 138-143. 
MCBRIDE, D., CARRÉ, W., SONTAKKE, S. D., HOGG, C. O., LAW, A., DONADEU, F. 
X. & CLINTON, M. 2012. Identification of miRNAs associated with the follicular-
luteal transition in the ruminant ovary. Reproduction, 144, 221-233. 
MCCALLIE, B., SCHOOLCRAFT, W. B. & KATZ-JAFFE, M. G. 2010. Aberration of 
blastocyst microRNA expression is associated with human infertility. Fertility and 
Sterility, 93, 2374-2382. 
MCCUBBIN, N. I., MCCALLIE, B. R., PARKS, J. C., SCHOOLCRAFT, W. B. & KATZ-
JAFFE, M. 2017. Disrupted sperm mirna expression profiles revealed a fingerprint of 
impaired spermatogenesis in oligozoospermia males. Fertility and Sterility, 108, 
e139-e139. 
MCIVER, S. C., STANGER, S. J., SANTARELLI, D. M., ROMAN, S. D., NIXON, B. & 
MCLAUGHLIN, E. A. 2012. A Unique Combination of Male Germ Cell miRNAs 
Coordinates Gonocyte Differentiation. PLoS One, 7, e35553. 
MENDELL, JOSHUA T. & OLSON, ERIC N. 2012. MicroRNAs in Stress Signaling and 
Human Disease. Cell, 148, 1172-1187. 
MENEZO, Y. J. R. & HERUBEL, F. 2002. Mouse and bovine models for human IVF. 
Reproductive BioMedicine Online, 4, 170-175. 
MENG, F.-L., WANG, W. & JIA, W.-D. 2014. Diagnostic and prognostic significance of 
serum miR-24-3p in HBV-related hepatocellular carcinoma. Medical Oncology, 31, 
1-6. 
MESEGUER, M., APLIN, J. D., CABALLERO-CAMPO, P., O’CONNOR J. E., MARTIN, 
J. C., REMOHI, J., PELLICER, A. & SIMON, C. 2001. Human endometrial mucin 
MUC1 is up-regulated by progesterone and down-regulated in vitro by the human 




MESEGUER, M., HERRERO, J., TEJERA, A., HILLIGSØE, K. M., RAMSING, N. B. & 
REMOHÍ, J. 2011. The use of morphokinetics as a predictor of embryo implantation. 
Human Reproduction, 26, 2658-2671. 
MILEWSKI, R., KUĆ, P., KUCZYŃSKA, A., STANKIEWICZ, B., ŁUKASZUK, K. & 
KUCZYŃSKI, W. 2015. A predictive model for blastocyst formation based on 
morphokinetic parameters in time-lapse monitoring of embryo development. Journal 
of Assisted Reproduction and Genetics, 32, 571-579. 
MITCHELL, P. S., PARKIN, R. K., KROH, E. M., FRITZ, B. R., WYMAN, S. K., 
POGOSOVA-AGADJANYAN, E. L., PETERSON, A., NOTEBOOM, J., 
O'BRIANT, K. C., ALLEN, A., LIN, D. W., URBAN, N., DRESCHER, C. W., 
KNUDSEN, B. S., STIREWALT, D. L., GENTLEMAN, R., VESSELLA, R. L., 
NELSON, P. S., MARTIN, D. B. & TEWARI, M. 2008. Circulating microRNAs as 
stable blood-based markers for cancer detection. Proceedings of the National 
Academy of Sciences of the United States of America, 105, 10513-10518. 
MOKÁNSZKI, A., MOLNÁR, Z., TÓTHNÉ, E. V., BODNÁR, B., JAKAB, A., BÁLINT, B. 
L. & BALOGH, I. 2019. Altered microRNAs expression levels of sperm and seminal 
plasma in patients with infertile ejaculates compared with normozoospermic males. 
Human Fertility, 246-255. 
MOMENI, A., NAJAFIPOUR, R., HAMTA, A., JAHANI, S. & MOGHBELINEJAD, S. 
2020. Expression and Methylation Pattern of hsa-miR-34 Family in Sperm Samples 
of Infertile Men. Reproductive Sciences, 27, 301-308. 
MOTATO, Y., DE LOS SANTOS, M. J., ESCRIBA, M. J., RUIZ, B. A., REMOHÍ, J. & 
MESEGUER, M. 2016. Morphokinetic analysis and embryonic prediction for 
blastocyst formation through an integrated time-lapse system. Fertility and Sterility, 
105, 376-384.e9. 
MOURIK, M. S. M., MACKLON, N. S. & HEIJNEN, C. J. 2009. Embryonic implantation: 
cytokines, adhesion molecules, and immune cells in establishing an implantation 
environment. Journal of Leukocyte Biology, 85, 4-19. 
MUMUSOGLU, S., OZBEK, I. Y., SOKMENSUER, L. K., POLAT, M., BOZDAG, G., 
PAPANIKOLAOU, E. & YARALI, H. 2017. Duration of blastulation may be 
associated with ongoing pregnancy rate in single euploid blastocyst transfer cycles. 
Reproductive BioMedicine Online, 35, 633-639. 
NISHI, K., NISHI, A., NAGASAWA, T., UI-TEI, K. 2013. Human TNRC6A is an 
Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus. 
RNA, 19,17-35. 
NIU, Z., GOODYEAR, M. S., RAO, S., WU, X., TOBIAS, W. J., AVARBOCK, R. M. & 
BRINSTER, L. R. 2011. MicroRNA-21 regulates the self-renewal of mouse 
spermatogonial stem cells. Proceedings of the National Academy of Sciences, 108, 
12740-12745. 
NIXON, B., STANGER, S. J., MIHALAS, B. P., REILLY, J. N., ANDERSON, A. L., 
TYAGI, S., HOLT, J. E. & MCLAUGHLIN, E. A. 2015. The microRNA signature 
of mouse spermatozoa is substantially modified during epididymal maturation. 
Biology of Reproduction, 93, 91. 
O'BRIEN, J., HAYDER, H., ZAYED, Y. & PENG, C. 2018. Overview of MicroRNA 
Biogenesis, Mechanisms of Actions, and Circulation. Frontiers in Endocrinology, 9, 
402. 
OHNISHI, Y., TOTOKI, Y., TOYODA, A., WATANABE, T., YAMAMOTO, Y., 
TOKUNAGA, K., SAKAKI, Y., SASAKI, H. & HOHJOH, H. 2010. Small RNA 
class transition from siRNA/piRNA to miRNA during pre-implantation mouse 
development. Nucleic Acids Research, 38, 5141-5151. 
OTSUKA, M., ZHENG, M., HAYASHI, M., LEE, J.-D., YOSHINO, O., LIN, S. & HAN, J. 
2008. Impaired microRNA processing causes corpus luteum insufficiency and 




OU, Z., CHEN, Z., YIN, M., DENG, Y., LIANG, Y., WANG, W., YAO, Y. & SUN, L. 2020. 
Re-analysis of whole blastocysts after trophectoderm biopsy indicated chromosome 
aneuploidy. Human Genomics, 14, 3. 
PAN, B., TOMS, D. & LI, J. 2018. MicroRNA-574 suppresses oocyte maturation via targeting 
hyaluronan synthase 2 in porcine cumulus cells. American Journal of Physiology. Cell 
Physiology, 314, C268-C277. 
PAN-CASTILLO, B., GAZZE, S. A., THOMAS, S., LUCAS, C., MARGARIT, L., 
GONZALEZ, D., FRANCIS, L. W. & CONLAN, R. S. 2018. Morphophysical 
dynamics of human endometrial cells during decidualization. Nanomedicine: 
Nanotechnology, Biology, and Medicine, 14, 2235-2245. 
POTHOF, J., VERKAIK, N., IJCKEN, W., WIEMER, E., TA, V., HORST, G., JASPERS, 
N., GENT, D., HOEIJMAKERS, J. & PERSENGIEV, S. 2009. MicroRNA-mediated 
gene silencing modulates the UV-induced DNA-damage response. The EMBO 
Journal, 28, 2090-2099. 
QI, L., HONGJUAN, H., NING, G., ZHENGBIN, H., YANJIANG, X., TIEBO, Z., ZHIJUN, 
H. & QIONG, W. 2013. miR‐370 is stage‐specifically expressed during mouse 
embryonic development and regulates Dnmt3a. FEBS Letters, 587, 775-781. 
QIU, Q., YANG, M., TSANG, B. K. & GRUSLIN, A. 2004. EGF-induced trophoblast 
secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK 
signalling pathways. Reproduction, 128, 355-363. 
RADTKE, A., DIECKMANN, K. P., GROBELNY, F., SALZBRUNN, A., OING, C., 
SCHULZE, W. & BELGE, G. 2019. Expression of miRNA‐371a‐3p in seminal 
plasma and ejaculate is associated with sperm concentration. Andrology, 7, 469-474. 
RED-HORSE, K., DRAKE, P. M., GUNN, M. D. & FISHER, S. J. 2001. Chemokine Ligand 
and Receptor Expression in the Pregnant Uterus. The American Journal of Pathology, 
159, 2199-2213. 
REZA, A. M. M. T., CHOI, Y.-J., HAN, S. G., SONG, H., PARK, C., HONG, K. & KIM, J.-
H. 2019. Roles of microRNAs in mammalian reproduction: from the commitment of 
germ cells to peri-implantation embryos. Biological Reviews of the Cambridge 
Philosophical Society, 94, 415-438. 
RIENZI, L., CIMADOMO, D., DELGADO, A., MINASI, M. G., FABOZZI, G., GALLEGO, 
R. D., STOPPA, M., BELLVER, J., GIANCANI, A., ESBERT, M., CAPALBO, A., 
REMOHÌ, J., GRECO, E., UBALDI, F. M. & MESEGUER, M. 2019. Time of 
morulation and trophectoderm quality are predictors of a live birth after euploid 
blastocyst transfer: a multicenter study. Fertility and Sterility, 112, 1080-1093.e1. 
ROBB, L., DIMITRIADIS, E., LI, R. & SALAMONSEN, L. A. 2002. Leukemia inhibitory 
factor and interleukin-11: cytokines with key roles in implantation. Journal of 
Reproductive Immunology, 57, 129-141. 
ROBB, L., LI, R., HARTLEY, L., NANDURKAR, H. H., KOENTGEN, F. & BEGLEY, C. 
G. 1998. Infertility in female mice lacking the receptor for interleukin 11 is due to a 
defective uterine response to implantation. Nature Medicine, 4, 303-308. 
ROMERO, Y., MEIKAR, O., PAPAIOANNOU, M. D., CONNE, B., GREY, C., WEIER, M., 
PRALONG, F., DE MASSY, B., KAESSMANN, H., VASSALLI, J.-D., KOTAJA, 
N. & NEF, S. 2011. Dicer1 Depletion in Male Germ Cells Leads to Infertility Due to 
Cumulative Meiotic and Spermiogenic Defects. PLoS One, 6, e25241. 
ROSENBLUTH, E. M., SHELTON, D. N., SPARKS, A. E. T., DEVOR, E., 
CHRISTENSON, L. & VAN VOORHIS, B. J. 2013. MicroRNA expression in the 
human blastocyst. Fertility and Sterility, 99, 855-861. 
ROSENBLUTH, E. M., SHELTON, D. N., WELLS, L. M., SPARKS, A. E. T. & VAN 
VOORHIS, B. J. 2014. Human embryos secrete microRNAs into culture media—a 
potential biomarker for implantation. Fertility and Sterility, 101, 1493-1500. 
ROTKRUA, P., SHIMADA, S., MOGUSHI, K., AKIYAMA, Y., TANAKA, H. & YUASA, 
Y. 2013. Circulating microRNAs as biomarkers for early detection of diffuse-type 




RUBIO, C., RIENZI, L., NAVARRO-SÁNCHEZ, L., CIMADOMO, D., GARCÍA-
PASCUAL, C. M., ALBRICCI, L., SOSCIA, D., VALBUENA, D., CAPALBO, A., 
UBALDI, F. & SIMÓN, C. 2019. Embryonic cell-free DNA versus trophectoderm 
biopsy for aneuploidy testing: concordance rate and clinical implications. Fertility 
and Sterility, 112, 510-519. 
SAADELDIN, I. M., OH, H. J. & LEE, B. C. 2015. Embryonic–maternal cross-talk via 
exosomes: potential implications. Stem Cells and Cloning: Advances and 
Applications, 8, 103-107. 
SAKURAI, T., TAKAI, R., BÜRGIN, H., ISHIHARA, K., SAKAMOTO, Y., AMANO, J., 
HIGUCHI, Y., CHIBA, S., SINGER, T., KAWAMURA, A., SUZUKI, M. & 
MÜLLER, L. 2012. The effects of interleukin-6 signal blockade on fertility, embryo-
fetal development, and immunization in vivo. Birth Defects Research Part B, 
Developmental and Reproductive Toxicology, 95, 304-317. 
SALILEW-WONDIM, D., AHMAD, I., GEBREMEDHN, S., SAHADEVAN, S., HOSSAIN, 
M. D. M., RINGS, F., HOELKER, M., THOLEN, E., NEUHOFF, C., LOOFT, C., 
SCHELLANDER, K. & TESFAYE, D. 2014. The expression pattern of microRNAs 
in granulosa cells of subordinate and dominant follicles during the early luteal phase 
of the bovine estrous cycle. PloS One, 9, e106795. 
SANG, Q., YAO, Z., WANG, H., FENG, R., WANG, H., ZHAO, X., XING, Q., JIN, L., HE, 
L., WU, L. & WANG, L. 2013. Identification of microRNAs in human follicular fluid: 
characterization of microRNAs that govern steroidogenesis in vitro and are associated 
with polycystic ovary syndrome in vivo. The Journal of Clinical Endocrinology and 
Metabolism, 98, 3068-3079. 
SANTANGELO, A., IMBRUCÈ, P., GARDENGHI, B., BELLI, L., AGUSHI, R., 
TAMANINI, A., MUNARI, S., BOSSI, A. M., SCAMBI, I., BENATI, D., 
MARIOTTI, R., DI GENNARO, G., SBARBATI, A., ECCHER, A., RICCIARDI, G. 
K., CICERI, E. M., SALA, F., PINNA, G., LIPPI, G., CABRINI, G. & DECHECCHI, 
M. C. 2017. A microRNA signature from serum exosomes of patients with glioma as 
complementary diagnostic biomarker. Journal of Neuro-Oncology, 136, 51-62. 
SANTONOCITO, M., VENTO, M., GUGLIELMINO, M. R., BATTAGLIA, R., 
WAHLGREN, J., RAGUSA, M., BARBAGALLO, D., BORZÌ, P., RIZZARI, S., 
MAUGERI, M., SCOLLO, P., TATONE, C., VALADI, H., PURRELLO, M. & DI 
PIETRO, C. 2014. Molecular characterization of exosomes and their microRNA 
cargo in human follicular fluid: bioinformatic analysis reveals that exosomal 
microRNAs control pathways involved in follicular maturation. Fertility and Sterility, 
102, 1751-1761.e1. 
SAZONOVA, A., KÄLLEN, K., THURIN-KJELLBERG, A., WENNERHOLM, U.-B. & 
BERGH, C. 2013. Neonatal and maternal outcomes comparing women undergoing 
two in vitro fertilization (IVF) singleton pregnancies and women undergoing one IVF 
twin pregnancy. Fertility and Sterility, 99, 731-737. 
SCALICI, E., TRAVER, S., MULLET, T., MOLINARI, N., FERRIÈRES, A., BRUNET, C., 
BELLOC, S. & HAMAMAH, S. 2016. Circulating microRNAs in follicular fluid, 
powerful tools to explore in vitro fertilization process. Scientific Reports, 6, 24976. 
SCHMITTGEN, T. D. & LIVAK, K. J. 2008. Analyzing real-time PCR data by the 
comparative C(T) method. Nature Protocols, 3, 1101-1108. 
SCHOOLCRAFT, W. B. M. D. 2016. Importance of embryo transfer technique in maximizing 
assisted reproductive outcomes. Fertility and Sterility, 105, 855-860. 
SEN, A., PRIZANT, H., LIGHT, A., BISWAS, A., HAYES, E., LEE, H.-J., BARAD, D., 
GLEICHER, N. & HAMMES, R. S. 2014. Androgens regulate ovarian follicular 
development by increasing follicle stimulating hormone receptor and microRNA-
125b expression. Proceedings of the National Academy of Sciences, 111, 3008-3013. 
SHARMA, S., GODBOLE, G. & MODI, D. 2016. Decidual Control of Trophoblast Invasion. 




SHEN, G., WU, R., LIU, B., DONG, W., TU, Z., YANG, J., XU, Z. & PAN, T. 2014. 
Upstream and downstream mechanisms for the promoting effects of IGF-1 on 
differentiation of spermatogonia to primary spermatocytes. Life Sciences, 101, 49-55. 
SHIMIZU, Y., KABIR-SALMANI, M., AZADBAKHT, M., SUGIHARA, K., SAKAI, K. & 
IWASHITA, M. 2008. Expression and localization of galectin-9 in the human 
uterodome. Endocrine Journal, 55, 879-887. 
SIMON, L., SPIEWAK, K. A., EKMAN, G. C., KIM, J., LYDON, J. P., BAGCHI, M. K., 
BAGCHI, I. C., DEMAYO, F. J. & COOKE, P. S. 2009. Stromal progesterone 
receptors mediate induction of Indian Hedgehog (IHH) in uterine epithelium and its 
downstream targets in uterine stroma. Endocrinology, 150, 3871-3876. 
SINGH, H. & APLIN, J. D. 2009. Adhesion molecules in endometrial epithelium: tissue 
integrity and embryo implantation. Journal of Anatomy, 215, 3-13. 
SMALLEY, D. M. & LEY, K. 2005. L‐selectin: mechanisms and physiological significance 
of ectodomain cleavage. Journal of Cellular and Molecular Medicine, 9, 255-266. 
SMORAG, L., ZHENG, Y., NOLTE, J., ZECHNER, U., ENGEL, W. & PANTAKANI, D. 
V. K. 2012. MicroRNA signature in various cell types of mouse spermatogenesis: 
evidence for stage-specifically expressed miRNA-221, -203 and -34b-5p mediated 
spermatogenesis regulation. Biology of the Cell, 104, 677-692. 
SOHEL, M. M. H., HOELKER, M., NOFERESTI, S. S., SALILEW-WONDIM, D., 
THOLEN, E., LOOFT, C., RINGS, F., UDDIN, M. J., SPENCER, T. E., 
SCHELLANDER, K., TESFAYE, D. & BUSSON, P. 2013. Exosomal and Non-
Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications 
for Bovine Oocyte Developmental Competence. PLoS One, 8, e78505. 
SONG, C., YAO, J., CAO, C., LIANG, X., HUANG, J., HAN, Z., ZHANG, Y., QIN, G., 
TAO, C., LI, C., YANG, H., ZHAO, J., LI, K. & WANG, Y. 2016. PPARγ is regulated 
by miR-27b-3p negatively and plays an important role in porcine oocyte maturation. 
Biochemical and Biophysical Research Communications, 479, 224-230. 
SONG, H., LIM, H., DAS, S. K., PARIA, B. C. & DEY, S. K. 2000. Dysregulation of EGF 
family of growth factors and COX-2 in the uterus during the preattachment and 
attachment reactions of the blastocyst with the luminal epithelium correlates with 
implantation failure in LIF-deficient mice. Molecular Endocrinology, 14, 1147-1161. 
SONTAKKE, S. D., MOHAMMED, B. T., MCNEILLY, A. S. & DONADEU, F. X. 2014. 
Characterization of microRNAs differentially expressed during bovine follicle 
development. Reproduction, 148, 271-283. 
SUH, N., BAEHNER, L., MOLTZAHN, F., MELTON, C., SHENOY, A., CHEN, J. & 
BLELLOCH, R. 2010. MicroRNA Function Is Globally Suppressed in Mouse 
Oocytes and Early Embryos. Current Biology, 20, 271-277. 
SVOBODA, P., FRANKE, V. & SCHULTZ, R. M. 2015. Sculpting the Transcriptome During 
the Oocyte-to-Embryo Transition in Mouse. Current Topics in Developmental 
Biology, 113, 305-349. 
TANG, F., KANEDA, M., O'CARROLL, D., HAJKOVA, P., BARTON, S. C., SUN, Y. A., 
LEE, C., TARAKHOVSKY, A., LAO, K. & SURANI, M. A. 2007. Maternal 
microRNAs are essential for mouse zygotic development. Genes & Development, 21, 
644-648. 
TAQI, M. O., SAEED‐ZIDANE, M., GEBREMEDHN, S., SALILEW‐WONDIM, D., 
KHDRAWY, O., RINGS, F., NEUHOFF, C., HOELKER, M., SCHELLANDER, K. 
& TESFAYE, D. 2019. Sexual dimorphic expression and release of transcription 
factors in bovine embryos exposed to oxidative stress. Molecular Reproduction and 
Development, 86, 2005-2019. 
TEKLENBURG, G., SALKER, M., MOLOKHIA, M., LAVERY, S., TREW, G., 
AOJANEPONG, T., MARDON, H. J., LOKUGAMAGE, A. U., RAI, R., LANDLES, 
C., ROELEN, B. A. J., QUENBY, S., KUIJK, E. W., KAVELAARS, A., HEIJNEN, 
C. J., REGAN, L., BROSENS, J. J. & MACKLON, N. S. 2010. Natural Selection of 
Human Embryos: Decidualizing Endometrial Stromal Cells Serve as Sensors of 




TESFAYE, D., WORKU, D., RINGS, F., PHATSARA, C., THOLEN, E., SCHELLANDER, 
K. & HOELKER, M. 2009. Identification and expression profiling of microRNAs 
during bovine oocyte maturation using heterologous approach. Molecular 
Reproduction and Development, 76, 665-677. 
TONG, M.-H., MITCHELL, D. A., MCGOWAN, S. D., EVANOFF, R. & GRISWOLD, M. 
D. 2012. Two miRNA clusters, Mir-17-92 (Mirc1) and Mir-106b-25 (Mirc3), are 
involved in the regulation of spermatogonial differentiation in mice. Biology of 
Reproduction, 86, 72. 
TRAN, G. T., HODGKINSON, S. J., CARTER, N. M., VERMA, N. D., PLAIN, K. M., 
BOYD, R., ROBINSON, C. M., NOMURA, M., KILLINGSWORTH, M. & HALL, 
B. M. 2012. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory 
cells that suppress autoimmunity. Blood, 119, 4441-4450. 
TRIPURANI, S. K., XIAO, C., SALEM, M. & YAO, J. 2010. Cloning and analysis of fetal 
ovary microRNAs in cattle. Animal Reproduction Science, 120, 16-22. 
TSAI, S.-J., WU, M.-H., CHEN, H.-M., CHUANG, P.-C. & WING, L.-Y. C. 2002. Fibroblast 
growth factor-9 is an endometrial stromal growth factor. Endocrinology, 143, 2715-
2721. 
TULAY, P. & SENGUPTA, S. 2016. MicroRNA expression and its association with DNA 
repair in preimplantation embryos. Journal of Reproduction and Development, 62, 
225-234. 
UHDE, K., VAN TOL, H. T. A., STOUT, T. A. E. & ROELEN, B. A. J. 2017. MicroRNA 
Expression in Bovine Cumulus Cells in Relation to Oocyte Quality. Non-coding RNA, 
3, 12. 
VAN DEN ABBEEL, E., BALABAN, B., ZIEBE, S., LUNDIN, K., CUESTA, M. J. G., 
KLEIN, B. M., HELMGAARD, L. & ARCE, J.-C. 2013. Association between 
blastocyst morphology and outcome of single-blastocyst transfer. Reproductive 
BioMedicine Online, 27, 353-361. 
VANNUCCINI, S., CLIFTON, V. L., FRASER, I. S., TAYLOR, H. S., CRITCHLEY, H., 
GIUDICE, L. C. & PETRAGLIA, F. 2016. Infertility and reproductive disorders: 
impact of hormonal and inflammatory mechanisms on pregnancy outcome. Human 
Reproduction Update, 22, 104-115. 
VASILEVA, A., TIEDAU, D., FIROOZNIA, A., MÜLLER-REICHERT, T. & 
JESSBERGER, R. 2009. Tdrd6 Is Required for Spermiogenesis, Chromatoid Body 
Architecture, and Regulation of miRNA Expression. Current Biology, 19, 630-639. 
VASUDEVAN, S. & STEITZ, J. A. 2007. AU-rich-element-mediated upregulation of 
translation by FXR1 and Argonaute 2. Cell, 128, 1105-1118. 
VERMEESCH, J. R., VOET, T. & DEVRIENDT, K. 2016. Prenatal and pre-implantation 
genetic diagnosis. Nature Reviews Genetics, 17, 643-656. 
VICHERA, G., MORO, L. N., BUEMO, C. & SALAMONE, D. 2014. DNA fragmentation, 
transgene expression and embryo development after intracytoplasmic injection of 
DNA–liposome complexes in IVF bovine zygotes. Zygote, 22, 195-203. 
VILELLA, F., MORENO-MOYA, J. M., BALAGUER, N., GRASSO, A., HERRERO, M., 
MARTÍNEZ, S., MARCILLA, A. & SIMÓN, C. 2015. Hsa-miR-30d, secreted by the 
human endometrium, is taken up by the pre-implantation embryo and might modify 
its transcriptome. Development, 142, 3210-3221. 
VISWANATHAN, S. R., MERMEL, C. H., LU, J., LU, C. W., GOLUB, T. R. & DALEY, G. 
Q. 2009. microRNA Expression during Trophectoderm Specification. Plos One, 4, 
e6143. 
WALKER, M. P., DIAUGUSTINE, R. P., ZERINGUE, E., BUNGER, M. K., SCHMITT, M., 
ARCHER, T. K. & RICHARDS, R. G. 2010. An IGF1/insulin receptor substrate-1 
pathway stimulates a mitotic kinase (cdk1) in the uterine epithelium during the 
proliferative response to estradiol. Journal of Endocrinology, 207, 225-235. 
WAN, G., MATHUR, R., HU, X., ZHANG, X. & LU, X. 2011. MicroRNA response to DNA 




WANG, L. & QIAN, L. 2014. miR-24 regulates intrinsic apoptosis pathway in mouse 
cardiomyocytes. PLoS One, 9, e85389. 
WANG, S., ZHANG, R., CLARET, F. X. & YANG, H. 2014. Involvement of microRNA-24 
and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing 
radiation. Molecular Cancer Therapeutics, 13, 3163-3174. 
WANG, Y., MEDVID, R., MELTON, C., JAENISCH, R. & BLELLOCH, R. 2007. DGCR8 
is essential for microRNA biogenesis and silencing of embryonic stem cell self-
renewal. Nature Genetics, 39, 380-385. 
WANG, Y., ZHOU, T., WAN, J. Y., YANG, Y., CHEN, X. J., WANG, J. Y., ZHOU, C., LIU, 
M. X., LING, X. F. & ZHANG, J. Q. 2016. Comparative transcriptome analysis 
reveals a regulatory network of microRNA-29b during mouse early embryonic 
development. Oncotarget, 7, 53772-53782. 
WIJNHOVEN, B. P. L., MICHAEL, M. Z. & WATSON, D. I. 2007. MicroRNAs and cancer. 
British Journal of Surgery, 94, 23-30. 
WINTER, J., JUNG, S., KELLER, S., GREGORY, R. I. & DIEDERICHS, S. 2009. Many 
roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell 
Biology, 11, 228-234. 
WU, M., YIN, Y., ZHAO, M., HU, L. & CHEN, Q. 2013. The low expression of leukemia 
inhibitory factor in endometrium: Possible relevant to unexplained infertility with 
multiple implantation failures. Cytokine, 62, 334-339. 
WU, S., AKSOY, M., SHI, J. & HOUBAVIY, H. B. 2014. Evolution of the miR-290-
295/miR-371-373 cluster family seed repertoire. PloS One, 9, e108519-e108519. 
XI, C., YI, B., LIJIA, M., XING, C., YUAN, Y., KEHUI, W., JIGANG, G., YUJING, Z., 
JIANGNING, C., XING, G., QIBIN, L., XIAOYING, L., WENJING, W., YAN, Z., 
JIN, W., XUEYUAN, J., YANG, X., CHEN, X., PINGPING, Z., JUANBIN, Z., 
RUIQIANG, L., HONGJIE, Z., XIAOBIN, S., TING, G., GUANG, N., JUN, W., KE, 
Z., JUNFENG, Z. & CHEN-YU, Z. 2008. Characterization of microRNAs in serum: 
a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research, 
18, 997-1006. 
XIE, R., LIN, X., DU, T., XU, K., SHEN, H., WEI, F., HAO, W., LIN, T., LIN, X., QIN, Y., 
WANG, H., CHEN, L., YANG, S., YANG, J., RONG, X., YAO, K., XIAO, D., JIA, 
J. & SUN, Y. 2016. Targeted Disruption of miR-17-92 Impairs Mouse 
Spermatogenesis by Activating mTOR Signaling Pathway. Medicine, 95, e2713. 
XIONG, L., WENBI, Z., JING, F., YAN, X., RUIHUAN, G., RONGGUI, Q., LU, L., 
YIJUAN, S. & XIAOXI, S. 2019. MicroRNA-451 is downregulated in the follicular 
fluid of women with endometriosis and influences mouse and human embryonic 
potential. Reproductive Biology and Endocrinology, 17, 1-11. 
XU, H., WANG, X., WANG, Z., LI, J., XU, Z., MIAO, M., CHEN, G., LEI, X., WU, J., SHI, 
H., WANG, K., ZHANG, T. & SUN, X. 2020. MicroRNA expression profile analysis 
in sperm reveals hsa-mir-191 as an auspicious omen of in vitro fertilization. BMC 
Genomics, 21, 165. 
XU, L., YANG, B. F. & AI, J. 2013. MicroRNA transport: A new way in cell communication. 
Journal of Cellular Physiology, 228, 1713-1719. 
XU, Y.-W., WANG, B., DING, C.-H., LI, T., GU, F. & ZHOU, C. 2011. Differentially 
expressed micoRNAs in human oocytes. Journal of Assisted Reproduction and 
Genetics, 28, 559-566. 
YANG, Q., LIN, J., LIU, M., LI, R., TIAN, B., ZHANG, X., XU, B., LIU, M., ZHANG, X., 
LI, Y., SHI, H. & WU, L. 2016. Highly sensitive sequencing reveals dynamic 
modifications and activities of small RNAs in mouse oocytes and early embryos. 
Science Advances, 2, e1501482. 
YANG, Q.-E., RACICOT, K. E., KAUCHER, A. V., OATLEY, M. J. & OATLEY, J. M. 
2013a. MicroRNAs 221 and 222 regulate the undifferentiated state in mammalian 
male germ cells. Development, 140, 280-290. 
YANG, S., WANG, S., LUO, A., DING, T., LAI, Z., SHEN, W., MA, X., CAO, C., SHI, L., 




Expression patterns and regulatory functions of microRNAs during the initiation of 
primordial follicle development in the neonatal mouse ovary. Biology of 
Reproduction, 89, 126. 
YAO, G., YIN, M., LIAN, J., TIAN, H., LIU, L., LI, X. & SUN, F. 2010. MicroRNA-224 is 
involved in transforming growth factor-beta-mediated mouse granulosa cell 
proliferation and granulosa cell function by targeting Smad4. Molecular 
Endocrinology, 24, 540-551. 
YOUNG, S. L. 2013. Oestrogen and progesterone action on endometrium: a translational 
approach to understanding endometrial receptivity. Reproductive BioMedicine 
Online, 27, 497-505. 
YU, B., VAN TOL, H. T. A., STOUT, T. A. E. & ROELEN, B. A. J. 2020. Initiation of X 
Chromosome Inactivation during Bovine Embryo Development. Cells, 9, 1016. 
YU, M., MU, H., NIU, Z., CHU, Z., ZHU, H. & HUA, J. 2014. miR‐34c Enhances Mouse 
Spermatogonial Stem Cells Differentiation by Targeting Nanos2. Journal of Cellular 
Biochemistry, 115, 232-242. 
YUAN, L., LI, S., ZHOU, Q., WANG, D., ZOU, D., SHU, J. & HUANG, Y. 2017. MiR-124 
inhibits invasion and induces apoptosis of ovarian cancer cells by targeting 
programmed cell death 6. Oncology Letters, 14, 7311-7317. 
YUAN, S., SCHUSTER, A., TANG, C., YU, T., ORTOGERO, N., BAO, J., ZHENG, H. & 
YAN, W. 2016. Sperm-borne miRNAs and endo-siRNAs are important for 
fertilization and preimplantation embryonic development. Development, 143, 635-
647. 
ZENG, B., LI, Z., CHEN, R., GUO, N., ZHOU, J., ZHOU, Q., LIN, Q., CHENG, D., LIAO, 
Q., ZHENG, L. & GONG, Y. 2012. Epigenetic regulation of miR‐124 by Hepatitis C 
Virus core protein promotes migration and invasion of intrahepatic 
cholangiocarcinoma cells by targeting SMYD3. FEBS Letters, 586, 3271-3278. 
ZERNICKA-GOETZ, M., MORRIS, S. A. & BRUCE, A. W. 2009. Making a firm decision: 
multifaceted regulation of cell fate in the early mouse embryo. Nature Reviews, 
Genetics, 10, 467-477. 
ZHANG, H., JIANG, X., ZHANG, Y., XU, B., HUA, J., MA, T., ZHENG, W., SUN, R., 
SHEN, W., COOKE, H. J., HAO, Q., QIAO, J. & SHI, Q. 2014. microRNA 376a 
regulates follicle assembly by targeting Pcna in fetal and neonatal mouse ovaries. 
Reproduction, 148, 43-54. 
ZHANG, J., WANG, Y., LIU, X., JIANG, S., ZHAO, C., SHEN, R., GUO, X., LING, X. & 
LIU, C. 2015. Expression and Potential Role of microRNA-29b in Mouse Early 
Embryo Development. Cellular Physiology and Biochemistry, 35, 1178-1187. 
ZHANG, Q., SUN, H., JIANG, Y., DING, L., WU, S., FANG, T., YAN, G., HU, Y. & 
FRANKS, S. 2013a. MicroRNA-181a Suppresses Mouse Granulosa Cell 
Proliferation by Targeting Activin Receptor IIA. PLoS One, 8, e59667. 
ZHANG, S., LIN, H., KONG, S., WANG, S., WANG, H., WANG, H. & ARMANT, D. R. 
2013b. Physiological and molecular determinants of embryo implantation. Molecular 
Aspects of Medicine, 34, 939-980. 
ZHAO, G., LIU, L., ZHAO, T., JIN, S., JIANG, S., CAO, S., HAN, J., XIN, Y., DONG, Q., 
LIU, X. & CUI, J. 2015. Upregulation of miR-24 promotes cell proliferation by 
targeting NAIF1 in non-small cell lung cancer. Tumor Markers, Tumor Targeting and 
Translational Cancer Research, 36, 3693-3701. 
ZHENG, G. X. Y., RAVI, A., CALABRESE, J. M., MEDEIROS, L. A., KIRAK, O., 
DENNIS, L. M., JAENISCH, R., BURGE, C. B. & SHARP, P. A. 2011. A Latent 
Pro-Survival Function for the Mir-290-295 Cluster in Mouse Embryonic Stem Cells 
(A Novel Anti-Apoptotic Role for Mir-290-295). PLoS Genetics, 7, e1002054. 
ZHU, L. & POLLARD, W. J. 2007. Estradiol-17β regulates mouse uterine epithelial cell 
proliferation through insulin-like growth factor 1 signaling. Proceedings of the 
National Academy of Sciences, 104, 15847-15851. 
ZHU, R., WANG, S.-C., SUN, C., TAO, Y., PIAO, H.-L., WANG, X.-Q., DU, M.-R., DA-




Promotes Growth of Decidual Stromal Cells in Human First-Trimester Pregnancy. 
PLoS One, 8, e74812. 
ZOU, H., YU, D., DU, X., WANG, J., CHEN, L., WANG, Y., XU, H., ZHAO, Y., ZHAO, 
S., PANG, Y., LIU, Y., HAO, H., ZHAO, X., DU, W., DAI, Y., LI, N., WU, S. & 
ZHU, H. 2019. No imprinted XIST expression in pigs: biallelic XIST expression in 
early embryos and random X inactivation in placentas. Cellular and molecular life 
sciences : CMLS, 76, 4525-4538. 
 
Online sources 
HFEA (2020) Fertility treatment 2018: trends and figures. Available at: 
www.hfea.gov.uk/about-us/publications/research-and-data/fertility-treatment-2018-
trends-and-figures/ (accessed 1 March 2021) 
miRBase (2021). Available at: www.mirbase.org (accessed 1 March 2021) 
UniProt (2021). Available at: www.uniprot.org (accessed 1 June 2021) 
targetscan (2021) Available at: www.targetscan.org (2021) (accessed 1 March 2021) 
WHO (2021) Infertility. Available at: www.who.int/news-room/fact-sheets/detail/infertility 





A. Studies on miRNAs as non-invasive biomarkers of embryo quality and predictors of clinical outcomes. 
Reference Type of 
study 
Aim Species Methodology Sample size Findings Implications Limitations 
Kropp et 
al. (2014) 
Experimental a) To study 
whether miRNAs 
are released by 
bovine and human 
blastocysts  
b) To study 
whether released 
miRNAs play a 





i) IVP bovine embryos cultured 
in groups to the morula stage, 
compacted and degenerate 
embryos were further cultured 
in individual drops in SOF with 
BSA (Exp.A) or without 
(Exp.B). Blastocysts (B) and 
degenerate (D) embryos and 
their SCM were collected and 
analysed with qPCR for miR-
25, -302c, -196A1, -181A1, -
370 
ii) human blastocyst SCM from 
individual drops were collected 
Exp.A: pools of n=83 
B and n=88 SCM, 
n=54 D embryos and 
n=69 SCM 
Exp.B: pools of n=39 
B and n=39 SCM, 
n=40 D embryos and 
n=40 SCM 
Exp.C: pool of n=5 
SCM from human 
blastocysts  
i) D bovine embryos 
express higher levels of 
all miRNAs (p<0.05) 
except miR-370 
ii) miR-25 is released 
by bovine and human 
embryos 
Quantification of 
miRNAs secreted in 




i) contamination of SCM 
from serum additives and 
proteins 
ii) analysis of pooled 
samples might not be 
reflective of the status of 
each individual embryo 
iii) 5 miRNAs tested 
iv) possible false discovery 













b) To study 
whether miRNAs 
in SCM reflect on 
embryo ploidy 
and can predict 
IVF outcomes 
human i) PN embryos cultured to 
blastocyst stage, SCM 
collected, TE biopsies analysed 
with aCGH, SCM analysed with 
TaqMan Low Density Arrays 
ii) PN embryos cultured to 
blastocyst stage, SCM 
collected, TE biopsies analysed 
with aCGH, SCM analysed with 
single assay qPCR for 
confirmation of identified 
miRNA (from Exp.1) and 
association with euploidy 
iii) SCM collected from day 4 
and 5 eSET cycles, PCR 
quantification of identified 
miRNAs (Exp.1 and 2) and 
analysed based on pregnancy 
i) n=18 TE biopsies, 
n=15 pooled SCM 
ii) n=17 TE biopsies, 
n=13 SCM  pooled 
together with n=15 
SCM from Exp.1 for 
confirmation 
iii) n=55 SCM 
i) miR-372 and miR-
191 released by human 
embryos, miR-645 
present in control media 
but not in SCM 
ii) miR-191 highly 
released by aneuploid 
embryos (p<0.05, FC 
4.7) 
iii) miR-191 and miR-
372 in higher levels in 
SCM of day 5 ICSI vs 
IVF embryos (p<0.05, 
FC 4.4 and 7.1 
respectively) but similar 
in day 4 SCM 
iv) miR-372 highly 
concentrated in day 5 





i) miRNAs not associated 
with specific type of 
chromosomal aneuploidy  
ii) SCM contamination 
from added serum protein 
substitute 
iii) possible miRNA 
leakage from ICSI opening 
iv) possible false discovery 





outcome, day of culture, and 
insemination method 
SCM compared to day 4 
(p<0.05, FC 5.4), miR-
191 and miR-372 higher 
in day 5 SCM of ICSI 
embryos compared to 
day 4 (p<0.05, FC 1.9 
and 12 respectively) 
v) miR-191, miR-645, 
miR-372 higher 
(p<0.05, FC 5.1, 6, 7.1 
respectively) in day 5 
SCM of IVF-
inseminated embryos 
that failed to lead to a 
live birth (n=9 failed, 







Experimental To characterise 
and identify 
miRNA in SCM 




bovine i)  IVP bovine embryos cultured 
in groups to the morula stage, 
compacted and degenerate 
embryos were further cultured 
in individual drops in SOF 
without BSA, SCM from 
blastocysts (B) and degenerate 
(D) embryos were collected, 
pooled, and analysed with small 
RNA-Sequencing  
ii) miR-24 mimic was 
supplemented at the morula 
stage, embryos were collected 
and analysed for miR-24 and 
CDKN1b expression with qPCR 
N=126 SCM from B 
and n=240 SCM from 
D 
i) D embryos release 
higher levels (p<0.05) 
of 11 miRNAs (miR-
2887, -24-3p, -22, -423-
5p, -146a, -191, -2904, -
286, -148a, -192, and 
uncharacterised PC-3p-
21760); miR-24, -191, -
148a were validated 
with qPCR 
ii) addition of the miR-
24 mimic causes 27.3% 
decline in blastocyst 
formation (p<0.0001), 
the grown blastocysts 
have higher miR-24 
levels (44.29 FC), and 
CDKN1b levels are 
repressed by 33% 
i) sequencing is 
beneficial for the 
annotation of 
multiple miRNAs in 
relation to embryo 
development  




iii) miRNA mimics 
are useful to study 
roles in embryo 
development 
iv) miRNAs in the 
extra-cellular 
environment are up-
taken by embryos 
i) miRNA contamination 
even in media without 
serum supplementation 
ii) possible miRNA leakage 
from degenerate/lysed 
embryos 
iii) mimic addition cannot 





(p<0.01) in these 
embryos 












relation to their 
implantation 
potential 
human i) human ICSI embryos were 
cultured to the blastocyst stage, 
SCM were collected and pooled 
in groups from implanted and 
non-implanted embryos and 
analysed with qPCR miRNA 
array 
ii) fluorescein-tagged miR-661 
mimic was transfected to 
trophoblast cells, the 
conditioned media (CM) was 
collected, exosomes in CM 
pooled n=8 SCM 
samples from 




samples were also 
analysed to verify 
results 
i) 47 miRNAs are 
exclusively detected in 
SCM, 22 solely in 
control media, 19 
miRNAs secreted by the 
implanted group, 22 
miRNAs from the non-
implanted group 
ii) miR-661 is the 
highest differentially 
expressed miRNA in 
the non-implanted SCM 
i) miRNAs in SCM 











i) possible miRNA leakage 
from ICSI opening 
ii) contamination in control 
media 
iii) information only about 
one miRNA while the other 
miRNAs were not 
investigated further, in vivo 
conditions might differ as 





were isolated with 
ultracentrifugation and 
transferred in cultures of human 
endometrial epithelial cells 
(hEECs) 
iii) in silico analysis was carried 
out to identify mRNA targets 
iv) hEECs were analysed for 
mRNA expression changes 
v) spheroid adhesion assay was 
performed using hEECs and 
miR-661 mimic and inhibitor 
(verified by single assay 
qPCR) and verified by 
analysis of the 10 
individual SCM 
samples (5 implanted, 
5-non-implanted) 
iii) increased up-take of 
miR-661 from hEECs 
iv) MTA2 and PVRL1 
are downregulated in 
hEECs by miR-661 
v) miR-661 blocks 
adhesion in hEECs via 
PVRL1 regulation 








which can change 
their competence to 
establish 
implantation 
iv) miRNAs in the 
embryo-maternal 
interface can affect 
the initial adhesion 
of the blastocyst to 
the uterus 
iv) implantation outcome 
might be affected by patient 
characteristics 








To assess whether 
miRNAs in SCM 
can be used as 
embryonic 
biomarkers 
human i) spare embryos were cultured 
to the blastocyst stage, TE was 
biopsied, SCM were collected, 
the TE and SCM samples 
analysed with TaqMan Low 
Density miRNA Array,  
miRNA profiles were compared 
between TE and SCM and 
results cross-validated with 
single assays 
ii) SCM from cleavage, morula, 
and expanded blastocysts were 
collected from SET IVF cycles, 
TE biopsies and 24-
chromosome screening was 
performed 
iii) SCM were collected from 
euploid implanted blastocysts 
i) n=5 TE and n=5 
SCM samples 
ii) n=3 SCM from the 
same embryos in each 
stage 
iii) SCM from n=25 
implanted and n=28 
non-implanted 
i) 96.6% concordance 
rate in miRNA profiles 
between SCM and TE, 






ii) cleavage and morula 
stages similar to blank 
controls, SCM from 
blastocysts consistently 
expressing 34 miRNAs 
iii) miR-20a and miR-
30c higher in SCM 
from implanted 
blastocysts (p<0.05), 
i) origin  of 
miRNAs in SCM is 
mainly the TE 
ii) miRNAs can be 
consistently 




miRNAs in SCM 





20a and miR-30c 
 
i) small sample size 
ii) blank samples showed 
consistent amplification for 
few miRNAs 
iii) pooled samples, 
although authors tested for 
biological variation between 
distinct SCM samples 
iv) patient characteristics 
are possible confounders of 
implantation 
v) potentially false positive 
signals (Ct threshold = 35) 





and non-implanted embryos and 
miRNA profiles were compared 
iv) in silico target prediction 
was carried out 
gene targets involved in 
cell adhesion, 
communication, 








To find whether 
miRNAs in SCM 
can be used as 
biomarkers of 
implantation 
human ICSI-fertilised embryos 
cultured to day 5 and 
transferred, SCM collected on 
day 3 and analysed only for 
blastocysts that were 
transferred, samples were split 
in pools according to 
implantation outcome and 7 
miRNAs analysed with single 
TaqMan assays (qPCR) 
n=18 SCM from 
positive implantation 
group and n=18 from 
negative implantation 
group 












i) small case basis 
ii) pooled samples 
iii) 7 miRNAs studied  
iv) possible miRNA leakage 
from ICSI opening 
v) SCM samples collected 
on day 3 when miRNA 
release is minimum 
Lin et al. 
(2019) 
Experimental To investigate if 
miRNAs in SCM 
have potential as 
bovine i) IVP bovine embryos cultured 
individually to blastocyst stage, 
embryos divided in 3 groups 
i) n=167 
embryos/replicate, 3 
i) FB and FD group 
excluded due to low 
concentration 
i) miRNAs in SCM 
can be used as 
biomarkers of 










according to the first cleavage 
pattern in “fast” (F), 
“intermediate” (I), and “slow” 
(S) groups then further divided 
in 2 sub-groups in degenerate 
embryos (D) and blastocysts 
(B) making 6 groups in total: 
FB, IB, SB, FD, ID, SD, SCM 
collected and pooled according 
to group, miRNAs analysed 
with small RNA-Sequencing 
ii) miR-30c mimic 
supplemented to embryo 
culture, embryos cultured to 
blastocyst stage, collected for 
qPCR, WB, or stained for 
apoptosis with TUNEL 
replicates from each 
group were analysed 
 
ii) I embryos produce 
significantly more 
blastocysts than S 
embryos 
i) 294 miRNAs present 
in SCM, miR-30c and 
miR-10b higher in S 
compared to I 
(p<0.001), miR-10b, 
miR-45 higher in D 
than in B SCM 
(p<0.001), miR-113 
and miR-139 higher in 
B than in D SCM 










30c is a potential 
marker of impaired 
development and 
extended apoptosis 
ii) low miRNA 
concentration in SCM for 
sequencing 
iii) pooled samples 
iv) mimic supplementation 
does not explain the 











affected by the 
differentially expressed 
miRNAs between IB 
and SB  
iii) miR-30c is up-taken 
by embryos and 
increases apoptosis at 
the blastocyst stage by 
8%, blastocyst 
formation rate is similar 
iv) miR-30c 
downregulates CDK12 




SCM: spent culture media, PN: pronuclear, aCGH: array comparative genome hybridisation, TE: trophectoderm, (e)SET: (elective) single embryo transfer, FC: fold change, 





pathways as confirmed 




B. TaqMan probes used for miRNA amplification. The assay name, miRNA accession 
number and the mature miRNA sequence are given for each target miRNA. 
*Although not a miRNA, U6 small nuclear RNA has often been used as a reference RNA in published 








TaqMan miRNA probes 
Target Assay name MiRBase accession 
number 
Mature miRNA sequence (5’-3’) 
miR-291a mmu-mir-291a-3p MIMAT0000368 AAAGUGCUUCCACUUUGUGUGC 
miR-294 mmu-mir-294-3p MIMAT0000372 AAAGUGCUUCCCUUUUGUGUGU 
miR-24 hsa-miR-24-3p MIMAT0000080 UGGCUCAGUUCAGCAGGAACAG 
miR-124 mmu-mir-124-3p MIMAT0000134 UAAGGCACGCGGUGAAUGCC 
let-7b hsa-let-7b-5p MIMAT0000063 UGAGGUAGUAGGUUGUGUGGUU 
let-7b hsa-let-7b-3p MIMAT0004482 CUAUACAACCUACUGCCUUCCC 
miR-320a hsa-miR-320a-3p MIMA0000510 AAAAGCUGGGUUGAGAGGGCGA 
miR-193 mmu-miR-193b-5p MIMAT0017271 CGGGGUUUUGAGGGCGAGAUGA 
miR-34c mmu-miR-34c-5p MIMAT0000381 AGGCAGUGUAGUUAGCUGAUUGC 
miR-122 mmu-miR-122-5p MIMAT0000246 UGGAGUGUGACAAUGGUGUUUG 
miR-26a mmu-miR-26a-5p MIMAT0000533 UUCAAGUAAUCCAGGAUAGGCU 
miR-10a mmu-miR-10a-5p MIMAT0000648 UACCCUGUAGAUCCGAAUUUGUG 
miR-103a hsa-miR-103a-3p MIMAT0000101 AGCAGCAUUGUACAGGGCUAUGA 
miR-17 mmu-miR-17-5p MIMAT0000649 CAAAGUGCUUACAGUGCAGGUAG 




C. Presence of miRNAs in KSOM culture medium without embryo culture and spent 





miRNA KSOM SCM 
miR-291a-3p - + 
miR-294-3p - + 
miR-24-3p - + 
miR-124-3p - + 
let-7b-5p + N/A 
let-7b-3p + N/A 
miR-320a-3p + N/A 
miR-193b-5p - - 
miR-34c-5p - - 
miR-122-5p - - 
miR-26a-5p - - 
miR-10a-5p - - 
miR-103a-3p + N/A 
miR-17-5p - - 
U6 snRNA - - 
